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Preface
Reports of tuberculosis (TB) cases are submit-
ted to the Division of TB Elimination (DTBE), 
Centers for Disease Control and Prevention 
(CDC), by 60 reporting areas (the 50 states, the 
District of Columbia, New York City, Puerto 
Rico, and seven other jurisdictions in the 
Pacifi c and Caribbean).  In January 1993, an 
expanded system was developed to collect ad-
ditional information for each reported TB case 
in order to better monitor trends in TB and TB 
control.  A software package (SURVS-TB) for 
data entry, analysis, and transmission of case 
reports to CDC was designed and implemented 
as part of the expanded TB surveillance system. 
In 1998, the Tuberculosis Information Manage-
ment System (TIMS) replaced SURVS-TB. 
This publication, Reported Tuberculosis in 
the United States, 2006, presents summary 
data for TB cases reported to DTBE, verifi ed, 
and counted in 2006.  It is similar to previous 
publications (see page xi, #19) and contains six 
major sections.  The fi rst section presents trends 
in the overall TB case counts and case rates by 
selected demographic and clinical characteris-
tics.  The second section presents overall case 
counts and case rates for the United States by 
selected demographic characteristics for 2006.
In the third section, TB case counts and case 
rates are presented by state and other jurisdic-
tions with tables of selected demographic and 
clinical characteristics.  In the fourth section, 
data collected as part of the expanded system 
(e.g., initial drug resistance, HIV status) are 
presented by reporting area.  Select tables 
report data from the Pacifi c and Caribbean 
jurisdictions. The fi fth section provides TB case 
counts and case rates by metropolitan statistical 
areas (MSAs: see Technical Notes, page 9, for 
further details) with tables of selected demo-
graphic and clinical characteristics.  Finally, the 
sixth section presents fi gures from the annual 
surveillance slide set, which emphasize key 
recent trends in TB epidemiology in the United 
States.  The slides with accompanying text 
can also be viewed and downloaded from the 
Division home page, which is accessible via the 
Internet at http://www.cdc.gov/tb/.
To help interpret the data, an Executive Com-
mentary (page 3) and Technical Notes (page 9) 
have been included.  In addition, the current case 
defi nition (MMWR 1997;46 [No. RR 10]:40-41) 
and “Recommendations for Counting Reported 
Tuberculosis Cases” are provided in Appendices 
A and B, respectively (page 119).  The recommen-
dations for counting TB cases, which update the 
original January 1977 recommendations, were fi rst 
published in Reported Tuberculosis in the United 
States, 1996.
After the publication of updated Guidelines for 
Targeted Tuberculin Testing and Treatment of La-
tent Tuberculosis Infection in April 2000,
1
 DTBE 
began receiving reports of serious adverse events 
(i.e., hospitalization or death) related to the use of 
a 2-month course of rifampin and pyrazinamide 
(RZ) for treatment of latent tuberculosis infection 
(TLTBI).  Subsequently, DTBE requested and 
received reports and conducted on-site investiga-
tions of liver injury in persons on TLTBI, and 
treatment guidelines were revised accordingly.
2
Severe adverse events among persons receiving 
TLTBI continue to be a public health concern, 
and data on the annual number and trends of such 
events are needed.  To this end, DTBE organized a 
working group on TLTBI adverse events in Sep-
tember 2003.  This working group was charged 
with the development of a national surveillance 
system with the following objectives:
• To assist public health offi cials, policy 
makers, and healthcare providers in the 
prevention of adverse events, and
• To serve as the basis for periodic evalua-
tion of guidelines for TLTBI and revision 
of these guidelines as needed.
Development of the National System for Severe 
Adverse Events Associated with Treatment of 
LTBI has been implemented, and will include 
xformal collaborations among CDC, FDA, and 
other participating agencies to ensure inter-
agency notifi cation of serious adverse events. 
Mechanisms for quality assurance and timely 
dissemination of data are also under develop-
ment.
At present, DTBE urges health departments, 
hospices, hospitals, jails, prisons, and private 
medical offi ces to report all severe adverse 
events (e.g., liver injury, metabolic acidosis, 
anaphylaxis, seizure, severe dermatitis) leading 
to hospitalization or death of a person receiving 
TLTBI that occurred after January 1, 2004, to 
DTBE by telephone (404-639-8401) or e-mail 
(LManangan@cdc.gov).
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State TB Statistics on the Internet*
AL http://www.adph.org/tb/
AK http://www.epi.hss.state.ak.us/id/tb.stm
AR None
AZ http://www.hs.state.az.us/phs/oids/stats/index.htm#TBStats
CA http://www.dhs.ca.gov/ps/dcdc/TBCB/publications.html 
CO http://www.cdphe.state.co.us/dc/tb/tbhome.html  
CT http://www.dph.state.ct.us/BCH/infectiousdise/tubercul.htm 
DC None
DE http://www.dhss.delaware.gov/dph/dpc/tuberculosis.html 
FL http://www.doh.state.fl .us/disease_ctrl/tb/ 
GA http://health.state.ga.us/epi/tuber.asp
HI http://www.hawaii.gov/health/tb
IA http://www.idph.state.ia.us/adper/tb_control.asp 
ID None
IL http://www.idph.state.il.us/health/infect/reportdis/tb.htm
IN http://www.in.gov/isdh/programs/tb 
KS http://www.kdhe.state.ks.us/tb/statistical_information.html 
KY http://chfs.ky.gov/dph/tb.htm 
LA http://www.oph.dhh.state.la.us/tuberculosis/index.html 
MA http://www.mass.gov/dph/cdc/tb/index.htm 
MD http://www.edcp.org/tb/index.html 
ME http://www.maine.gov/dhs/boh/ddc/tuberculosis.htm 
MI http://www.michigantb.org  
MN http://www.health.state.mn.us/tb 
MO http://dhss.mo.gov/Tuberculosis/
MT http://www.dphhs.state.mt.us/hpsd/Communicable-disease/commun-disease-index.htm 
MS None
ND http://www.health.state.nd.us/disease/tb/ 
NC http://www.epi.state.nc.us/epi/tb 
NE http://www.hhs.state.ne.us/cod/Tuberculosis/tbindex.htm 
NH http://www.dhhs.state.nh.us/DHHS/BCDCS/LIBRARY/Data-Statistical+Report/tb-counties.htm 
NJ None
NM None
NYC http://www.nyc.gov/html/doh/html/tb/tb.shtml
NV http://health2k.state.nv.us/tuberculosis/Trends.htm
NY None
OH http://www2.odh.ohio.gov/Data/Inf_Dis/TB/tb1.htm 
OK http://www.health.ok.gov/program/tb/index.html 
OR http://egov.oregon.gov/dhs/ph/tb/index.shtml  
PA http://www.health.state.pa.us/PHP/TB/tb.htm 
RI http://www.health.ri.gov/disease/communicable/tb/index.php 
PR http://www.salud.gov.pr/PDFs/Impresos/estFinalesTB-2003.pdf 
SC http://www.dhec.sc.gov/health/disease/tb 
SD http://www.state.sd.us/doh/TB/statistics.htm 
TN http://www2.state.tn.us/health/CEDS/tb/index.htm  
TX http://www.tdh.state.tx.us/tb 
UT http://health.utah.gov/els/hivaids/tb/tbrefugee.html
VA http://www.vdh.virginia.gov/std/tbindex.asp 
VT None
WA http://www.doh.wa.gov/cfh/tb 
WI http://www.dhfs.wisconsin.gov/tb
WV http://www.wvdhhr.org/idep/dsdc.asp
WY http://wdh.state.wy.us/tb/index.asp 
*As reported to CDC by U.S. reporting area TB programs as of July 2007. Includes responses from the reporting areas of New York City 
(NYC) and Puerto Rico (PR).
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3Executive Commentary
Highlights of 2006 Report
Since 1953, in cooperation with state and local health departments, the Centers for Disease Control 
and Prevention (CDC) have collected information on each newly reported case of tuberculosis (TB) 
disease in the United States.  Currently, each individual TB case report (Report of Verifi ed Case of 
Tuberculosis, or RVCT) is submitted electronically to CDC’s Division of Tuberculosis Elimination.  
The following are highlights of the 2006 report:
1. Updated case counts for each year from 1993 through 2005.
2. Case counts: 13,779 TB cases were reported to CDC from the 50 states and the District of Co-
lumbia (DC) for 2006, representing a 2.1% decrease from 2005.
• Twenty states reported increased case counts from 2005 (Table 28).
• California, New York, Texas, and Florida accounted for 48% of the national case total (Table 
28).
• For the third consecutive year, Hispanics (30%) exceeded non-Hispanic blacks or African-
Americans (27%) as the racial and ethnic group with the largest percentage of total cases 
(Table 2).
• Blacks or African-Americans born in the United States represented 44% of TB cases in U.S.-
born persons and accounted for approximately 19% of the overall national case total (Tables 
17, 18).
3. Case rates: The TB case rate declined from 4.7 to 4.6 per 100,000 population, representing a 
3.1% decrease from 2005.
• Twelve states and DC reported rates above the national average (Table 20).
• Twenty-six states met the defi nition for low incidence, which is 3.5 cases per 100,000 popu-
lation (Table 20).
• The TB case rate was 2.3 per 100,000 for U.S.-born persons and 22.0 for foreign-born per-
sons (Table 5). 
• Asians and Native Hawaiians or Other Pacifi c Islanders continue to have the highest case 
rates (25.6 per 100,000 population) among all racial and ethnic groups (Table 2).
4. Burden in the foreign-born: The percentage of cases occurring in foreign-born persons continued 
to increase and was 57%.
• Hispanics and Asians together represented almost 80% of TB cases in foreign-born persons 
and accounted for 45% of the national case total (Tables 17, 18).
• In 27 states, the percentage of TB cases among foreign-born persons was  50% (Table 23).
• In 11 states, the percentage of cases among foreign-born persons was 70% (Table 23).
• The top fi ve countries of origin of foreign-born persons with TB were Mexico, Philippines, 
Vietnam, India, and China (Table 6).
5. Drug resistance: Less than 1% of reported cases had primary multidrug resistance, which is de-
fi ned as no previous history of TB disease and resistance to at least isoniazid and rifampin (Table 
10).
4Tuberculosis in the United States
In 2006, the number of TB cases reported 
(13,779) and case rate (4.6 cases per 100,000) 
both decreased; this represented declines of 
2.1% and 3.1%, respectively, compared to 2005. 
Since the 1992 TB resurgence peak in the United 
States, the number of TB cases reported annu-
ally decreased by 48%. However, the decreasing 
trend in the annual case rate has slowed, from an 
annual average decline of 6.6% for 1993 through 
2002 to an annual average decline of 3.1% for 
2003 through 2006 (Table 1).
The proportion of total cases occurring in for-
eign-born persons has been increasing since 
1993. In 2006, 57% of TB cases occurred in 
foreign-born persons. Foreign-born persons 
accounted for the majority of TB cases in the 
United States for the sixth consecutive year.  
Moreover, the case rate among foreign-born 
persons was more than nine times higher than 
among U.S.-born persons (Table 5).
Tuberculosis deaths decreased by 1.7%, from 
657 deaths in 2004 to 646 deaths in 2005, the 
latest year for which complete data are available 
(Table 1).
Age
Since 1993, TB case rates have declined annu-
ally for all age groups. TB case rates vary by 
well-known factors such as age, race and ethnic-
ity, and country of origin. In 2006, TB case rates 
declined for all age groups except adults aged 25 
to 44 years, which remained constant, compared 
to 2005. The highest burden of disease continues 
to be among older adults. In 2006, adults aged 
65 years and older had the highest TB case rate 
at 7.2 cases per 100,000, and children aged 0 to 
14 years had the lowest at 1.3 cases per 100,000 
(Table 4).  
Race and Ethnicity
In 2003, the race and ethnicity category, “non-
Hispanic, Asian or Pacifi c Islander,” was split 
into two categories: “non-Hispanic Asian” and 
“non-Hispanic Native Hawaiian or Other Pacifi c 
Islander.” In 2006, non-Hispanic Asians had the 
highest TB case rate at 25.6 cases per 100,000, 
which was a slight decline from 25.7 in 2005. In 
2006, non-Hispanic Native Hawaiians or Other 
Pacifi c Islanders had the second-highest TB case 
rate at 13.6 cases per 100,000, an increase com-
pared to 12.8 cases per 100,000 reported in 2005. 
Both Native Hawaiian or Other Pacifi c Islanders 
and American Indian or Alaska Natives race and 
ethnicity categories had increases in TB case 
rates compared to 2005 (Table 2).
Since 1993, TB case rates declined over 50% in 
each of the other racial and ethnic groups: among 
Hispanic or Latinos from 19.9 to 9.2 cases per 
100,000; among black or African-Americans 
from 28.5 to 10.2 cases per 100,000; and among 
non-Hispanic whites from 3.6 to 1.2 cases per 
100,000 (Table 2).
Origin of Birth
Since 1993, the TB case rate among U.S.-born 
persons has declined annually. In 2006, the TB 
case rate for U.S.-born persons was 2.3 cases 
per 100,000, representing a 69% decrease from 
7.4 cases per 100,000 in 1993. The TB case rate 
among foreign-born persons also declined dur-
ing the same interval, but was less substantial. 
In 2006, the TB case rate among foreign-born 
persons was 22.0 cases per 100,000, representing 
a 35% decrease from 34.0 cases per 100,000 in 
1993 (Table 5). 
The proportion of TB cases among persons born 
in the United States has declined annually since 
1993.  In 2006, 43% of TB cases were among 
U.S-born persons compared to 69% in 1993 (Ta-
ble 5). In 27 states, the proportion of TB cases 
among foreign-born persons was  50%. In 11 
states (California, Hawaii, Iowa, Massachusetts, 
Minnesota, Nebraska, New Hampshire, New Jer-
sey, New York, Rhode Island, and Washington), 
the proportion of TB cases among foreign-born 
persons was  70% (Table 23).
5Country of Origin and World Region
From 2001 through 2006, the top fi ve countries 
of origin of foreign-born persons with TB were 
Mexico, Philippines, Vietnam, India, and China 
(Table 6). However, the changes in the distribu-
tion of TB cases by world region of origin refl ect 
the changing immigration patterns among per-
sons settling in the United States1. Of the 7,799 
TB cases reported among foreign-born persons 
in 2006, 45% occurred among persons born in 
the Americas region, and 30% occurred among 
persons born in the Western Pacifi c region (Table 
19). From 1993 to 2006, the proportion of cases 
increased among persons born in the Eastern 
Mediterranean region (3% in 1993 to 5% in 
2006), the Southeast Asia region (6% in 1993 
to 10% in 2006), and the African region (2% in 
1993 and 8% in 2006) (Table 19).
Multidrug-Resistant Tuberculosis
Since 1993, when the RVCT was expanded to 
include drug-susceptibility results, the propor-
tion of patients with primary multidrug-resistant 
TB (MDR TB), which is defi ned as no previous 
history of TB disease and resistance to at least 
isoniazid and rifampin, has decreased from 2.4% 
to 0.9% in 2006. Since 1998, the percentage of 
U.S.-born patients with MDR TB has remained 
0.7%. However, of the total number of reported 
primary MDR TB cases, the proportion occur-
ring in foreign-born persons increased from 
25.5% (103 of 407) in 1993 to 80% (73 of 91) in 
2006 (Table 10). 
Extensively Drug-Resistant Tuberculosis
For the fi rst time in 2006, CDC included a case 
count of extensively drug-resistant TB (XDR 
TB) cases from 1993 to 2006 in the slide set that 
accompanies this report.  Extensively drug-resis-
tant TB is defi ned as resistance to isoniazid and 
rifampin, plus resistance to any fl uoroquinolone 
and at least one of three injectable second-line 
anti-TB drugs (i.e., amikacin, kanamycin, or 
capreomycin)2,3. Three cases of XDR TB were 
reported during 2006.
Tuberculosis Therapy
The proportion of TB patients prescribed an ini-
tial treatment regimen of three or more anti-TB 
drugs increased annually from 72.1% in 1993 to 
87.8% in 2006. The proportion of patients who 
completed therapy within 1 year increased from 
64.1% in 1993 to 82.3% in 2004, and the pro-
portion of persons receiving directly observed 
therapy for at least a portion of treatment also 
increased from 35.4% in 1993 to 83.9% in 2004, 
the latest year for which complete outcome data 
are available (Table 12).
Summary
Essential elements for controlling TB in the 
United States include suffi cient resources, in-
terventions targeted to populations at high risk 
for TB, and collaborative efforts with the inter-
national community to reduce the burden of TB 
globally.
During 1993 through 2006, TB case rates in the 
United States decreased for U.S.-born and for-
eign-born persons; however, the decrease among 
foreign-born persons continues to be less sub-
stantial. Despite the decreasing case rate among 
foreign-born persons, more than half of the TB 
cases in the United States in 2006 occurred in 
this population, and the case rate was more than 
nine times higher than among U.S.-born per-
sons.  To address these high TB case rates among 
foreign-born persons, CDC is collaborating with 
other national and international public health 
organizations to 1) improve overseas screening 
of immigrants and refugees by systematically 
monitoring and evaluating the screening process; 
2) strengthen the current notifi cation system that 
alerts local health departments about the arrival 
of immigrants or refugees who have suspected 
TB to enhance the evaluation and treatment of 
such persons; 3) improve coordination of TB 
control activities between the United States and 
Mexico to ensure completion of treatment among 
TB patients who cross the border; 4) test recent 
arrivals from high-incidence countries for latent 
TB infection and monitor treatment comple-
tion; and 5) survey foreign-born TB patients in 
6the United States to determine opportunities for 
improving prevention and control interventions. 
In addition, CDC continues to strengthen col-
laborations with international partners, including 
the World Health Organization’s Stop TB Part-
nership, to improve TB control in high-incidence 
countries.
Accelerating progress in national TB elimina-
tion activities will require broader prevention 
efforts among high-risk population groups such 
as African- and Asian-American communi-
ties, persons who are incarcerated, persons with 
excess alcohol and drug use, persons with human 
immunodefi ciency virus infection, and persons 
living in poverty with limited access to medical 
care and stable housing.
In addition, low-incidence areas in the United 
States require continued support to maintain 
the capacity and expertise needed to respond to 
future TB cases4. CDC has updated the compre-
hensive national action plan to refl ect the align-
ment of CDC priorities with the 2000 Institute of 
Medicine report on TB and to ensure that priority 
prevention activities are undertaken with optimal 
collaboration and coordination among national 
and international public health partners5,6.
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Technical Notes
National Surveillance for Tuberculosis
All reporting areas (i.e., the 50 states, the District 
of Columbia, New York City, Puerto Rico, and 
other U.S. jurisdictions in the Pacifi c and Carib-
bean) report tuberculosis (TB) cases to CDC us-
ing a standard case report form, Report of Veri-
fi ed Case of Tuberculosis (RVCT).1  Reported 
TB cases are verifi ed according to the TB case 
defi nition for public health surveillance (MMWR 
1997;46[No. RR-10]:40–41).
Cases may be verifi ed using the laboratory, the 
clinical case defi nition, or a provider diagnosis.  
A case may be verifi ed by the laboratory case 
defi nition either by 1) isolation of Mycobacte-
rium tuberculosis from a clinical specimen, or 2) 
detection of M. tuberculosis nucleic acid using 
an FDA approved nucleic acid amplifi cation test 
and testing methods, or 3) demonstration of acid-
fast bacilli (AFB) in a clinical specimen when a 
culture has not been or cannot be obtained.
A case may be verifi ed by the clinical case 
defi nition in the presence of all of the following 
clinical criteria: 1) a positive tuberculin skin test 
(TST) result, 2) signs and symptoms compatible 
with TB, such as an abnormal, unstable (worsen-
ing or improving) chest radiograph, or clinical 
evidence of current disease, 3) treatment with 
two or more antituberculosis medications, and 4) 
a completed diagnostic evaluation.
When cases of TB are diagnosed but do not meet 
the clinical case defi nition, reporting areas also 
have the option of verifying TB cases based on 
provider diagnosis.  Currently, the RVCT does 
not collect information on results from inter-
feron gamma release (IGRA) assays.  If this test 
is performed in lieu of the TST, then the RVCT 
should refl ect that the TST was not performed.  
Cases without a TST that are diagnosed by a 
positive IGRA test result should be considered 
to have been confi rmed by provider diagnosis.  
Another example of a provider diagnosis would 
be anergic patients with a clinical picture consis-
tent with TB but without laboratory evidence of 
M. tuberculosis.
In January 1993, in conjunction with state and 
local health departments, CDC implemented 
an expanded surveillance system for TB that 
would collect additional data to better moni-
tor and target groups at risk for TB disease, to 
estimate and follow the extent of drug-resistant 
TB, and to evaluate outcomes of TB cases.  The 
RVCT form for reporting TB cases was revised 
to collect information on occupation, the initial 
drug regimen, human immunodefi ciency virus 
(HIV) test results, history of substance abuse and 
homelessness, and residence in correctional or 
longterm care facilities at the time of diagnosis.
RVCT Follow Up Report-1 was added to collect 
drug susceptibility results for the initial M. tuber-
culosis isolate from patients with culture-positive 
disease.
To evaluate the outcomes of TB therapy, RVCT 
Follow Up Report-2 was added to collect in-
formation on the reason and date therapy was 
stopped, the type of healthcare provider, sputum 
culture conversion, the use of directly observed 
therapy (DOT), and the results of drug-suscepti-
bility testing for the fi nal M. tuberculosis isolate 
from patients with culture-positive disease.
Since 1993, RVCT data have been reported to 
CDC using software specifi cally developed for 
expanded TB surveillance (i.e., SURVS-TB, 
1993–1997; TIMS, 1998–present).  The instruc-
tions for completing the RVCT forms and the 
defi nitions for all data items were included in the 
software user’s guide.  The summary data pre-
sented in this publication for 2006 (and for 2004, 
Tables 39–44) and the trend data for 1993–2006 
(Tables 1–14) were received at CDC by April 1, 
2007.
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Completion of Tuberculosis Therapy
Tables 12, 41, 43, and 44 present rates of com-
pletion of TB therapy (COT).  Data collected by 
RVCT Follow Up Report-2 on date and reason 
therapy stopped (e.g., patient completed therapy, 
moved, was lost) were used to calculate rates 
of COT.  Cases were stratifi ed by the indicated 
length of therapy, based on American Thoracic 
Society/CDC/Infectious Diseases Society of 
America treatment guidelines2 in effect dur-
ing the period covered, and the patient’s initial 
drug susceptibility test results, age, and site of 
disease.  The adequacy of the treatment regimen 
(e.g., the suffi ciency of the duration of therapy, 
the appropriateness of the prescribed TB drugs) 
was not evaluated in this analysis. Acquired drug 
resistance during therapy with the need for a lon-
ger duration of therapy was also not considered 
in this analysis.
In Table 41, the fi rst column shows the total 
number of cases reported during 2004.  The 
remaining columns are grouped under three 
headings: therapy of 1 year or less indicated, 
therapy greater than 1 year indicated, and over-
all. Patients eligible to complete therapy within 
one year had to have been alive at diagnosis and 
initiated therapy with at least one drug. Eligible 
patients did not have rifampin resistance, did not 
die during therapy and did not have meningeal 
tuberculosis, regardless of age.  In addition, tu-
berculosis cases under the age of 15 were not eli-
gible to complete therapy within one year if they 
had disseminated disease (disseminated disease 
is defi ned as miliary tuberculosis and/or a posi-
tive tuberculosis blood culture). For patients with 
culture-negative disease, those with an unknown 
culture status, and those with culture-positive 
disease but unknown initial drug-susceptibility 
test results, data were included under the cate-
gory of 1 year or less of therapy indicated. Table 
12 presents data only for cases where therapy of 
1 year or less was indicated.  This is a change in 
COT calculation from previous years.
In Table 41, each group under an indicated 
2CDC.  Treatment of Tuberculosis, American Thoracic Society, CDC, and the Infectious Diseases Society of America.  MMWR 
2003;52(No.RR-11):1-77.  
length of therapy has an initial column showing 
the number of cases in persons who were alive 
at diagnosis and prescribed an initial regimen of 
one or more drugs, and who did not die during 
therapy.  This number was used as the denomina-
tor in COT rate calculations.
COT rates, shown as percentages, were only 
calculated for areas reporting reason therapy 
stopped for at least 90% of cases shown in the 
overall column. For the group with an indi-
cated length of therapy of 1 year or less, rates 
are shown for both COT in 1 year or less (COT 
<1 year) and for COT, regardless of duration 
(i.e., duration of therapy <1 year, >1 year, or 
unknown).  For COT <1 year, the numerator 
included only those patients completing therapy 
in <366 days (based on the dates therapy started 
and stopped).  Patients with missing dates were 
classifi ed as “treatment not completed” for this 
calculation.
Rates of COT, regardless of duration, were 
calculated by dividing the number of patients 
reported as having completed therapy by the 
number of total eligible patients.  Patients with 
an outcome other than completed therapy (i.e., 
moved, lost, refused treatment, and other) were 
classifi ed as “treatment not completed.”  Patients 
with an unknown outcome were also classifi ed 
as “treatment not completed.”  For the remaining 
two groups of indicated therapy length (greater 
than 1 year and overall), only rates of COT, 
regardless of duration, are presented.  Table 12 
provides rates for COT <1 year and for COT, 
regardless of duration, only for the group with 
an indicated therapy of 1 year or less.  Table 
43 presents rates of COT by ethnicity and non-
Hispanic race, and by state for those in whom 
therapy less than 1 year was indicated.
Site of TB Disease
Miliary disease is classifi ed as both an extrapul-
monary and a pulmonary form of TB (Tables 8, 
9, 26, 27, and 47).  In publications prior to 1997, 
miliary disease was classifi ed as extrapulmonary 
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TB, unless pulmonary disease was reported as 
the major site of TB disease. 
Reporting of HIV Status 
Table 37 shows information on HIV status for 
persons with TB aged 25–44 years, the age 
group in which 73% of AIDS cases occur (CDC. 
HIV/AIDS Surveillance Report 2003; 15).  The 
information on HIV status for TB cases reported 
in 2006 is incomplete.  Reasons for incomplete 
reporting of HIV test results to the national TB 
surveillance system include concerns about 
confi dentiality, which may limit the exchange 
of data between TB and HIV/AIDS programs; 
laws and regulations in certain states and local 
jurisdictions that have been interpreted as pro-
hibiting the HIV/AIDS program from sharing the 
HIV status of TB patients with the TB program, 
or from reporting patients with TB and AIDS to 
the TB program; and reluctance by health care 
providers to report HIV test results to the TB 
surveillance program staff.  In addition, health-
care providers may not offer HIV counseling, 
testing, and referral to some TB patients because 
of a lack of resources or of appropriately trained 
staff, or due to the perception that selected pa-
tients (e.g., foreign-born persons) are not at risk 
for HIV infection.
Data on the HIV-infection status of reported TB 
cases should be interpreted with caution.  These 
data are not representative of all TB patients with 
HIV infection.  HIV testing is performed after a 
patient receives counseling and gives informed 
consent.  Since testing is voluntary, some TB 
patients may decline HIV testing.  (Current CDC 
policy, not refl ected in 2006 data, recommends 
all patients in healthcare setting be notifi ed that 
testing will be performed unless patient declines, 
or opts out.) TB patients who are tested anony-
mously may choose not to share the results of 
HIV testing with their healthcare provider.  TB 
patients managed in the private sector may 
receive confi dential HIV testing, but results may 
not be reported to the TB program in the health 
department.  In addition, many factors may infl u-
ence HIV testing of TB patients, including the 
extent to which testing is targeted or routinely 
offered to specifi c groups (e.g., 25- to 44-year-
old males, injecting drug users, homeless per-
sons), and the availability of and access to HIV 
testing services.  These data may overrepresent 
or underrepresent the proportion of TB patients 
known to be HIV infected in a reporting area.
Tabulation and Presentation of TB Data  
This report primarily presents summary data for 
TB cases reported to CDC in 2006.  Data from 
the RVCT Follow Up Report-2 (i.e., completion 
of therapy, use of directly observed therapy, and 
type of health care provider) are presented for 
cases reported in 2004.  In addition, trend data 
are presented in Tables 1 through 14.  TB cases 
are tabulated by the year in which the reporting 
area verifi ed that the patient had TB and included 
the patient in its offi cial annual TB case count.  
In contrast to previous annual summaries, in 
which TB case counts for preceding years were 
not updated, the current summary refl ects up-
dated information on the numbers of cases of 
confi rmed TB for each year from 1993 to 2005.  
Therefore, case counts for these years differ from 
those reported in the annual summaries previ-
ously published.  Totals for the United States 
only include data from the 50 states, the District 
of Columbia, and New York City.  Age group 
tabulations are based on the patient’s age in the 
month and year the patient was reported to the 
health department as a suspected TB case.  State 
or metropolitan area data tabulations are based 
on the patient’s residence at diagnosis of TB (see 
Appendix B: “Recommendations for Counting 
Reported Tuberculosis Cases”).
Tables 46 through 50 present data by metropoli-
tan statistical areas (MSAs) with an estimated 
2006 population of 500,000 or more.  MSAs are 
defi ned by the federal Offi ce of Management 
and Budget, and the defi nitions effective as of 
December 2006 were used for this publication 
(www.census.gov/population/www/estimates/
metro_general/2006/List4.txt).  On June 6, 2003, 
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the OMB announced new MSA defi nitions based 
on Census 2000 data, and the information has 
been updated annually. Some MSAs added or 
dropped counties and some MSAs merged.  The 
MSA defi nitions apply to all areas except the six 
New England states; for these states, the New 
England County Metropolitan Areas (NECMAs) 
are used.  MSAs are named for a central city 
in the MSA or NECMA, may include several 
cities and counties, and may cross state boundar-
ies.  For example, the TB cases and case rates 
presented for the District of Columbia in Table 
20 include only persons residing within the 
geographic boundaries of the District.  However, 
the TB cases and case rates for the Washington, 
D.C., MSA (Table 46) include persons residing 
within the several counties in the metropolitan 
area, including counties in Maryland, Virginia, 
and West Virginia.   
Rates
Rates are expressed as the number of cases 
reported each calendar year per 100,000 popula-
tion.  Population denominators used in calculat-
ing TB rates were based on offi cial census and 
midyear (July 1) postcensal estimates from the 
U.S. Census Bureau.  Specifi cally, in Tables 1 
and 20, the U.S. total populations for 2000 to 
2006 were obtained from the Annual Estimates 
of the Population for the United States and 
States, and for Puerto Rico (July 1, 2000– July 
1, 2006).3 In 2003, two modifi cations were made 
to the RVCT form: 1) entries for multiple race 
(two or more races reported for a person) were 
allowed, and 2) the previous category of Asian/
Pacifi c Islander was divided into “Asian” and 
“Native Hawaiian or Other Pacifi c Islander.”  To 
calculate rates in Tables 2 and 3, denominators 
for 2000 to 2006 were obtained from the Annual 
Estimates of the Population by Sex, Race, and 
Hispanic or Latino Origin for the United States: 
April 1, 2000, to July 1, 2006.4 To calculate rates 
for Table 4, denominators were obtained from 
the Annual Estimates of the Population by Sex 
and Five-Year Age Groups for the United States: 
April 1, 2000, to July 1, 2006.5  Denomina-
tors for computing 2006 rates in Table 16 were 
obtained from U.S. Census Bureau Monthly 
Postcensal Resident Population, by single year of 
age, sex, race, and Hispanic origin: July 1, 2006.6
In 2004, the method for calculating the annual 
percentage change in the TB case rate was modi-
fi ed.  In contrast to methods used in previous 
summaries, unrounded fi gures are now applied 
to calculate the percentage change in the case 
rate, providing a greater degree of precision and 
accuracy than in the past.
In Table 5, the populations for U.S.-born and 
foreign-born persons for 1993 and 1994 were 
obtained from Quarterly Estimates of the United 
States Foreign-born and Native Resident Popula-
tions: April 1, 1990, to July 1, 1999.7  Denomi-
nators for computing the 1995–2006 rates were 
based on extrapolations from the U.S. Census 
Current Population Survey (March Supplement). 
Mortality Data
Offi cial TB mortality statistics for the United 
States are compiled by the National Center for 
Health Statistics (NCHS), CDC.  The annual 
mortality rate is calculated as the number of 
deaths due to TB in that year, divided by the 
estimated population for the year, multiplied by 
100,000 (Table 1).  The number of deaths for 
2005 (preliminary) was obtained from the Na-
tional Center for Health Statistics, e-Stat Deaths: 
Preliminary Data for 2005, September 2007. For
previous years, offi cial tuberculosis mortality 
statistics were compiled by the National Center 
for Health Statistics, CDC. The number of deaths 
for 2006 was not available at the time of this 
publication.
3 http://www.census.gov/popest/states/tables/NST-EST2006-01.xls
4 http://www.census.gov/popest/national/asrh/NC-EST2006/NC-EST2006-03.xls
5 http://www.census.gov/popest/national/asrh/NC-EST2006/NC-EST2006-01.xls
6 http://www.census.gov/popest/national/asrh/fi les/NC-EST2005-ALLDATA-R-Files14.txt
7 http://www.census.gov/popest/archives/1990s/nat-nativity-sum.txt
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1953 84,304 52.6 – – 19,707 12.4 – – 
1954 79,775 48.9 - 5.4 - 7.0 16,527 10.2 -16.1 -17.7
1955 77,368 46.6 - 3.0 - 4.7 15,016 9.1 - 9.1 -10.8 
1956 69,895 41.4 - 9.7 -11.2 14,137 8.4 - 5.9 - 7.7
1957 67,149 39.0 - 3.9 - 5.8 13,390 7.8 - 5.3 - 7.1
1958 63,534 36.3 - 5.4 - 6.9 12,417 7.1 - 7.3 - 9.0
1959 57,535 32.4 - 9.4 -10.7 11,474 6.5 - 7.6 - 8.5
1960 55,494 30.7 - 3.5 - 5.2 10,866 6.0 - 5.3 - 7.7
1961 53,726 29.2 - 3.2 - 4.9 9,938 5.4 - 8.5 -10.0 
1962 53,315 28.6 - 0.8 - 2.1 9,506 5.1 - 4.3 - 5.6
1963 54,042 28.6 + 1.4 0.0 9,311 4.9 - 2.1 - 3.9
1964 50,874 26.5 - 5.9 - 7.3 8,303 4.3 -10.8 -12.2
1965 49,016 25.2 - 3.7 - 4.9 7,934 4.1 - 4.4 - 4.7
1966 47,767 24.3 - 2.5 - 3.6 7,625 3.9 - 3.9 - 4.9
1967 45,647 23.0 - 4.4 - 5.3 6,901 3.5 - 9.5 -10.3
1968 42,623 21.2 - 6.6 - 7.8 6,292 3.1 - 8.8 -11.4
1969 39,120 19.3 - 8.2 - 9.0 5,567 2.8 -11.5 - 9.7
1970 37,137 18.1 - 5.1 - 6.2 5,217 2.6 - 6.3 - 7.1
1971 35,217 17.0 - 5.2 - 6.1 4,501 2.2 -13.7 -15.4
1972 32,882 15.7 - 6.6 - 7.6 4,376 2.1 - 2.8 - 4.5
1973 30,998 14.6 - 5.7 - 7.0 3,875 1.8 -11.4 -14.5
1974 30,122 14.1 - 2.8 - 3.4 3,513 1.7 - 9.3 - 5.6
1975 33,989 15.7 – – 3,333 1.6 - 5.1 - 5.9
1976 32,105 14.7 - 5.5 - 6.4 3,130 1.5 - 6.1 - 6.3
1977 30,145 13.7 - 6.1 - 6.8 2,968 1.4 - 5.2 - 6.7
1978 28,521 12.8 - 5.4 - 6.6 2,914 1.3 - 1.8 - 7.1
1979 27,669 12.3 - 3.0 - 3.9 2,0071 0.91 -31.11 30.81
1980 27,749 12.2 + 0.3 - 0.8 1,978 0.9 - 1.4 0.0
1981 27,373 11.9 - 1.4 - 2.5 1,937 0.8 - 2.1 -11.1
1982 25,520 11.0 - 6.8 - 7.6 1,807 0.8 - 6.7 0.0
1983 23,846 10.2 - 6.6 - 7.3 1,779 0.8 - 1.5 0.0
1984 22,255 9.4 - 6.7 - 7.8 1,729 0.7 - 2.8 -12.5
1985 22,201 9.3 - 0.2 - 1.1 1,752 0.7 + 1.3 0.0
1986 22,768 9.5 + 2.6 + 2.2 1,782 0.7 + 1.7 0.0
1987 22,517 9.3 - 1.1 - 2.1 1,755 0.7 - 1.5 0.0
1988 22,436 9.2 - 0.4 - 1.1 1,921 0.8 + 9.5 +14.3
1989 23,495 9.5 + 4.7 + 3.3 1,970 0.8 + 2.6 0.0
1990 25,701 10.3 + 9.4 + 8.4 1,810 0.7 - 8.1 -12.5
1991 26,283 10.4 + 2.3 + 1.0 1,713 0.7 - 5.4 0.0
1992 26,673 10.4 + 1.5 + 0.1 1,705 0.7 - 0.5 0.0
1993 25,107 9.7 - 5.9 - 7.1 1,631 0.6 - 4.3 -14.3
1994 24,205 9.2 - 3.6 - 4.8 1,478 0.6 - 9.4 0.0
1995 22,728 8.5  - 6.1 - 7.2 1,336 0.5 - 9.6 -16.7
1996 21,210 7.9 - 6.7 - 7.8 1,202 0.5 -10.0 0.0
1997 19,751 7.2 - 6.9 - 8.0 1,166 0.4 - 3.0 -20.0
1998 18,287 6.6 - 7.4 - 8.5 1,112 0.4 - 4.6 0.0
1999 17,501 6.3 - 4.3 - 5.4 930 0.3 -16.4 -25.0
2000 16,310 5.8 - 6.8 - 7.9 776 0.3 -16.6 0.0
2001 15,945 5.6 -2.2 - 3.2 764 0.3 - 1.5 0.0
2002 15,056 5.2 -5.6 - 6.5 784 0.3 + 2.6 0.0
2003 14,838 5.1 -1.4 - 2.4 711 0.2 - 9.3 -33.3
2004 14,502 4.9 -2.2 - 3.1 657 0.2 - 7.6 0.0
2005 14,080 4.7 -2.9 - 3.8 6462 0.22 - 1.72 0.02
2006 13,779 4.6 -2.1 - 3.1 ... ... ... ...
Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates 
per 100,000 Population, and Percent Change:  United States, 1953–2006
Tuberculosis Cases Tuberculosis Deaths
Percent ChangePercent Change
Number Rate Number RateNumber NumberRate RateYear
1The large decrease in death rate in 1979 occurred because late effects of tuberculosis (e.g., bronchiectasis or fi brosis) and pleu-
risy with effusion (without mention of cause) are no longer included in tuberculosis deaths.
2Preliminary data obtained from National Center for Health Statistics, E-Stat Deaths: Preliminary Data for 2005, September, 2007. 
For previous years, offi cial tuberculosis mortality statistics were compiled by the National Center for Health Statistics, CDC. Percent 
change in tuberculosis death rates is calculated with rounded fi gures. See Technical Notes (page 9). 
Note: 1993 to 2006 tuberculosis case counts and rates updated as of April 6, 2007, using Bridged-Race 1990–1999 Intercensal 
Population Estimates for 1990–1999 (ftp://ftp.cdc.gov/pub/health_statistics/nchs/datasets/nvss/bridgepop/documentationbridged-
intercena1.doc) (accessed May 21, 2007) and Annual Estimates of the Population for the United States and States, and for Puerto
Rico (July 1, 2000– July 1, 2005)  (www.census.gov/popest/states/tables/NST-EST2006-01.xls) (accessed May 8, 2007).  Percent-
age change results reported to one decimal. Ellipses indicate data not available. Case data after 1974 are not comparable to prior
years due to changes in the surveillance case defi nition that became effective in 1975.  See Surveillance Slides #2 and #3.
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1993 25107 17422 69 7.4 7403 29 34.0 282 1
1994 24205 16171 67 6.8 7741 32 34.6 293 1
1995 22728 14647 64 6.1 7987 35 34.8 94 0
1996 21210 13315 63 5.6 7726 36 31.5 169 1
1997 19751 11879 60 4.9 7742 39 30.0 130 1
1998 18287 10632 58 4.4 7599 42 28.9 56 0
1999 17501 9806 56 4.0 7602 43 29.2 93 1
2000 16310 8648 53 3.5 7619 47 27.3 43 0
2001 15945 7869 49 3.2 8011 50 27.0 65 0
2002 15056 7281 48 2.9 7718 51 25.4 57 0
2003 14838 6861 46 2.7 7930 53 23.5 47 0
2004 14502 6656 46 2.6 7822 54 23.2 24 0
2005 14080 6332 45 2.5 7718 55 22.3 30 0
2006 13779 5934 43 2.3 7799 57 22.0 46 0
1993 25107 1661 (7) 2.9 1823 (7) 5.0 9587 (38) 11.5 6197 (25) 12.4 5820 (23) 17.7 19 (0)
1994 24205 1659 (7) 2.9 1833 (8) 5.0 9043 (37) 10.7 6125 (25) 11.9 5539 (23) 16.6 6 (0)
1995 22728 1536 (7) 2.6 1698 (7) 4.6 8201 (36) 9.7 5960 (26) 11.3 5328 (23) 15.8 5 (0)
1996 21210 1356 (6) 2.3 1637 (8) 4.4 7564 (36) 8.9 5572 (26) 10.2 5076 (24) 14.9 5 (0)
1997 19751 1251 (6) 2.1 1675 (8) 4.5 6884 (35) 8.0 5277 (27) 9.4 4663 (24) 13.6 1 (0)
1998 18287 1077 (6) 1.8 1542 (8) 4.1 6335 (35) 7.4 4956 (27) 8.5 4377 (24) 12.6 0 (0)
1999 17501 1039 (6) 1.7 1518 (9) 3.9 6063 (35) 7.1 4858 (28) 8.0 4020 (23) 11.6 3 (0)
2000 16310 964 (6) 1.6 1617 (10) 4.1 5575 (34) 6.6 4637 (28) 7.4 3516 (22) 10.0 1 (0)
2001 15945 929 (6) 1.5 1597 (10) 4.0 5609 (35) 6.6 4515 (28) 7.0 3293 (21) 9.3 2 (0)
2002 15056 944 (6) 1.6 1497 (10) 3.7 5288 (35) 6.3 4182 (28) 6.3 3141 (21) 8.8 4 (0)
2003 14838 912 (6) 1.5 1573 (11) 3.8 5073 (34) 6.0 4283 (29) 6.2 2994 (20) 8.3 3 (0)
2004 14502 954 (7) 1.6 1602 (11) 3.8 4940 (34) 5.9 4194 (29) 5.9 2811 (19) 7.7 1 (0)
2005 14080 857 (6) 1.4 1544 (11) 3.7 4739 (34) 5.6 4125 (29) 5.7 2815 (20) 7.7 0 (0)
2006 13779 807 (6) 1.3 1540 (11) 3.6 4702 (34) 5.6 4053 (29) 5.4 2676 (19) 7.2 1 (0)
Table 4.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age 
Group: United States, 1993–2006 
Year
Total
Cases
0–14 15–24 25–44 45–64 >65 Unk.1.
No. No. No. No. No. No. (%)(%)(%)(%)(%)(%) Rate Rate Rate Rate Rate
1Includes unknown and missing.
Note: Previously published rates for 1993–1999 have been updated using Bridged-Race 1990–1999 Intercensal Population Estimates
(http://www.cdc.gov/nchs/about/major/dvs/popbridge/popridge.htm) (accessed May 18, 2007). Denominators for computing 2000–2006 
case rates were obtained from the Annual Estimates of the Population by Sex and Five-Year Age Groups for the United States: April 1, 
2000, to July 1, 2006  (http://www.census.gov/popest/national/asrh/NC-EST2006/NC-EST2006-01.xls) (accessed May 18, 2007).
Data for all years updated through April 6, 2007.
See Technical Notes (page 9).
Zero % (0) denotes <0.5%.
See Surveillance Slides #5 and #6.
Table 5.  Tuberculosis Cases, Percentages, and Case Rates per 100,000 
Population by Origin of Birth: United States, 1993–2006
Year
Total
Cases
U.S.-born Persons Foreign-born Persons1 Unknown or Missing
No. (%)No. (%) RateNo. (%) Rate
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the 
Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, 
the Republic of Palau, the U.S. Virgin Islands, and U.S. minor and outlying Pacifi c islands.
Note:  Denominators for computing rates for years 1993–1994 were obtained from Quarterly Estimates of the 
United States Foreign-born and Native Resident Populations: April 1, 1990–July 1, 1999, located at http://www.
census.gov/population/estimates/nation/nativity/fbtab001.txt (accessed May 31, 2007). Denominators for computing 
the 1995–2006 rates are based on the U.S. Census Bureau, Current Population Survey (March Supplement).  Data 
for all years updated through April 6, 2007.
Zero % (0) denotes <0.5%.
See Surveillance Slides #11 through #16.
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Total Cases 7799 (100) 7718 (100) 7822 (100) 7930 (100) 7718 (100)
Mexico 1,929 (25) 1,956 (25) 1,988 (25) 2,034 (26) 1,906 (25)
Philippines 861 (11) 828 (11) 829 (11) 913 (12) 870 (11)
Vietnam 632 (8) 576 (7) 620 (8) 662 (8) 658 (9)
India 544 (7) 563 (7) 561 (7) 609 (8) 587 (8)
China 377 (5) 396 (5) 350 (4) 374 (5) 356 (5)
Haiti 211 (3) 239 (3) 247 (3) 264 (3) 264 (3)
Korea, Rep. 206 (3) 176 (2) 219 (3) 194 (2) 210 (3)
Guatemala 226 (3) 211 (3) 189 (2) 173 (2) 149 (2)
Ethiopia 201 (3) 154 (2) 169 (2) 142 (2) 131 (2)
Peru 159 (2) 154 (2) 159 (2) 157 (2) 151 (2)
Ecuador 117 (2) 156 (2) 159 (2) 159 (2) 150 (2)
Somalia 196 (3) 148 (2) 140 (2) 105 (1) 142 (2)
Honduras 163 (2) 165 (2) 112 (1) 125 (2) 136 (2)
El Salvador 145 (2) 141 (2) 125 (2) 116 (1) 152 (2)
Cambodia 99 (1) 106 (1) 107 (1) 118 (1) 75 (1)
Dominican Republic 112 (1) 76 (1) 104 (1) 96 (1) 91 (1)
Pakistan 80 (1) 78 (1) 89 (1) 91 (1) 80 (1)
Lao, PDR 60 (1) 84 (1) 88 (1) 73 (1) 89 (1)
Kenya 73 (1) 66 (1) 68 (1) 79 (1) 80 (1)
Thailand 55 (1) 72 (1) 60 (1) 45 (1) 33 (0)
Colombia 45 (1) 37 (0) 68 (1) 58 (1) 52 (1)
Cuba 42 (1) 55 (1) 56 (1) 49 (1) 58 (1)
Indonesia 45 (1) 57 (1) 36 (0) 54 (1) 52 (1)
Nigeria 37 (0) 36 (0) 52 (1) 56 (1) 56 (1)
Liberia 52 (1) 64 (1) 54 (1) 30 (0) 26 (0)
Nepal 43 (1) 33 (0) 48 (1) 39 (0) 28 (0)
Burma 40 (1) 39 (1) 41 (1) 31 (0) 38 (0)
Russia 47 (1) 44 (1) 28 (0) 30 (0) 38 (0)
Bangladesh 42 (1) 34 (0) 38 (0) 29 (0) 34 (0)
Brazil 42 (1) 37 (0) 30 (0) 26 (0) 35 (0)
All Others3 918 (12) 937 (13) 988 (13) 999 (13) 991 (13)
 Table 6. Tuberculosis Cases and Percentages Among Foreign-born Persons1 by 
the Top 30 Countries2 of Origin of Birth: United States, 2002–2006
Country of Origin
2006 2005 2004 2003 2002
Year
No. No. No. No. No.(%) (%) (%) (%) (%)
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the 
Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the 
Republic of Palau, the U.S. Virgin Islands, and U.S. minor and outlying Pacifi c islands.
2The top 30 countries were selected based on their ranked 5-year average number of TB cases.
3 Includes Not Specifi ed for Country of Origin.  Excludes missing.
Note: Zero (0) denotes <0.5%.
Data for all years updated through April 6, 2007.
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1993 21158 9429 (45) 7915 (37) 3814 (18) 14878 (70) 2814 (13) 3466 (16)
1994 20318 8964 (44) 7914 (39) 3440 (17) 14210 (70) 2807 (14) 3301 (16)
1995 18888 8093 (43) 7713 (41) 3082 (16) 13282 (70) 2626 (14) 2980 (16)
1996 17387 7454 (43) 7352 (42) 2581 (15) 12270 (71) 2559 (15) 2558 (15)
1997 16239 6935 (43) 6916 (43) 2388 (15) 11568 (71) 2259 (14) 2412 (15)
1998 14801 6624 (45) 6038 (41) 2139 (14) 10486 (71) 2138 (14) 2177 (15)
1999 14067 6275 (45) 5662 (40) 2130 (15) 9820 (70) 2097 (15) 2150 (15)
2000 13087 5883 (45) 5347 (41) 1857 (14) 9251 (71) 1948 (15) 1888 (14)
2001 12723 5650 (44) 5322 (42) 1751 (14) 8902 (70) 2011 (16) 1810 (14)
2002 11901 5439 (46) 4792 (40) 1670 (14) 8329 (70) 1837 (15) 1735 (15)
2003 11809 5368 (45) 4879 (41) 1562 (13) 8207 (69) 1978 (17) 1624 (14)
2004 11527 5277 (46) 4891 (42) 1359 (12) 8048 (70) 2042 (18) 1437 (12)
2005 11141 5111 (46) 4739 (43) 1291 (12) 7689 (69) 2052 (18) 1400 (13)
2006 10883 5091 (47) 4564 (42) 1228 (11) 7642 (70) 1881 (17) 1360 (12)
1993 25107 20307 (81) 185 (1) 3085 (12) 1530 (6) 21158 (84) 3940 (16)
1994 24205 19506 (81) 189 (1) 2899 (12) 1611 (7) 20318 (84) 3885 (16)
1995 22728 18267 (80) 189 (1) 2727 (12) 1545 (7) 18888 (83) 3835 (17)
1996 21210 17154 (81) 131 (1) 2599 (12) 1326 (6) 17387 (82) 3814 (18)
1997 19751 15979 (81) 155 (1) 2405 (12) 1212 (6) 16239 (82) 3509 (18)
1998 18287 14790 (81) 155 (1) 2252 (12) 1090 (6) 14801 (81) 3484 (19)
1999 17501 13995 (80) 172 (1) 2101 (12) 1233 (7) 14067 (80) 3431 (20)
2000 16310 13014 (80) 148 (1) 1950 (12) 1198 (7) 13087 (80) 3211 (20)
2001 15945 12749 (80) 123 (1) 1887 (12) 1186 (7) 12723 (80) 3218 (20)
2002 15056 11976 (80) 104 (1) 1819 (12) 1157 (8) 11901 (79) 3148 (21)
2003 14838 11683 (79) 115 (1) 1782 (12) 1258 (8) 11809 (80) 3019 (20)
2004 14502 11328 (78) 79 (1) 1825 (13) 1270 (9) 11527 (80) 2971 (20)
2005 14080 10945 (78) 107 (1) 1774 (13) 1254 (9) 11141 (79) 2939 (21)
2006 13779 10783 (78) 101 (1) 1596 (12) 1299 (9) 10883 (79) 2889 (21)
Table 9.  Pulmonary Tuberculosis Cases and Percentages by Sputum Smear and Sputum 
Culture Results: United States, 1993–2006
Year
Total 
Pulmonary
Cases1
Sputum Smear Result Sputum Culture Result
Positive Negative
Not Done or 
Unknown
Positive Negative
Not Done or 
Unknown
No. (%) No. (%) No. No. No. No.(%) (%) (%) (%)
1Includes cases among persons with both pulmonary and extrapulmonary disease and cases of miliary TB.
Note:  Data for all years updated through April 6, 2007.
Table 8.  Tuberculosis Cases and Percentages by Case Verifi cation Criterion and Site of 
Disease: United States, 1993–2006
Year
Total
Cases
Verifi cation Criterion1 Site of Disease4
Positive
Culture
Positive
Smear
Clinical
Case Defi nition
Provider
Diagnosis Pulmonary
2
Extra-
pulmonary3
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
1Based on the public health surveillance case defi nition for tuberculosis:  CDC. Case defi nitions for infectious conditions under public 
health surveillance.  MMWR 1997:46(No. RR-10):40–41.  See Appendix A.
2Includes cases among persons with both pulmonary and extrapulmonary disease and cases of miliary TB.
3Includes cases among persons with extrapulmonary TB disease only.
4Excludes missing and unknowns.
Note: See Technical Notes (page 9) for a description of national TB surveillance.
Data for all years updated through April 6, 2007.
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1993 1399 (8.4) 804 (6.8) 579 (12.3) 407 (2.4) 301 (2.5) 103 (2.2)
1994 1360 (8.3) 711 (6.4) 635 (12.0) 353 (2.1) 238 (2.2) 110 (2.1)
1995 1174 (7.3) 555 (5.4) 618 (10.9) 254 (1.6) 169 (1.6) 85 (1.5)
1996 1136 (7.4) 494 (5.1) 639 (11.3) 206 (1.3) 104 (1.1) 101 (1.8)
1997 1079 (7.4) 435 (5.0) 640 (11.2) 155 (1.1) 76 (0.9) 79 (1.4)
1998 1013 (7.5) 367 (4.7) 644 (11.3) 132 (1.0) 55 (0.7) 76 (1.3)
1999 899 (7.0) 283 (4.0) 614 (10.9) 127 (1.0) 39 (0.6) 88 (1.6)
2000 892 (7.5) 268 (4.3) 621 (10.9) 121 (1.0) 38 (0.6) 83 (1.5)
2001 805 (7.0) 243 (4.3) 561 (9.5) 116 (1.0) 34 (0.6) 82 (1.4)
2002 821 (7.6) 206 (4.1) 614 (10.8) 126 (1.2) 36 (0.7) 90 (1.6)
2003 821 (7.7) 215 (4.5) 603 (10.3) 91 (0.9) 24 (0.5) 67 (1.1)
2004 802 (7.6) 214 (4.5) 588 (10.2) 103 (1.0) 27 (0.6) 76 (1.3)
2005 756 (7.5) 186 (4.2) 565 (10.0) 98 (1.0) 19 (0.4) 78 (1.4)
2006 752 (7.7) 173 (4.3) 577 (10.2) 91 (0.9) 18 (0.4) 73 (1.3)
1993 164 (16.5) 85 (12.6) 76 (24.8) 75 (7.6) 30 (4.5) 45 (14.7)
1994 176 (17.0) 81 (11.6) 94 (27.9) 74 (7.1) 35 (5.0) 38 (11.3)
1995 168 (17.5) 77 (12.9) 91 (25.1) 70 (7.3) 28 (4.7) 42 (11.6)
1996 142 (16.4) 67 (12.0) 74 (24.3) 43 (5.0) 20 (3.6) 22 (7.2)
1997 109 (14.7) 35 (7.7) 74 (25.8) 44 (5.9) 12 (2.6) 32 (11.1)
1998 98 (13.0) 38 (7.8) 60 (22.7) 23 (3.1) 6 (1.2) 17 (6.4)
1999 82 (12.2) 25 (6.5) 55 (19.3) 28 (4.2) 6 (1.6) 22 (7.7)
2000 82 (12.9) 22 (6.0) 60 (22.1) 24 (3.8) 2 (0.5) 22 (8.1)
2001 85 (13.5) 28 (8.6) 57 (18.9) 31 (4.9) 7 (2.2) 24 (8.0)
2002 79 (13.9) 23 (7.6) 56 (21.3) 25 (4.4) 3 (1.0) 22 (8.4)
2003 65 (12.4) 16 (6.3) 49 (18.0) 20 (3.8) 2 (0.8) 18 (6.6)
2004 62 (11.6) 15 (5.5) 47 (18.0) 25 (4.7) 4 (1.5) 21 (8.0)
2005 73 (14.5) 20 (8.4) 53 (19.9) 23 (4.6) 2 (0.8) 21 (7.9)
2006 64 (13.6) 9 (4.6) 55 (19.9) 20 (4.2) 2 (1.0) 18 (6.5)
Table 10. Tuberculosis Cases and Percentages, by Resistance to INH or Multidrug 
Resistance1 in Persons with No Previous History of TB, by Origin of Birth: United 
States, 1993–2006
1Resistance to at least isoniazid and rifampin 
2Isolates may be resistant to other drugs.
3All cases were culture positive, and initial drug susceptibility testing done.
4Includes persons of unknown country of birth.
5Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacifi c islands.
6Includes Not Specifi ed for Country of Origin.  Excludes missing.
Note:  Data for all years updated through April 6, 2007.
Percentages are of total cases for given year with no previous history of TB, culture positive, and initial drug susceptibility testing done 
(total cases not shown). More than 95% of all persons in each group had drug-susceptibility test results reported for an initial isolate.
See Surveillance Slides #19 through #22.
Year
Resistance to Isoniazid2 Resistance to Isoniazid and Rifampin2
Total Cases3,4 Foreign-born5,6U.S.-born Total Cases3,4 U.S.-born Foreign-born5,6
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
1Resistance to at least isoniazid and rifampin
2Isolates may be resistant to other drugs.
3All cases were culture positive, and initial drug susceptibility testing done.
4Includes persons of unknown country of birth.
5Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacifi c islands.
6 Includes Not Specifi ed for Country of Origin.  Excludes missing.
Note:  Data for all years updated through April 6, 2007.
Percentages are of total cases for given year with previous history of TB, culture positive, and initial drug susceptibility testing done (total 
cases not shown). More than 95% of all persons in each group had drug-susceptibility test results reported for an initial isolate.
Table 11. Tuberculosis Cases and Percentages, by Resistance to INH or Multidrug 
Resistance1 in Persons with Previous History of TB, by Origin of Birth: United 
States, 1993–2006
Year
Resistance to Isoniazid2 Resistance to Isoniazid and Rifampin2
Total Cases3,4 Foreign-born5,6U.S.-born Total Cases3,4 U.S.-born Foreign-born5,6
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
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1993 (12.9) (31.2) (40.9) (40.3) (21.3) (14.1) (64.1) (87.5)
1994 (7.0) (23.3) (56.3) (55.7) (26.8) (19.6) (69.0) (87.9)
1995 (5.2) (20.3) (63.4) (62.7) (36.1) (20.8) (73.9) (89.6)
1996 (4.2) (17.5) (67.9) (67.3) (41.5) (21.9) (76.4) (90.5)
1997 (3.2) (15.1) (72.4) (71.9) (45.9) (23.3) (78.2) (91.3)
1998 (2.6) (12.9) (74.7) (74.3) (46.8) (26.1) (80.6) (92.5)
1999 (2.2) (11.2) (77.2) (76.9) (48.5) (27.1) (80.8) (92.3)
2000 (2.0) (10.4) (78.6) (78.5) (51.8) (25.5) (81.5) (92.6)
2001 (1.7) (9.6) (80.2) (79.8) (52.6) (27.0) (81.5) (92.5)
2002 (1.8) (8.9) (80.5) (80.3) (54.4) (27.3) (82.1) (92.3)
2003 (1.4) (8.1) (81.4) (81.3) (55.8) (28.0) (82.7) (92.6)
2004 (1.5) (6.3) (82.5) (82.4) (57.2) (26.7) (82.3) (91.0)
2005 (1.2) (5.5) (83.6) (83.6) ... ... ... ...
2006 (1.2) (4.8) (83.0) (82.9) ... ... ... ...
1993 4375 (46) 2788 (29) 7454 (30) 3681 (15)
1994 4442 (49) 2667 (29) 7883 (33) 3599 (15)
1995 4277 (52) 2172 (26) 8179 (36) 3038 (13)
1996 4366 (58) 1856 (25) 8832 (42) 2615 (12)
1997 4142 (60) 1473 (21) 8771 (44) 2092 (11)
1998 3861 (61) 1240 (20) 8291 (45) 1831 (10)
1999 3811 (63) 1175 (19) 8420 (48) 1726 (10)
2000 3524 (63) 955 (17) 8111 (50) 1464 (9)
2001 3566 (64) 911 (16) 8037 (50) 1407 (9)
2002 3486 (66) 845 (16) 7941 (53) 1389 (9)
2003 3422 (67) 807 (16) 8104 (55) 1320 (9)
2004 3342 (68) 681 (14) 8226 (57) 1188 (8)
2005 3192 (67) 606 (13) 7992 (57) 1035 (7)
Table 13.  Tuberculosis Cases and Percentages in Persons with HIV Test Results1 and with 
HIV Coinfection by Age Group: United States, 1993–2005
Year
25–44 Years Old All Ages
HIV Test
Results HIV Positive
HIV Test
Results HIV Positive
No. No. No. No.(%) (%) (%) (%)
1Includes persons with positive, negative, or indeterminate HIV test results and persons from California with co-diagnosis of TB and 
AIDS. In California, the number of patients testing negative, indeterminate, refusing testing, not offered testing, test performed but status 
unknown, unknown, or missing HIV data is not reported to CDC. California did not report AIDS test results for 2005. Rhode Island did not 
report HIV test results for years 1993–1997.
Note:  Data for all years updated through April 6, 2007.
See Surveillance Slides #23 and #24. 
Table 12.  Percentages of Tuberculosis Cases by Initial Drug Regimen, Use of Directly 
Observed Therapy (DOT), and Completion of Therapy (COT): United States, 1993–2006
Year
Initial Drug Regimen1,2
Directly Observed Therapy3
Therapy <1 Year Indicated4
IRZ IRZ, E/S DOT Only
Both DOT and Self-
Administered COT <1 Year COTI R
1Includes persons alive at diagnosis.
2I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.  Excludes cases with no information on initial drug regimen;
3% received no initial drug therapy, less than 1% were started on one drug, and approximately 10% had an initial multidrug regimen other 
than IR, IRZ, or IRZ,E/S.
3Includes persons alive at diagnosis with initial drug regimen of one or more drugs prescribed.
4Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy.  Excludes 
persons with initial isolate resistant to rifampin and pediatric (aged <15) cases with meningeal, bone or joint, or miliary disease.  See 
Technical Notes (page 9) for description of COT calculation.
Note: Ellipses indicate data not available.
Data for all years updated through April 6, 2007.
See Surveillance Slides #25 and #26.
IRZE
24
1993 23741 18041 (76.0) 1121 (4.7) 1086 (4.6) 223 (0.9) 3052 (12.9) 218 (0.9)
1994 23051 17761 (77.1) 1194 (5.2) 739 (3.2) 183 (0.8) 2743 (11.9) 431 (1.9)
1995 21712 17286 (79.6) 970 (4.5) 563 (2.6) 155 (0.7) 2390 (11.0) 348 (1.6)
1996 20297 16510 (81.3) 783 (3.9) 520 (2.6) 156 (0.8) 1992 (9.8) 336 (1.7)
1997 18930 15654 (82.7) 667 (3.5) 435 (2.3) 119 (0.6) 1755 (9.3) 300 (1.6)
1998 17584 14762 (84.0) 534 (3.0) 400 (2.3) 104 (0.6) 1578 (9.0) 206 (1.2)
1999 16863 14218 (84.3) 456 (2.7) 356 (2.1) 104 (0.6) 1436 (8.5) 293 (1.7)
2000 15786 13395 (84.9) 411 (2.6) 391 (2.5) 112 (0.7) 1295 (8.2) 182 (1.2)
2001 15409 13195 (85.6) 374 (2.4) 364 (2.4) 97 (0.6) 1115 (7.2) 264 (1.7)
2002 14558 12427 (85.4) 336 (2.3) 364 (2.5) 86 (0.6) 1071 (7.4) 274 (1.9)
2003 14381 12376 (86.1) 315 (2.2) 356 (2.5) 84 (0.6) 986 (6.9) 264 (1.8)
2004 14078 11910 (84.6) 348 (2.5) 322 (2.3) 79 (0.6) 941 (6.7) 478 (3.4)
Table 14.  Tuberculosis (TB) Cases and Percentages by Reason Tuberculosis Therapy 
Stopped: United States, 1993–2004
Year
Total
Cases1 Completed Therapy Moved Lost Refused Died2 Unknown3
1Includes all cases in persons reported as alive at diagnosis and taking one or more TB drugs.
2Died = died of any cause (not only TB).
3Includes cases in persons reporting reason therapy stopped = Other, Missing, or Unknown. 
Note: Data for all years are updated through April 6, 2007.
Data complete through 2004 only.  See Technical Notes (page 9) for details.
No. (%) No. No. No. No. No.(%) (%) (%) (%) (%)No.
25
26
27
Total Cases 13,779 485 322 1,540 4,702 4,053 2,676 1
  Male 8,548 247 171 869 2,798 2,827 1,635 1
  Female 5,227 238 151 671 1,902 1,225 1,040 0
  Unknown 4 0 0 0 2 1 1 0
Hispanic or Latino1 4,066 260 128 681 1,580 925 492 0
  Male 2,684 138 65 442 1,089 651 299 0
  Female 1,381 122 63 239 491 274 192 0
  Unknown 1 0 0 0 0 0 1 0
Non-Hispanic
American Indian or Alaska Native 167 4 5 11 55 64 28 0
  Male 94 2 3 4 32 39 14 0
  Female 73 2 2 7 23 25 14 0
  Unknown 0 0 0 0 0 0 0 0
Asian 3,298 45 39 320 1,200 934 759 1
  Male 1,812 22 20 147 568 579 475 1
  Female 1,483 23 19 173 630 354 284 0
  Unknown 3 0 0 0 2 1 0 0
Black or African American 3,737 132 120 413 1,300 1,263 509 0
  Male 2,312 62 63 211 767 906 303 0
  Female 1,425 70 57 202 533 357 206 0
  Unknown 0 0 0 0 0 0 0 0
Native Hawaiian or Other Pacifi c 
Islander 56 1 4 12 22 12 5 0
  Male 30 0 2 4 15 7 2 0
  Female 26 1 2 8 7 5 3 0
  Unknown 0 0 0 0 0 0 0 0
White 2,403 42 25 99 530 838 869 0
  Male 1,580 22 18 58 316 634 532 0
  Female 823 20 7 41 214 204 337 0
  Unknown 0 0 0 0 0 0 0 0
Multiple Race2 35 1 1 2 9 15 7 0
  Male 21 1 0 1 6 9 4 0
  Female 14 0 1 1 3 6 3 0
  Unknown 0 0 0 0 0 0 0 0
Unknown 17 0 0 2 6 2 7 0
  Male 15 0 0 2 5 2 6 0
  Female 2 0 0 0 1 0 1 0
  Unknown 0 0 0 0 0 0 0 0
Table 15.  Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age 
Group: United States, 2006
1Persons of Hispanic or Latino ethnicity may be of any race or multiple race.             
2Indicates two or more races reported for a person. Category fi rst reported in 2003.        
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacifi c Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does 
not include persons of Hispanic ethnicity.
See Technical Notes (page 9).                 
See Surveillance Slides #6 and #9.
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >65
Not
Stated
28
Table 16.  Tuberculosis Case Rates per 100,000 Population by Hispanic Ethnicity and Non-
Hispanic Race, Sex, and Age Group: United States, 2006
1Persons of Hispanic or Latino origin may be of any race or multiple race.             
2Indicates two or more races reported for a person. Category first reported in 2003.        
Note: Denominators for computing case rates were obtained from the U.S. Census Bureau Monthly Postcensal Resident Population, by 
single year of age, sex, race, and Hispanic origin: July 1, 2006 (http://www.census.gov/popest/national/asrh/files/NC-EST2006-ALLDATA-
R-File14.dat) (Accessed May 21, 2007).
Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific 
Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does not 
include persons of Hispanic ethnicity.
See Technical Notes (page 9).                 
See Surveillance Slide #10.                 
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45 –64 >65
Total Rate 4.6 2.4 0.8 3.6 5.6 5.4 7.2
Male 5.8 2.4 0.8 4.0 6.6 7.7 10.4
Female 3.4 2.4 0.8 3.3 4.6 3.2 4.8
Hispanic or Latino1 9.2 5.5 1.6 9.2 10.7 13.1 20.5
Male 11.7 5.7 1.6 11.3 13.6 18.6 29.3
Female 6.5 5.3 1.6 6.9 7.3 7.7 13.9
American Indian or Alaska Native 7.4 2.3 1.4 2.7 8.6 12.6 16.0
Male 8.4 2.2 1.6 1.9 10.1 16.1 18.2
Female 6.4 2.3 1.1 3.5 7.2 9.5 14.3
Asian 25.6 5.2 2.5 19.1 26.1 30.9 65.2
Male 29.0 5.0 2.5 17.1 25.3 41.2 95.0
Female 22.3 5.5 2.5 21.2 26.8 22.0 42.7
Black/African American 10.2 4.5 2.0 6.7 12.3 15.7 16.5
Male 13.2 4.2 2.1 6.8 15.2 24.8 25.6
Female 7.4 4.9 2.0 6.6 9.6 8.2 10.8
Native Hawaiian or Pacific Islander 13.6 3.6 6.4 17.0 16.1 13.9 17.5
Male 14.4 0.0 6.2 11.0 21.6 16.4 15.5
Female 12.7 7.6 6.5 23.4 10.4 11.5 19.1
White 1.2 0.4 0.1 0.4 1.0 1.5 2.9
Male 1.6 0.4 0.1 0.4 1.2 2.3 4.2
Female 0.8 0.4 0.1 0.3 0.8 0.7 1.9
Multiple Race2 0.9 0.2 0.1 0.3 1.0 2.5 3.2
Male 1.0 0.3 0.0 0.3 1.3 3.1 4.3
Female 0.7 0.0 0.2 0.3 0.6 1.9 2.4
29
Age Group
Total Cases 5,934 412 194 438 1,442 2,079 1,369 0
  Male 3,865 207 104 243 911 1,544 856 0
  Female 2,069 205 90 195 531 535 513 0
  Unknown 0 0 0 0 0 0 0 0
Hispanic or Latino1 992 224 84 133 207 207 137 0
  Male 614 116 42 82 138 149 87 0
  Female 378 108 42 51 69 58 50 0
  Unknown 0 0 0 0 0 0 0 0
Non-Hispanic
American Indian or Alaska Native 163 4 5 9 54 63 28 0
  Male 91 2 3 2 31 39 14 0
  Female 72 2 2 7 23 24 14 0
  Unknown 0 0 0 0 0 0 0 0
Asian 135 32 14 34 27 14 14 0
  Male 74 15 10 15 13 10 11 0
  Female 61 17 4 19 14 4 3 0
  Unknown 0 0 0 0 0 0 0 0
Black or African American 2,606 115 70 178 739 1,053 451 0
  Male 1,706 54 35 100 467 772 278 0
  Female 900 61 35 78 272 281 173 0
  Unknown 0 0 0 0 0 0 0 0
Native Hawaiian or Other Pacifi c Islander 41 1 4 12 12 7 5 0
  Male 19 0 2 4 7 4 2 0
  Female 22 1 2 8 5 3 3 0
  Unknown 0 0 0 0 0 0 0 0
White 1,976 35 16 70 399 728 728 0
  Male 1,348 19 12 39 253 565 460 0
  Female 628 16 4 31 146 163 268 0
  Unknown 0 0 0 0 0 0 0 0
Multiple Race2 12 1 1 1 2 6 1 0
  Male 6 1 0 0 1 4 0 0
  Female 6 0 1 1 1 2 1 0
  Unknown 0 0 0 0 0 0 0 0
Unknown 9 0 0 1 2 1 5 0
  Male 7 0 0 1 1 1 4 0
  Female 2 0 0 0 1 0 1 0
  Unknown 0 0 0 0 0 0 0 0
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >65
Not
Stated
Table 17.  Tuberculosis Cases in U.S.-born Persons by Hispanic Ethnicity and Non-Hispanic 
Race, Sex, and Age Group: United States, 2006
1Persons of Hispanic or Latino origin may be of any race or multiple race.             
2Indicates two or more races reported for a person. Category fi rst reported in 2003.        
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacifi c Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple race does 
not include persons of Hispanic ethnicity.
See Technical Notes (page 9).
See Surveillance Slide #13.
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Total Cases 7,799 73 128 1,095 3,244 1,956 1,302 1
Male 4,648 40 67 623 1,875 1,268 774 1
Female 3,147 33 61 472 1,367 687 527 0
Unknown 4 0 0 0 2 1 1 0
Hispanic or Latino2 3,048 36 44 543 1,366 708 351 0
Male 2,049 22 23 358 945 493 208 0
Female 998 14 21 185 421 215 142 0
Unknown 1 0 0 0 0 0 1 0
Non-Hispanic
American Indian or Alaska Native 4 0 0 2 1 1 0 0
Male 3 0 0 2 1 0 0 0
Female 1 0 0 0 0 1 0 0
Unknown 0 0 0 0 0 0 0 0
Asian 3,157 13 25 286 1,171 917 744 1
Male 1,733 7 10 132 554 566 463 1
Female 1,421 6 15 154 615 350 281 0
Unknown 3 0 0 0 2 1 0 0
Black or African American 1,123 17 50 234 556 208 58 0
Male 602 8 28 111 297 133 25 0
Female 521 9 22 123 259 75 33 0
Unknown 0 0 0 0 0 0 0 0
Native Hawaiian or Other Pacifi c Islander 15 0 0 0 10 5 0 0
Male 11 0 0 0 8 3 0 0
Female 4 0 0 0 2 2 0 0
Unknown 0 0 0 0 0 0 0 0
White 423 7 9 29 130 107 141 0
Male 229 3 6 19 62 67 72 0
Female 194 4 3 10 68 40 69 0
Unknown 0 0 0 0 0 0 0 0
Multiple Race3 23 0 0 1 7 9 6 0
Male 15 0 0 1 5 5 4 0
Female 8 0 0 0 2 4 2 0
Unknown 0 0 0 0 0 0 0 0
Unknown 6 0 0 0 3 1 2 0
Male 6 0 0 0 3 1 2 0
Female 0 0 0 0 0 0 0 0
Unknown 0 0 0 0 0 0 0 0
Table 18.  Tuberculosis Cases in Foreign-born Persons1 by Hispanic Ethnicity and Non-His-
panic Race, Sex, and Age Group: United States, 2006
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacifi c islands.                 
2Persons of Hispanic or Latino ethnicity may be of any race or multiple race.            
3Indicates two or more races reported for a person. Category fi rst reported in 2003.        
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacifi c Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple race does 
not include persons of Hispanic ethnicity.
See Technical Notes (page 9). See Surveillance Slide #13.
Age Group
Race/Ethnicity and Sex All Ages Under 5 5–14 15–24 25–44 45–64 >65
Not
Stated
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Eastern Mediterranean Region
Total Cases=395
Algeria 5 Ethiopia 201 Niger 4
Angola 3 Gabon 2 Nigeria 37
Benin 1 Gambia 11 Rwanda 3
Botswana 1 Ghana 23 Sao Tome and Principe 0
Burkina Faso 2 Guinea 10 Senegal 10
Burundi 1 Guinea-Bissau 2 Seychelles 1
Cameroon 19 Kenya 73 Sierra Leone 17
Cape Verde 11 Lesotho 0 South Africa 21
Central African Republic 1 Liberia 52 Swaziland 0
Chad 1 Madagascar 0 Tanzania, UR 3
Comoros 0 Malawi 4 Togo 4
Congo, Republic of 10 Mali 6 Uganda 13
Côte d’Ivoire 10 Mauritania 2 Zambia 9
DR Congo 2 Mauritius 0 Zimbabwe 13
Equatorial Guinea 2 Mozambique 2   
Eritrea 1 Namibia 1
Anguilla 0 Cuba 42 Panama 9
Antigua and Barbuda 2 Dominica 1 Paraguay 1
Argentina 6 Dominican Republic 112 Peru 159
Bahamas 0 Ecuador 117 Puerto Rico 85
Barbados 3 El Salvador 145 St. Kitts and Nevis 2
Belize 4 Grenada 2 St. Lucia 1
Bermuda 0 Guatemala 226 St. Vincent & Grenadines 1
Bolivia 22 Guyana 31 Suriname 0
Brazil 42 Haiti 211 Trinidad and Tobago 21
British Virgin Islands 0 Honduras 163 Turks and Caicos Islands 0
Canada 5 Jamaica 29 Uruguay 5
Cayman Islands 1 Mexico 1929 U.S. Virgin Islands 1
Chile 3 Montserrat 2 United States of America 5807
Colombia 45 Netherland Antilles 0 Venezuela 10
Costa Rica 6 Nicaragua 27
Afghanistan 15 Lebanon 1 Sudan 34
Bahrain 0 Libyan Arab Jamahiriya 1 Syrian Arab Republic 3
Djibouti 1 Morocco 8 Tunisia 1
Egypt 3 Oman 0 United Arab Emirates 0
Iran, Islamic Republic of 24 Pakistan 80 West Bank and Gaza 0
Iraq 8 Qatar 0 Yemen 10
Jordan 5 Saudi Arabia 3
Kuwait 2 Somalia 196
Table 19. Tuberculosis Cases by Country of Origin1: United States, 2006
African Region
Total Cases=594
Americas Region
Total Cases=9,278
33
Albania 5  Germany 11 Norway 0
Andorra 0 Greece 5  Poland 28
Armenia 10 Hungary 1 Portugal 9
Austria 3 Iceland 1 Romania 20
Azerbaijan 1 Ireland 6 Russian Federation 47
Belarus 0 Israel 1 San Marino 0
Belguim 0 Italy 12 Serbia 4
Bosnia and Herzegovina 21 Kazakhstan 2 Slovakia 0
Bulgaria 3 Kyrgyzstan 0 Slovenia 0
Croatia 3 Latvia 1 Spain 2
Cyprus 0 Lithuania 1 Sweden 0
Czech Republic 2 Luxembourg 0 Switzerland 0
Czechoslovakia 4 Macedonia, TFYR 2 Tajikistan 0
Denmark 0 Malta 0 Turkey 7
Estonia 2 Moldova, Republic of 3 Turkmenistan 1
Finland 0 Monaco 0 Ukraine 14
France 4 Montenegro 0 United Kingdom 11
Georgia 6 Netherlands 2 Uzbekistan 9
Yugoslavia 7
Bangladesh 42 Korea, DPR 21 Sri Lanka 6
Bhutan 2 Maldives 0 Thailand 55
India 544 Myanmar 40 Timor-Leste 0
Indonesia 45 Nepal 43
American Samoa 4 Korea, Rep. 206 Philippines 861
Australia 2 Lao, PDR 60 Samoa 1
Brunei Darussalam 0 Malaysia 12 Singapore 0
Cambodia 99 Marshall Islands, Republic of 11 Solomon Islands 0
China 377 Micronesia, Federated States of 18 Tokelau 0
China, Hong Kong SAR 26 Mongolia 9 Tonga 2
China, Macao SAR 1 Nauru 0 Tuvalu 0
Cook Islands 0 New Caledonia 0 Vanuatu 0
Fiji 3 New Zealand 2 Vietnam 632
French Polynesia 0 Niue 0 Wallis and Futuna 0
Guam 6 N. Mariana Islands, Commonwealth of 0
Japan 18 Palau, Republic of 2
Kiribati 1 Papua New Guinea 1
1Country as reported by patient.
2Includes country codes currently reported via the National Tuberculosis Surveillance System that are not represented by WHO member
states.
Note:  Regional composition of countries based on WHO 2006 Report Global Tuberculosis Control, Surveillance, Planning, Financing, 
World Health Organization  (WHO/HTM/TB/2006.362) (http://www.who.int/tb/publications/global_report/en/).
Table 19.  (Cont’d) Tuberculosis Cases by Country of Origin1: United States, 2006
European Region
Total Cases=271
Other2
Total Cases=43
Unknown
Total Cases=46
Southeast Asia Region
Total Cases=798
Western Pacifi c Region
Total Cases=2,354
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36
37
United States 13,779 14,080 4.6 4.7 -- -- 299,398,484
Alabama 196 216 4.3 4.7 16 13 4,599,030
Alaska 70 59 10.4 8.9 1 1 670,053
Arizona 315 281 5.1 4.7 10 14 6,166,318
Arkansas 102 115 3.6 4.1 24 19 2,810,872
California 2,779 2,901 7.6 8.0 3 3 36,457,549
Colorado 124 101 2.6 2.2 28 35 4,753,377
Connecticut 89 95 2.5 2.7 29 29 3,504,809
Delaware 29 27 3.4 3.2 25 26 853,476
District of Columbia1 72 55 12.4 9.4 -- -- 581,530
Florida 1,038 1,093 5.7 6.2 7 6 18,089,888
Georgia 504 505 5.4 5.5 8 10 9,363,941
Hawaii 115 112 8.9 8.8 2 2 1,285,498
Idaho 20 23 1.4 1.6 42 41 1,466,465
Illinois 569 590 4.4 4.6 14 17 12,831,970
Indiana 125 146 2.0 2.3 36 32 6,313,520
Iowa 40 55 1.3 1.9 44 40 2,982,085
Kansas 82 60 3.0 2.2 26 34 2,764,075
Kentucky 84 124 2.0 3.0 35 27 4,206,074
Louisiana 207 257 4.8 5.7 11 8 4,287,768
Maine 16 17 1.2 1.3 48 44 1,321,574
Maryland 253 283 4.5 5.1 13 11 5,615,727
Massachusetts 259 265 4.0 4.1 21 20 6,437,193
Michigan 221 246 2.2 2.4 32 31 10,095,643
Minnesota 217 199 4.2 3.9 18 23 5,167,101
Mississippi 115 103 4.0 3.5 23 25 2,910,540
Missouri 104 108 1.8 1.9 38 39 5,842,713
Montana 13 10 1.4 1.1 41 47 944,632
Nebraska 25 35 1.4 2.0 40 38 1,768,331
Nevada 101 112 4.0 4.6 20 16 2,495,529
New Hampshire 17 4 1.3 0.3 46 49 1,314,895
New Jersey 508 482 5.8 5.5 6 9 8,724,560
New Mexico 48 39 2.5 2.0 30 37 1,954,599
New York 1,271 1,284 6.6 6.6 5 5 19,306,183
North Carolina 374 329 4.2 3.8 17 24 8,856,505
North Dakota 9 6 1.4 0.9 39 48 635,867
Ohio 239 260 2.1 2.3 34 33 11,478,006
Oklahoma 144 144 4.0 4.1 22 21 3,579,212
Oregon 81 103 2.2 2.8 33 28 3,700,758
Pennsylvania 341 326 2.7 2.6 27 30 12,440,621
Rhode Island 26 47 2.4 4.4 31 18 1,067,610
South Carolina 222 261 5.1 6.1 9 7 4,321,249
South Dakota 14 16 1.8 2.1 37 36 781,919
Tennessee 279 299 4.6 5.0 12 12 6,038,803
Texas 1,585 1,535 6.7 6.7 4 4 23,507,783
Utah 34 29 1.3 1.2 45 46 2,550,063
Vermont 8 8 1.3 1.3 47 45 623,908
Virginia 332 355 4.3 4.7 15 15 7,642,884
Washington 262 254 4.1 4.0 19 22 6,395,798
West Virginia 22 28 1.2 1.5 49 42 1,818,470
Wisconsin 75 78 1.3 1.4 43 43 5,556,506
Wyoming 4 ... 0.8 ... 50 50 515,004
American Samoa1,2 ... 5 ... 8.6 -- -- 57,794
Fed. States of Micronesia1,2 71 74 65.7 68.5 -- -- 108,004
Guam1,2 53 64 31.0 38.0 -- -- 171,019
Marshall Islands1,2 27 66 44.7 111.7 -- -- 60,422
N. Mariana Islands1,2 35 56 42.4 69.7 -- -- 82,459
Puerto Rico1,2 112 113 2.9 2.9 -- -- 3,927,776
Republic of Palau1,2 5 10 24.3 49.3 -- -- 20,579
U.S. Virgin Islands1,2 ... ... ... ... -- -- 108,605
Table 20. Tuberculosis Cases and Case Rates per 100,000 Population: States, 2006 and 2005
1Not ranked with the states. See Table 28, page 50, for District of Columbia ranking among states.
2Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Denominators for computing 2005 and 2006 rates for states, the District of Columbia, and Puerto Rico were obtained from An-
nual Estimates of the Population for the United States and States, and for Puerto Rico: April 1, 2000–July 1, 2006 (NST-EST2006-01)
(accessed May 29, 2007)  (http://www.census.gov/popest/states/tables/NST-EST2006-01.xls); for all other areas, from IDB Summary 
Demographic Data (http://www.census.gov/ipc/www/idbpyr.html).
Ellipses indicate data not available.
See Surveillance Slide #4.
State
Cases Case Rates Rank According to Rate
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1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacifi c islands.
Note: See Surveillance Slide #14.
Table 23. Tuberculosis Cases and Percentages, U.S.-born and Foreign-born Persons: States, 
2006
States
Total
Cases No. No. No.(%) (%) (%)
U.S.-born Persons Foreign-born Persons1 Unknown Origin
United States 13,779 5,934 (43.1) 7,799 (56.6) 46 (0.3)
Alabama 196 141 (71.9) 53 (27.0) 2 (1.0)
Alaska 70 59 (84.3) 11 (15.7) 0 (0.0)
Arizona 315 128 (40.6) 179 (56.8) 8 (2.5)
Arkansas 102 76 (74.5) 26 (25.5) 0 (0.0)
California 2,779 638 (23.0) 2,128 (76.6) 13 (0.5)
Colorado 124 41 (33.1) 83 (66.9) 0 (0.0)
Connecticut 89 36 (40.4) 53 (59.6) 0 (0.0)
Delaware 29 15 (51.7) 14 (48.3) 0 (0.0)
District of Columbia 72 48 (66.7) 24 (33.3) 0 (0.0)
Florida 1,038 567 (54.6) 471 (45.4) 0 (0.0)
Georgia 504 300 (59.5) 204 (40.5) 0 (0.0)
Hawaii 115 26 (22.6) 89 (77.4) 0 (0.0)
Idaho 20 10 (50.0) 10 (50.0) 0 (0.0)
Illinois 569 263 (46.2) 293 (51.5) 13 (2.3)
Indiana 125 74 (59.2) 51 (40.8) 0 (0.0)
Iowa 40 12 (30.0) 28 (70.0) 0 (0.0)
Kansas 82 32 (39.0) 50 (61.0) 0 (0.0)
Kentucky 84 67 (79.8) 17 (20.2) 0 (0.0)
Louisiana 207 180 (87.0) 27 (13.0) 0 (0.0)
Maine 16 7 (43.8) 9 (56.3) 0 (0.0)
Maryland 253 84 (33.2) 169 (66.8) 0 (0.0)
Massachusetts 259 60 (23.2) 198 (76.4) 1 (0.4)
Michigan 221 129 (58.4) 92 (41.6) 0 (0.0)
Minnesota 217 44 (20.3) 173 (79.7) 0 (0.0)
Mississippi 115 98 (85.2) 17 (14.8) 0 (0.0)
Missouri 104 54 (51.9) 50 (48.1) 0 (0.0)
Montana 13 7 (53.8) 6 (46.2) 0 (0.0)
Nebraska 25 5 (20.0) 20 (80.0) 0 (0.0)
Nevada 101 31 (30.7) 70 (69.3) 0 (0.0)
New Hampshire 17 5 (29.4) 12 (70.6) 0 (0.0)
New Jersey 508 132 (26.0) 376 (74.0) 0 (0.0)
New Mexico 48 25 (52.1) 23 (47.9) 0 (0.0)
New York 1,271 374 (29.4) 892 (70.2) 5 (0.4)
North Carolina 374 238 (63.6) 135 (36.1) 1 (0.3)
North Dakota 9 5 (55.6) 4 (44.4) 0 (0.0)
Ohio 239 134 (56.1) 104 (43.5) 1 (0.4)
Oklahoma 144 107 (74.3) 37 (25.7) 0 (0.0)
Oregon 81 33 (40.7) 48 (59.3) 0 (0.0)
Pennsylvania 341 173 (50.7) 168 (49.3) 0 (0.0)
Rhode Island 26 4 (15.4) 22 (84.6) 0 (0.0)
South Carolina 222 182 (82.0) 40 (18.0) 0 (0.0)
South Dakota 14 7 (50.0) 7 (50.0) 0 (0.0)
Tennessee 279 210 (75.3) 69 (24.7) 0 (0.0)
Texas 1,585 826 (52.1) 759 (47.9) 0 (0.0)
Utah 34 12 (35.3) 22 (64.7) 0 (0.0)
Vermont 8 4 (50.0) 4 (50.0) 0 (0.0)
Virginia 332 101 (30.4) 230 (69.3) 1 (0.3)
Washington 262 75 (28.6) 187 (71.4) 0 (0.0)
West Virginia 22 18 (81.8) 4 (18.2) 0 (0.0)
Wisconsin 75 35 (46.7) 39 (52.0) 1 (1.3)
Wyoming 4 2 (50.0) 2 (50.0) 0 (0.0)
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Table 25. Tuberculosis Cases and Percentages in Foreign-born Persons1 by Number of Years 
in the United States: States, 2006
States
Total
Cases
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacifi c islands.
Note: See Surveillance Slide #18.                 
<1 Year 1–4 5–9 10–19 >20
Unknown or 
Missing
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
United States 7,799 1,507 (19.3) 1,658 (21.3) 1,169 (15.0) 1,318 (16.9) 1,348 (17.3) 799 (10.2)
Alabama 53 17 (32.1) 23 (43.4) 9 (17.0) 2 (3.8) 2 (3.8) 0 (0.0)
Alaska 11 2 (18.2) 2 (18.2) 2 (18.2) 3 (27.3) 2 (18.2) 0 (0.0)
Arizona 179 39 (21.8) 40 (22.3) 13 (7.3) 19 (10.6) 38 (21.2) 30 (16.8)
Arkansas 26 4 (15.4) 6 (23.1) 3 (11.5) 5 (19.2) 8 (30.8) 0 (0.0)
California 2,128 369 (17.3) 335 (15.7) 228 (10.7) 426 (20.0) 499 (23.4) 271 (12.7)
Colorado 83 23 (27.7) 20 (24.1) 8 (9.6) 7 (8.4) 10 (12.0) 15 (18.1)
Connecticut 53 7 (13.2) 16 (30.2) 11 (20.8) 11 (20.8) 8 (15.1) 0 (0.0)
Delaware 14 3 (21.4) 1 (7.1) 7 (50.0) 2 (14.3) 1 (7.1) 0 (0.0)
District of Columbia 24 4 (16.7) 10 (41.7) 4 (16.7) 1 (4.2) 1 (4.2) 4 (16.7)
Florida 471 77 (16.3) 108 (22.9) 88 (18.7) 86 (18.3) 60 (12.7) 52 (11.0)
Georgia 204 41 (20.1) 64 (31.4) 47 (23.0) 31 (15.2) 15 (7.4) 6 (2.9)
Hawaii 89 34 (38.2) 10 (11.2) 3 (3.4) 21 (23.6) 15 (16.9) 6 (6.7)
Idaho 10 3 (30.0) 4 (40.0) 0 (0.0) 2 (20.0) 0 (0.0) 1 (10.0)
Illinois 293 45 (15.4) 62 (21.2) 47 (16.0) 48 (16.4) 45 (15.4) 46 (15.7)
Indiana 51 12 (23.5) 13 (25.5) 7 (13.7) 2 (3.9) 4 (7.8) 13 (25.5)
Iowa 28 4 (14.3) 10 (35.7) 7 (25.0) 4 (14.3) 3 (10.7) 0 (0.0)
Kansas 50 11 (22.0) 11 (22.0) 8 (16.0) 4 (8.0) 5 (10.0) 11 (22.0)
Kentucky 17 5 (29.4) 4 (23.5) 4 (23.5) 3 (17.6) 1 (5.9) 0 (0.0)
Louisiana 27 9 (33.3) 2 (7.4) 1 (3.7) 7 (25.9) 4 (14.8) 4 (14.8)
Maine 9 2 (22.2) 5 (55.6) 1 (11.1) 1 (11.1) 0 (0.0) 0 (0.0)
Maryland 169 36 (21.3) 53 (31.4) 32 (18.9) 26 (15.4) 21 (12.4) 1 (0.6)
Massachusetts 198 41 (20.7) 48 (24.2) 38 (19.2) 43 (21.7) 21 (10.6) 7 (3.5)
Michigan 92 7 (7.6) 28 (30.4) 19 (20.7) 20 (21.7) 15 (16.3) 3 (3.3)
Minnesota 173 61 (35.3) 33 (19.1) 21 (12.1) 20 (11.6) 7 (4.0) 31 (17.9)
Mississippi 17 9 (52.9) 2 (11.8) 3 (17.6) 1 (5.9) 2 (11.8) 0 (0.0)
Missouri 50 18 (36.0) 12 (24.0) 7 (14.0) 8 (16.0) 4 (8.0) 1 (2.0)
Montana 6 3 (50.0) 1 (16.7) 1 (16.7) 1 (16.7) 0 (0.0) 0 (0.0)
Nebraska 20 4 (20.0) 6 (30.0) 4 (20.0) 2 (10.0) 4 (20.0) 0 (0.0)
Nevada 70 12 (17.1) 16 (22.9) 8 (11.4) 18 (25.7) 16 (22.9) 0 (0.0)
New Hampshire 12 3 (25.0) 0 (0.0) 4 (33.3) 2 (16.7) 0 (0.0) 3 (25.0)
New Jersey 376 57 (15.2) 67 (17.8) 51 (13.6) 37 (9.8) 40 (10.6) 124 (33.0)
New Mexico 23 5 (21.7) 3 (13.0) 1 (4.3) 5 (21.7) 7 (30.4) 2 (8.7)
New York 892 128 (14.3) 217 (24.3) 154 (17.3) 162 (18.2) 156 (17.5) 75 (8.4)
North Carolina 135 31 (23.0) 42 (31.1) 26 (19.3) 22 (16.3) 9 (6.7) 5 (3.7)
North Dakota 4 1 (25.0) 2 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (25.0)
Ohio 104 27 (26.0) 35 (33.7) 23 (22.1) 4 (3.8) 10 (9.6) 5 (4.8)
Oklahoma 37 7 (18.9) 8 (21.6) 10 (27.0) 4 (10.8) 8 (21.6) 0 (0.0)
Oregon 48 11 (22.9) 7 (14.6) 3 (6.3) 4 (8.3) 4 (8.3) 19 (39.6)
Pennsylvania 168 31 (18.5) 38 (22.6) 47 (28.0) 16 (9.5) 26 (15.5) 10 (6.0)
Rhode Island 22 5 (22.7) 3 (13.6) 1 (4.5) 0 (0.0) 1 (4.5) 12 (54.5)
South Carolina 40 4 (10.0) 17 (42.5) 12 (30.0) 3 (7.5) 3 (7.5) 1 (2.5)
South Dakota 7 2 (28.6) 3 (42.9) 2 (28.6) 0 (0.0) 0 (0.0) 0 (0.0)
Tennessee 69 21 (30.4) 23 (33.3) 11 (15.9) 11 (15.9) 3 (4.3) 0 (0.0)
Texas 759 165 (21.7) 124 (16.3) 119 (15.7) 146 (19.2) 196 (25.8) 9 (1.2)
Utah 22 1 (4.5) 8 (36.4) 8 (36.4) 3 (13.6) 2 (9.1) 0 (0.0)
Vermont 4 2 (50.0) 2 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Virginia 230 54 (23.5) 66 (28.7) 35 (15.2) 41 (17.8) 32 (13.9) 2 (0.9)
Washington 187 36 (19.3) 41 (21.9) 24 (12.8) 29 (15.5) 33 (17.6) 24 (12.8)
West Virginia 4 0 (0.0) 1 (25.0) 2 (50.0) 0 (0.0) 0 (0.0) 1 (25.0)
Wisconsin 39 13 (33.3) 6 (15.4) 5 (12.8) 5 (12.8) 6 (15.4) 4 (10.3)
Wyoming 2 1 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (50.0) 0 (0.0)
47
United States 13,779 9,678 (70.2) 2,889 (21.0) 1,205 (8.7) 251
Alabama 196 151 (77.0) 27 (13.8) 18 (9.2) 3
Alaska 70 63 (90.0) 6 (8.6) 1 (1.4) 0
Arizona 315 254 (80.6) 39 (12.4) 22 (7.0) 7
Arkansas 102 86 (84.3) 11 (10.8) 3 (2.9) 1
California 2,779 1,907 (68.6) 610 (22.0) 262 (9.4) 51
Colorado 124 76 (61.3) 32 (25.8) 16 (12.9) 1
Connecticut 89 60 (67.4) 24 (27.0) 5 (5.6) 1
Delaware 29 17 (58.6) 8 (27.6) 4 (13.8) 2
District of Columbia 72 58 (80.6) 12 (16.7) 2 (2.8) 1
Florida 1,038 844 (81.3) 148 (14.3) 45 (4.3) 5
Georgia 504 360 (71.4) 106 (21.0) 37 (7.3) 8
Hawaii 115 89 (77.4) 15 (13.0) 11 (9.6) 2
Idaho 20 13 (65.0) 6 (30.0) 1 (5.0) 0
Illinois 569 372 (65.4) 156 (27.4) 40 (7.0) 13
Indiana 125 97 (77.6) 23 (18.4) 5 (4.0) 3
Iowa 40 26 (65.0) 14 (35.0) 0 (0.0) 0
Kansas 82 66 (80.5) 10 (12.2) 6 (7.3) 2
Kentucky 84 67 (79.8) 8 (9.5) 9 (10.7) 2
Louisiana 207 160 (77.3) 35 (16.9) 11 (5.3) 3
Maine 16 11 (68.8) 5 (31.3) 0 (0.0) 0
Maryland 253 163 (64.4) 66 (26.1) 24 (9.5) 2
Massachusetts 259 156 (60.2) 59 (22.8) 44 (17.0) 8
Michigan 221 141 (63.8) 65 (29.4) 15 (6.8) 0
Minnesota 217 115 (53.0) 74 (34.1) 28 (12.9) 0
Mississippi 115 101 (87.8) 7 (6.1) 7 (6.1) 2
Missouri 104 76 (73.1) 15 (14.4) 13 (12.5) 2
Montana 13 10 (76.9) 3 (23.1) 0 (0.0) 0
Nebraska 25 12 (48.0) 13 (52.0) 0 (0.0) 0
Nevada 101 75 (74.3) 19 (18.8) 7 (6.9) 1
New Hampshire 17 9 (52.9) 7 (41.2) 1 (5.9) 1
New Jersey 508 333 (65.6) 124 (24.4) 51 (10.0) 6
New Mexico 48 26 (54.2) 13 (27.1) 9 (18.8) 2
New York 1,271 856 (67.3) 279 (22.0) 136 (10.7) 7
North Carolina 374 259 (69.3) 83 (22.2) 32 (8.6) 13
North Dakota 9 6 (66.7) 3 (33.3) 0 (0.0) 0
Ohio 239 170 (71.1) 54 (22.6) 15 (6.3) 2
Oklahoma 144 106 (73.6) 27 (18.8) 11 (7.6) 0
Oregon 81 59 (72.8) 22 (27.2) 0 (0.0) 0
Pennsylvania 341 230 (67.4) 77 (22.6) 33 (9.7) 6
Rhode Island 26 13 (50.0) 12 (46.2) 1 (3.8) 0
South Carolina 222 137 (61.7) 44 (19.8) 41 (18.5) 18
South Dakota 14 6 (42.9) 7 (50.0) 1 (7.1) 0
Tennessee 279 190 (68.1) 57 (20.4) 32 (11.5) 0
Texas 1,585 1,171 (73.9) 279 (17.6) 135 (8.5) 57
Utah 34 18 (52.9) 10 (29.4) 6 (17.6) 1
Vermont 8 2 (25.0) 5 (62.5) 1 (12.5) 0
Virginia 332 237 (71.4) 69 (20.8) 26 (7.8) 7
Washington 262 157 (59.9) 72 (27.5) 33 (12.6) 7
West Virginia 22 16 (72.7) 6 (27.3) 0 (0.0) 0
Wisconsin 75 50 (66.7) 20 (26.7) 5 (6.7) 4
Wyoming 4 1 (25.0) 3 (75.0) 0 (0.0) 0
American Samoa4 ... ... ... ... ... ... ... ...
Fed. States of Micronesia4 71 50 (70.4) 19 (26.8) 2 (2.8) 1
Guam4 53 41 (77.4) 9 (17.0) 3 (5.7) 1
Marshall Islands4 27 25 (92.6) 2 (7.4) 0 (0.0) 0
N. Mariana Islands4 35 30 (85.7) 4 (11.4) 1 (2.9) 0
Puerto Rico4 112 103 (92.0) 7 (6.3) 2 (1.8) 0
Republic of Palau4 5 3 (60.0) 2 (40.0) 0 (0.0) 0
U.S. Virgin Islands4 ... ... ... ... ... ... ... ...
Table 26. Tuberculosis Cases and Percentages by Pulmonary and Extrapulmonary Disease: 
Reporting Areas, 2006
States
Total
Cases
Pulmonary1 Extrapulmonary2
Pulmonary and
Extrapulmonary Cases
Total3 Miliary
No. No. No. No.(%) (%) (%)
1Includes cases with pulmonary listed as major site of disease and no additional site of disease.
2Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, genitourinary, or other site, excluding pulmonary, listed 
as major site of disease.
3Includes miliary cases.
4Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: 7 cases had missing and/or unknown site of disease.
Ellipses indicate data not available.
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>500 cases in 2006
.California 2779 7.6 2901 8.0 -4.2 -5.0 4
.Texas 1585 6.7 1535 6.7 3.3 0.7 5
.New York1 1271 6.6 1284 6.6 -1.0 -1.0 6
.Florida 1038 5.7 1093 6.2 -5.0 -6.7 8
.Illinois 569 4.4 590 4.6 -3.6 -4.1 15
.New Jersey 508 5.8 482 5.5 5.4 5.1 7
.Georgia 504 5.4 505 5.5 -0.2 -2.7 9
100-499 cases in 2006
.North Carolina 374 4.2 329 3.8 13.7 11.3 18
.Pennsylvania 341 2.7 326 2.6 4.6 4.3 28
.Virginia 332 4.3 355 4.7 -6.5 -7.4 16
.Arizona 315 5.1 281 4.7 12.1 8.2 11
.Tennessee 279 4.6 299 5.0 -6.7 -8.0 12
.Washington 262 4.1 254 4.0 3.1 1.5 20
.Massachusetts 259 4.0 265 4.1 -2.3 -2.3 21
.Maryland 253 4.5 283 5.1 -10.6 -11.0 14
.Ohio 239 2.1 260 2.3 -8.1 -8.1 35
.South Carolina 222 5.1 261 6.1 -14.9 -16.4 10
.Michigan 221 2.2 246 2.4 -10.2 -10.1 33
.Minnesota 217 4.2 199 3.9 9.0 8.2 18
.Louisiana 207 4.8 257 5.7 -19.5 -15.3 12
.Alabama 196 4.3 216 4.7 -9.3 -10.3 16
.Oklahoma 144 4.0 144 4.1 0.0 -1.0 21
.Colorado 124 2.6 101 2.2 22.8 20.4 29
.Indiana 125 2.0 146 2.3 -14.4 -15.0 36
.Mississippi 115 4.0 103 3.5 11.7 11.6 21
.Hawaii 115 8.9 112 8.8 2.7 1.7 3
.Missouri 104 1.8 108 1.9 -3.7 -4.4 38
.Arkansas 102 3.6 115 4.1 -11.3 -12.4 25
.Nevada 101 4.0 112 4.6 -9.8 -12.8 21
<100 cases in 2006
.Connecticut 89 2.5 95 2.7 -6.3 -6.4 30
.Kentucky 84 2.0 124 3.0 -32.3 -32.8 36
.Kansas 82 3.0 60 2.2 36.7 35.9 27
.Oregon 81 2.2 103 2.8 -21.4 -22.7 33
.Wisconsin 75 1.3 78 1.4 -3.8 -4.3 45
.District of Columbia 72 12.4 55 9.4 30.9 31.0 1
.Alaska 70 10.4 59 8.9 18.6 17.4 2
.New Mexico 48 2.5 39 2.0 23.1 21.3 30
.Iowa 40 1.3 55 1.9 -27.3 -27.7 45
.Utah 34 1.3 29 1.2 17.2 14.5 45
.Delaware 29 3.4 27 3.2 7.4 5.9 26
.Rhode Island 26 2.4 47 4.4 -44.7 -44.4 32
.Nebraska 25 1.4 35 2.0 -28.6 -29.0 40
.West Virginia 22 1.2 28 1.5 -21.4 -21.6 49
.Idaho 20 1.4 23 1.6 -13.0 -15.2 40
.New Hampshire 17 1.3 4 0.3 325.0 322.4 45
.Maine 16 1.2 17 1.3 -5.9 -6.1 49
.South Dakota 14 1.8 16 2.1 -12.5 -13.3 38
.Montana 13 1.4 10 1.1 30.0 28.6 40
.North Dakota 9 1.4 6 0.9 50.0 49.7 40
.Vermont 8 1.3 8 1.3 0.0 -0.2 40
.Wyoming 4 0.8 0 0.0 … … 51
Total 13779 4.6 14080 4.7 -2.1 -3.1
Table 28.  Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and 
Grouped by Number of Cases: States and the District of Columbia, 2005 and 2006
States
2006 2005 2005–2006 % Change
No. Rate No. No.
Overall
Rank by 
2006 RateRate Rate
1Includes New York City.
Note: Denominators for computing 2005 and 2006 rates for states and the District of Columbia were obtained from Annual
Estimates of the Population for the United States and States, and for Puerto Rico: April 1, 2000–July 1, 2006 (NST-EST2006-01) 
(http://www.census.gov/popest/states/tables/NST-EST2006-01.xls) (accessed May 17, 2007).
See Table 20, page 37, for ranking of states without the District of Columbia.
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United States 12,971 12,956 (99.9) 505 (3.9)
Alabama 191 191 (100.0) 3 (1.6)
Alaska 63 63 (100.0) 2 (3.2)
Arizona 274 273 (99.6) 38 (13.9)
Arkansas 95 94 (98.9) 2 (2.1)
California 2,646 2,640 (99.8) 59 (2.2)
Colorado 117 117 (100.0) 1 (0.9)
Connecticut 85 85 (100.0) 0 (0.0)
Delaware 27 27 (100.0) 1 (3.7)
District of Columbia 67 67 (100.0) 1 (1.5)
Florida 981 978 (99.7) 53 (5.4)
Georgia 465 465 (100.0) 35 (7.5)
Hawaii 113 113 (100.0) 0 (0.0)
Idaho 19 19 (100.0) 1 (5.3)
Illinois 525 525 (100.0) 20 (3.8)
Indiana 109 109 (100.0) 3 (2.8)
Iowa 40 40 (100.0) 0 (0.0)
Kansas 81 81 (100.0) 4 (4.9)
Kentucky 84 84 (100.0) 2 (2.4)
Louisiana 194 194 (100.0) 12 (6.2)
Maine 15 15 (100.0) 1 (6.7)
Maryland 245 245 (100.0) 1 (0.4)
Massachusetts 251 251 (100.0) 8 (3.2)
Michigan 211 211 (100.0) 4 (1.9)
Minnesota 193 193 (100.0) 3 (1.6)
Mississippi 107 107 (100.0) 2 (1.9)
Missouri 92 92 (100.0) 2 (2.2)
Montana 13 13 (100.0) 0 (0.0)
Nebraska 22 22 (100.0) 0 (0.0)
Nevada 97 96 (99.0) 3 (3.1)
New Hampshire 15 15 (100.0) 1 (6.7)
New Jersey 492 492 (100.0) 4 (0.8)
New Mexico 46 46 (100.0) 1 (2.2)
New York State2 301 300 (99.7) 3 (1.0)
New York City 916 916 (100.0) 18 (2.0)
North Carolina 357 357 (100.0) 14 (3.9)
North Dakota 9 9 (100.0) 1 (11.1)
Ohio 223 223 (100.0) 5 (2.2)
Oklahoma 133 133 (100.0) 8 (6.0)
Oregon 77 77 (100.0) 1 (1.3)
Pennsylvania 307 306 (99.7) 4 (1.3)
Rhode Island 23 23 (100.0) 1 (4.3)
South Carolina 215 215 (100.0) 6 (2.8)
South Dakota 13 13 (100.0) 0 (0.0)
Tennessee 261 261 (100.0) 10 (3.8)
Texas 1,479 1,479 (100.0) 155 (10.5)
Utah 28 28 (100.0) 1 (3.6)
Vermont 8 8 (100.0) 0 (0.0)
Virginia 306 306 (100.0) 4 (1.3)
Washington 250 249 (99.6) 6 (2.4)
West Virginia 22 22 (100.0) 0 (0.0)
Wisconsin 64 64 (100.0) 1 (1.6)
Wyoming 4 4 (100.0) 0 (0.0)
American Samoa3 ... ... ... ... ...
Fed. States of Micronesia3 54 53 (98.1) 0 (0.0)
Guam3 44 44 (100.0) 1 (2.3)
Marshall Islands3 24 24 (100.0) 0 (0.0)
N. Mariana Islands3 34 34 (100.0) 1 (2.9)
Puerto Rico3 104 104 (100.0) 3 (2.9)
Republic of Palau3 3 3 (100.0) 0 (0.0)
U.S. Virgin Islands3     ... ... ... ... ...
Table 29. Tuberculosis Cases and Percentages by Residence in Correctional Facilities, 
Age > 15: Reporting Areas, 2006
Reporting Area
Total 
Cases
Cases with Information on Residence
 in Correctional Facilities
Cases Reported As Residents
 of Correctional Facilities1
No. No.(%) (%)
1Resident of correctional facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the Dis-
trict of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
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United States 12,971 12,842 (99.0) 796 (6.2)
Alabama 191 191 (100.0) 10 (5.2)
Alaska 63 63 (100.0) 28 (44.4)
Arizona 274 242 (88.3) 29 (12.0)
Arkansas 95 94 (98.9) 2 (2.1)
California 2,646 2,617 (98.9) 163 (6.2)
Colorado 117 117 (100.0) 7 (6.0)
Connecticut 85 85 (100.0) 4 (4.7)
Delaware 27 27 (100.0) 1 (3.7)
District of Columbia 67 67 (100.0) 7 (10.4)
Florida 981 969 (98.8) 80 (8.3)
Georgia 465 463 (99.6) 29 (6.3)
Hawaii 113 113 (100.0) 1 (0.9)
Idaho 19 19 (100.0) 1 (5.3)
Illinois 525 522 (99.4) 27 (5.2)
Indiana 109 109 (100.0) 7 (6.4)
Iowa 40 40 (100.0) 2 (5.0)
Kansas 81 81 (100.0) 4 (4.9)
Kentucky 84 84 (100.0) 6 (7.1)
Louisiana 194 188 (96.9) 17 (9.0)
Maine 15 15 (100.0) 1 (6.7)
Maryland 245 245 (100.0) 6 (2.4)
Massachusetts 251 249 (99.2) 11 (4.4)
Michigan 211 211 (100.0) 9 (4.3)
Minnesota 193 193 (100.0) 3 (1.6)
Mississippi 107 107 (100.0) 6 (5.6)
Missouri 92 91 (98.9) 11 (12.1)
Montana 13 13 (100.0) 2 (15.4)
Nebraska 22 22 (100.0) 1 (4.5)
Nevada 97 95 (97.9) 9 (9.5)
New Hampshire 15 15 (100.0) 1 (6.7)
New Jersey 492 492 (100.0) 24 (4.9)
New Mexico 46 44 (95.7) 3 (6.8)
New York State2 301 287 (95.3) 5 (1.7)
New York City 916 904 (98.7) 52 (5.8)
North Carolina 357 356 (99.7) 20 (5.6)
North Dakota 9 9 (100.0) 0 (0.0)
Ohio 223 220 (98.7) 10 (4.5)
Oklahoma 133 133 (100.0) 9 (6.8)
Oregon 77 77 (100.0) 11 (14.3)
Pennsylvania 307 305 (99.3) 8 (2.6)
Rhode Island 23 23 (100.0) 0 (0.0)
South Carolina 215 215 (100.0) 11 (5.1)
South Dakota 13 13 (100.0) 0 (0.0)
Tennessee 261 261 (100.0) 15 (5.7)
Texas 1,479 1,479 (100.0) 98 (6.6)
Utah 28 28 (100.0) 3 (10.7)
Vermont 8 8 (100.0) 1 (12.5)
Virginia 306 306 (100.0) 1 (0.3)
Washington 250 249 (99.6) 33 (13.3)
West Virginia 22 19 (86.4) 1 (5.3)
Wisconsin 64 63 (98.4) 6 (9.5)
Wyoming 4 4 (100.0) 0 (0.0)
American Samoa3 ... ... ... ... ...
Fed. States of Micronesia3 54 49 (90.7) 0 (0.0)
Guam3 44 43 (97.7) 1 (2.3)
Marshall Islands3 24 24 (100.0) 0 (0.0)
N. Mariana Islands3 34 33 (97.1) 0 (0.0)
Puerto Rico3 104 104 (100.0) 3 (2.9)
Republic of Palau3 3 3 (100.0) 0 (0.0)
U.S. Virgin Islands3 ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information
on Homeless Status
Cases Reported As
Being Homeless 
No. No.(%) (%)
Table 30. Tuberculosis Cases and Percentages by Homeless Status,1 Age >15: Reporting 
Areas, 2006
1Homeless within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the District of 
Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
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United States 12,971 12,953 (99.9) 312 (2.4)
Alabama 191 191 (100.0) 9 (4.7)
Alaska 63 63 (100.0) 0 (0.0)
Arizona 274 273 (99.6) 10 (3.7)
Arkansas 95 95 (100.0) 3 (3.2)
California 2,646 2,640 (99.8) 62 (2.3)
Colorado 117 117 (100.0) 7 (6.0)
Connecticut 85 85 (100.0) 2 (2.4)
Delaware 27 27 (100.0) 1 (3.7)
District of Columbia 67 67 (100.0) 0 (0.0)
Florida 981 978 (99.7) 15 (1.5)
Georgia 465 465 (100.0) 6 (1.3)
Hawaii 113 113 (100.0) 1 (0.9)
Idaho 19 19 (100.0) 3 (15.8)
Illinois 525 525 (100.0) 11 (2.1)
Indiana 109 109 (100.0) 4 (3.7)
Iowa 40 40 (100.0) 2 (5.0)
Kansas 81 81 (100.0) 4 (4.9)
Kentucky 84 84 (100.0) 6 (7.1)
Louisiana 194 194 (100.0) 4 (2.1)
Maine 15 15 (100.0) 0 (0.0)
Maryland 245 245 (100.0) 12 (4.9)
Massachusetts 251 251 (100.0) 3 (1.2)
Michigan 211 211 (100.0) 6 (2.8)
Minnesota 193 193 (100.0) 1 (0.5)
Mississippi 107 107 (100.0) 7 (6.5)
Missouri 92 92 (100.0) 5 (5.4)
Montana 13 13 (100.0) 0 (0.0)
Nebraska 22 22 (100.0) 0 (0.0)
Nevada 97 96 (99.0) 0 (0.0)
New Hampshire 15 15 (100.0) 1 (6.7)
New Jersey 492 492 (100.0) 7 (1.4)
New Mexico 46 46 (100.0) 1 (2.2)
New York State2 301 297 (98.7) 14 (4.7)
New York City 916 916 (100.0) 7 (0.8)
North Carolina 357 357 (100.0) 7 (2.0)
North Dakota 9 9 (100.0) 0 (0.0)
Ohio 223 223 (100.0) 11 (4.9)
Oklahoma 133 133 (100.0) 8 (6.0)
Oregon 77 77 (100.0) 5 (6.5)
Pennsylvania 307 305 (99.3) 11 (3.6)
Rhode Island 23 23 (100.0) 0 (0.0)
South Carolina 215 215 (100.0) 9 (4.2)
South Dakota 13 13 (100.0) 0 (0.0)
Tennessee 261 261 (100.0) 4 (1.5)
Texas 1,479 1,479 (100.0) 24 (1.6)
Utah 28 28 (100.0) 1 (3.6)
Vermont 8 8 (100.0) 0 (0.0)
Virginia 306 306 (100.0) 11 (3.6)
Washington 250 249 (99.6) 5 (2.0)
West Virginia 22 22 (100.0) 0 (0.0)
Wisconsin 64 64 (100.0) 1 (1.6)
Wyoming 4 4 (100.0) 1 (25.0)
American Samoa3 ... ... ... ... ...
Fed. States of Micronesia3 54 53 (98.1) 3 (5.7)
Guam3 44 44 (100.0) 0 (0.0)
Marshall Islands3 24 24 (100.0) 0 (0.0)
N. Mariana Islands3 34 34 (100.0) 0 (0.0)
Puerto Rico3 104 104 (100.0) 3 (2.9)
Republic of Palau3 3 3 (100.0) 0 (0.0)
U.S. Virgin Islands3 ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information on
Residence in Long-term Care Facilities
Cases Reported As Residents of
Long-term Care Facilities
No. No.(%) (%)
Table 31. Tuberculosis Cases and Percentages by Residence in Long-term Care Facilities,1
Age >15: Reporting Areas, 2006
1Resident of long-term care facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
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United States 12,971 12,655 (97.6) 247 (2.0)
Alabama 191 191 (100.0) 2 (1.0)
Alaska 63 62 (98.4) 0 (0.0)
Arizona 274 230 (83.9) 6 (2.6)
Arkansas 95 95 (100.0) 1 (1.1)
California 2,646 2,577 (97.4) 41 (1.6)
Colorado 117 117 (100.0) 0 (0.0)
Connecticut 85 85 (100.0) 2 (2.4)
Delaware 27 27 (100.0) 1 (3.7)
District of Columbia 67 67 (100.0) 1 (1.5)
Florida 981 972 (99.1) 28 (2.9)
Georgia 465 456 (98.1) 7 (1.5)
Hawaii 113 55 (48.7) -- --
Idaho 19 15 (78.9) 0 (0.0)
Illinois 525 494 (94.1) 8 (1.6)
Indiana 109 109 (100.0) 2 (1.8)
Iowa 40 40 (100.0) 1 (2.5)
Kansas 81 81 (100.0) 5 (6.2)
Kentucky 84 84 (100.0) 2 (2.4)
Louisiana 194 180 (92.8) 4 (2.2)
Maine 15 15 (100.0) 1 (6.7)
Maryland 245 242 (98.8) 6 (2.5)
Massachusetts 251 245 (97.6) 5 (2.0)
Michigan 211 210 (99.5) 3 (1.4)
Minnesota 193 192 (99.5) 1 (0.5)
Mississippi 107 107 (100.0) 1 (0.9)
Missouri 92 91 (98.9) 1 (1.1)
Montana 13 13 (100.0) 0 (0.0)
Nebraska 22 22 (100.0) 0 (0.0)
Nevada 97 96 (99.0) 3 (3.1)
New Hampshire 15 15 (100.0) 0 (0.0)
New Jersey 492 491 (99.8) 8 (1.6)
New Mexico 46 42 (91.3) 0 (0.0)
New York State2 301 285 (94.7) 2 (0.7)
New York City 916 900 (98.3) 27 (3.0)
North Carolina 357 354 (99.2) 7 (2.0)
North Dakota 9 8 (88.9) 1 (12.5)
Ohio 223 222 (99.6) 1 (0.5)
Oklahoma 133 133 (100.0) 8 (6.0)
Oregon 77 76 (98.7) 5 (6.6)
Pennsylvania 307 302 (98.4) 3 (1.0)
Rhode Island 23 23 (100.0) 0 (0.0)
South Carolina 215 214 (99.5) 3 (1.4)
South Dakota 13 13 (100.0) 0 (0.0)
Tennessee 261 260 (99.6) 6 (2.3)
Texas 1,479 1,479 (100.0) 32 (2.2)
Utah 28 28 (100.0) 0 (0.0)
Vermont 8 8 (100.0) 0 (0.0)
Virginia 306 306 (100.0) 6 (2.0)
Washington 250 242 (96.8) 6 (2.5)
West Virginia 22 19 (86.4) 0 (0.0)
Wisconsin 64 61 (95.3) 0 (0.0)
Wyoming 4 4 (100.0) 0 (0.0)
Amercian Samoa3 ... ... ... ... ...
Fed. States of Micronesia3 54 48 (88.9) 0 (0.0)
Guam3 44 44 (100.0) 0 (0.0)
Marshall Islands3 24 24 (100.0) 0 (0.0)
N. Mariana Islands3 34 33 (97.1) 0 (0.0)
Puerto Rico3 104 104 (100.0) 18 (17.3)
Republic of Palau3 3 3 (100.0) 0 (0.0)
U.S. Virgin Islands3 ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information on
Injecting Drug Use
Cases Reporting Injecting Drug Use
No. No.(%) (%)
Table 32. Tuberculosis Cases and Percentages by Injecting Drug Use,1 Age >15: 
Reporting Areas, 2006
1Injecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
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United States 12,971 12,611 (97.2) 990 (7.9)
Alabama 191 191 (100.0) 9 (4.7)
Alaska 63 61 (96.8) 2 (3.3)
Arizona 274 230 (83.9) 16 (7.0)
Arkansas 95 95 (100.0) 2 (2.1)
California 2,646 2,567 (97.0) 160 (6.2)
Colorado 117 117 (100.0) 4 (3.4)
Connecticut 85 85 (100.0) 5 (5.9)
Delaware 27 27 (100.0) 2 (7.4)
District of Columbia 67 65 (97.0) 3 (4.6)
Florida 981 973 (99.2) 145 (14.9)
Georgia 465 456 (98.1) 58 (12.7)
Hawaii 113 56 (49.6) -- --
Idaho 19 14 (73.7) -- --
Illinois 525 490 (93.3) 46 (9.4)
Indiana 109 109 (100.0) 5 (4.6)
Iowa 40 40 (100.0) 0 (0.0)
Kansas 81 81 (100.0) 9 (11.1)
Kentucky 84 84 (100.0) 8 (9.5)
Louisiana 194 173 (89.2) 27 (15.6)
Maine 15 15 (100.0) 1 (6.7)
Maryland 245 242 (98.8) 10 (4.1)
Massachusetts 251 236 (94.0) 10 (4.2)
Michigan 211 210 (99.5) 12 (5.7)
Minnesota 193 192 (99.5) 4 (2.1)
Mississippi 107 107 (100.0) 9 (8.4)
Missouri 92 91 (98.9) 6 (6.6)
Montana 13 13 (100.0) 0 (0.0)
Nebraska 22 22 (100.0) 0 (0.0)
Nevada 97 93 (95.9) 7 (7.5)
New Hampshire 15 15 (100.0) 1 (6.7)
New Jersey 492 491 (99.8) 25 (5.1)
New Mexico 46 42 (91.3) 3 (7.1)
New York State2 301 275 (91.4) 6 (2.2)
New York City 916 901 (98.4) 70 (7.8)
North Carolina 357 355 (99.4) 44 (12.4)
North Dakota 9 7 (77.8) 1 (14.3)
Ohio 223 222 (99.6) 18 (8.1)
Oklahoma 133 133 (100.0) 20 (15.0)
Oregon 77 74 (96.1) 8 (10.8)
Pennsylvania 307 302 (98.4) 10 (3.3)
Rhode Island 23 23 (100.0) 0 (0.0)
South Carolina 215 214 (99.5) 33 (15.4)
South Dakota 13 13 (100.0) 1 (7.7)
Tennessee 261 261 (100.0) 26 (10.0)
Texas 1,479 1,479 (100.0) 122 (8.2)
Utah 28 28 (100.0) 1 (3.6)
Vermont 8 8 (100.0) 0 (0.0)
Virginia 306 306 (100.0) 8 (2.6)
Washington 250 242 (96.8) 23 (9.5)
West Virginia 22 19 (86.4) 2 (10.5)
Wisconsin 64 62 (96.9) 6 (9.7)
Wyoming 4 4 (100.0) 0 (0.0)
American Samoa3 ... ... ... ... ...
Fed. States of Micronesia3 54 41 (75.9) 0 (0.0)
Guam3 44 41 (93.2) 0 (0.0)
Marshall Islands3 24 18 (75.0) 0 (0.0)
N. Mariana Islands3 34 31 (91.2) 0 (0.0)
Puerto Rico3 104 104 (100.0) 22 (21.2)
Republic of Palau3 3 3 (100.0) 0 (0.0)
U.S. Virgin Islands3 ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information on
Noninjecting Drug Use
Cases Reporting Noninjecting Drug Use
No. No.(%) (%)
Table 33. Tuberculosis Cases and Percentages by Noninjecting Drug Use,1 Age >15: 
Reporting Areas, 2006
1Noninjecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and
the District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
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United States 12,971 12,674 (97.7) 1,795 (14.2)
Alabama 191 191 (100.0) 21 (11.0)
Alaska 63 63 (100.0) 30 (47.6)
Arizona 274 232 (84.7) 38 (16.4)
Arkansas 95 95 (100.0) 6 (6.3)
California 2,646 2,576 (97.4) 222 (8.6)
Colorado 117 117 (100.0) 11 (9.4)
Connecticut 85 85 (100.0) 11 (12.9)
Delaware 27 27 (100.0) 3 (11.1)
District of Columbia 67 67 (100.0) 4 (6.0)
Florida 981 974 (99.3) 199 (20.4)
Georgia 465 452 (97.2) 83 (18.4)
Hawaii 113 74 (65.5) -- --
Idaho 19 16 (84.2) 3 (18.8)
Illinois 525 492 (93.7) 74 (15.0)
Indiana 109 109 (100.0) 22 (20.2)
Iowa 40 40 (100.0) 3 (7.5)
Kansas 81 81 (100.0) 17 (21.0)
Kentucky 84 84 (100.0) 11 (13.1)
Louisiana 194 179 (92.3) 36 (20.1)
Maine 15 15 (100.0) 3 (20.0)
Maryland 245 242 (98.8) 20 (8.3)
Massachusetts 251 245 (97.6) 20 (8.2)
Michigan 211 210 (99.5) 23 (11.0)
Minnesota 193 192 (99.5) 10 (5.2)
Mississippi 107 107 (100.0) 28 (26.2)
Missouri 92 91 (98.9) 13 (14.3)
Montana 13 13 (100.0) 4 (30.8)
Nebraska 22 22 (100.0) 1 (4.5)
Nevada 97 97 (100.0) 8 (8.2)
New Hampshire 15 15 (100.0) 2 (13.3)
New Jersey 492 491 (99.8) 31 (6.3)
New Mexico 46 44 (95.7) 11 (25.0)
New York State2 301 280 (93.0) 21 (7.5)
New York City 916 901 (98.4) 133 (14.8)
North Carolina 357 355 (99.4) 64 (18.0)
North Dakota 9 8 (88.9) 3 (37.5)
Ohio 223 221 (99.1) 27 (12.2)
Oklahoma 133 133 (100.0) 31 (23.3)
Oregon 77 74 (96.1) 6 (8.1)
Pennsylvania 307 302 (98.4) 19 (6.3)
Rhode Island 23 23 (100.0) 0 (0.0)
South Carolina 215 214 (99.5) 65 (30.4)
South Dakota 13 13 (100.0) 2 (15.4)
Tennessee 261 261 (100.0) 37 (14.2)
Texas 1,479 1,479 (100.0) 314 (21.2)
Utah 28 28 (100.0) 2 (7.1)
Vermont 8 8 (100.0) 0 (0.0)
Virginia 306 306 (100.0) 27 (8.8)
Washington 250 244 (97.6) 35 (14.3)
West Virginia 22 19 (86.4) 8 (42.1)
Wisconsin 64 63 (98.4) 10 (15.9)
Wyoming 4 4 (100.0) 1 (25.0)
American Samoa3 ... ... ... ... ...
Fed. States of Micronesia3 54 48 (88.9) 1 (2.1)
Guam3 44 43 (97.7) 0 (0.0)
Marshall Islands3 24 23 (95.8) 1 (4.3)
N. Mariana Islands3 34 32 (94.1) 0 (0.0)
Puerto Rico3 104 104 (100.0) 19 (18.3)
Republic of Palau3 3 3 (100.0) 0 (0.0)
U.S. Virgin Islands3 ... ... ... ... ...
Reporting Area
Total 
Cases
Cases with Information on
Excess Alcohol Use
Cases Reporting
Excess Alcohol Use
No. No.(%) (%)
Table 34. Tuberculosis Cases and Percentages by Excess Alcohol Use,1 Age >15: 
Reporting Areas, 2006
1Excess alcohol use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the 
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
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United States 13,779 13,458 13,402 (99.6) (1.2) (4.8) (83.0) (82.9)
Alabama 196 192 192 (100.0) (0.5) (2.1) (89.6) (89.6)
Alaska 70 68 68 (100.0) (1.5) (10.3) (80.9) (80.9)
Arizona 315 308 306 (99.4) (0.7) (3.9) (86.3) (84.6)
Arkansas 102 99 99 (100.0) (18.2) (27.3) (37.4) (37.4)
California 2,779 2,714 2,712 (99.9) (0.8) (2.9) (86.9) (86.8)
Colorado 124 121 121 (100.0) (0.8) (3.3) (79.3) (79.3)
Connecticut 89 85 85 (100.0) (1.2) (7.1) (82.4) (82.4)
Delaware 29 28 28 (100.0) (0.0) (3.6) (92.9) (92.9)
District of Columbia 72 72 64 (88.9) (1.6) (3.1) (93.8) (93.8)
Florida 1,038 1,013 1,012 (99.9) (0.2) (5.5) (85.1) (85.1)
Georgia 504 489 488 (99.8) (0.4) (5.9) (75.0) (75.0)
Hawaii 115 115 115 (100.0) (1.7) (5.2) (81.7) (80.9)
Idaho 20 20 19 (95.0) (5.3) (10.5) (78.9) (78.9)
Illinois 569 562 552 (98.2) (1.1) (5.8) (84.8) (84.8)
Indiana 125 123 122 (99.2) (0.0) (9.0) (84.4) (84.4)
Iowa 40 39 39 (100.0) (0.0) (10.3) (82.1) (82.1)
Kansas 82 78 78 (100.0) (0.0) (3.8) (84.6) (84.6)
Kentucky 84 83 83 (100.0) (0.0) (2.4) (88.0) (88.0)
Louisiana 207 196 195 (99.5) (3.1) (7.7) (87.2) (87.2)
Maine 16 16 16 (100.0) (0.0) (18.8) (81.3) (81.3)
Maryland 253 244 244 (100.0) (0.0) (4.5) (93.4) (93.4)
Massachusetts 259 257 255 (99.2) (0.4) (0.8) (85.1) (85.1)
Michigan 221 218 218 (100.0) (5.0) (19.7) (69.7) (69.7)
Minnesota 217 213 213 (100.0) (0.5) (4.2) (87.3) (87.3)
Mississippi 115 112 112 (100.0) (1.8) (13.4) (80.4) (80.4)
Missouri 104 102 102 (100.0) (2.0) (15.7) (78.4) (78.4)
Montana 13 12 12 (100.0) (0.0) (0.0) (100.0) (100.0)
Nebraska 25 24 24 (100.0) (0.0) (20.8) (79.2) (79.2)
Nevada 101 100 100 (100.0) (0.0) (0.0) (94.0) (94.0)
New Hampshire 17 17 17 (100.0) (0.0) (5.9) (88.2) (88.2)
New Jersey 508 497 497 (100.0) (1.0) (4.4) (82.7) (82.7)
New  Mexico 48 46 46 (100.0) (0.0) (10.9) (82.6) (82.6)
New York State4 317 310 309 (99.7) (1.0) (5.5) (84.8) (84.8)
New York City 954 939 939 (100.0) (1.6) (1.8) (86.5) (86.5)
North Carolina 374 367 367 (100.0) (0.5) (1.9) (90.7) (90.2)
North Dakota 9 9 9 (100.0) (0.0) (0.0) (100.0) (100.0)
Ohio 239 234 234 (100.0) (1.3) (3.4) (88.0) (87.6)
Oklahoma 144 141 141 (100.0) (12.8) (12.8) (63.1) (63.1)
Oregon 81 78 78 (100.0) (0.0) (2.6) (89.7) (89.7)
Pennsylvania 341 331 331 (100.0) (0.6) (3.6) (42.6) (42.6)
Rhode Island 26 26 26 (100.0) (7.7) (3.8) (76.9) (76.9)
South Carolina 222 213 213 (100.0) (0.9) (3.8) (81.2) (81.2)
South Dakota 14 14 14 (100.0) (0.0) (14.3) (71.4) (71.4)
Tennessee 279 273 273 (100.0) (1.5) (5.5) (61.9) (61.9)
Texas 1,585 1,541 1,518 (98.5) (1.1) (4.2) (84.4) (84.4)
Utah 34 34 34 (100.0) (0.0) (5.9) (88.2) (88.2)
Vermont 8 7 6 (85.7) (0.0) (50.0) (50.0) (50.0)
Virginia 332 321 321 (100.0) (0.9) (5.3) (83.5) (83.5)
Washington 262 257 257 (100.0) (1.2) (4.7) (86.8) (86.8)
West Virginia 22 22 21 (95.5) (0.0) (0.0) (90.5) (90.5)
Wisconsin 75 74 73 (98.6) (0.0) (6.8) (84.9) (84.9)
Wyoming 4 4 4 (100.0) (0.0) (0.0) (100.0) (100.0)
American Samoa5 ... ... ... ... ... ... ... ...
Fed. States of Micronesia5 71 69 68 (98.6) (0.0) (13.2) (80.9) (76.5)
Guam5 53 53 53 (100.0) (0.0) (1.9) (96.2) (96.2)
Marshall Islands5 27 27 27 (100.0) (0.0) (11.1) (81.5) (81.5)
N. Mariana Islands5 35 35 35 (100.0) (0.0) (2.9) (97.1) (97.1)
Puerto Rico5 112 105 105 (100.0) (2.9) (1.9) (92.4) (92.4)
Republic of Palau5 5 5 4 (80.0) (0.0) (25.0) (75.0) (75.0)
U.S. Virgin Islands5 ... ... ... ... ... ... ... ...
Table 35. Tuberculosis Cases and Percentages by Initial Drug Regimen: 
Reporting Areas, 2006
1Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia). Counts and percentages
shown only for reporting areas with information reported for >75% of cases.
2I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.
3 Streptomycin is no longer considered a fi rst-line drug.  CDC.  Treatment of Tuberculosis. American Thoracic Society, CDC, and Infec-
tious Diseases Society of America.  MMWR 2003;52(No.RR-11): 1–77.
4Excludes New York City.
5Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Excluding cases with no information on drug regimen, 421 (3.1%) persons were not started on any drugs, 12 (<0.1%) were started
on one drug, and 1,313 (9.6%) had an initial multidrug regimen other than IR, IRZ, or IRZ,E/S.
Ellipses indicate data not available.
Reporting Area
Total 
Cases
Cases with Information on
Initial Drug Regimen
Percentage of Cases in Persons with
Initial Drug Regimen1,2
No. (%) IRZ
Cases in 
Persons
Alive at 
Diagnosis IR IRZ,E/S IRZE3
60
United States 10,783 9,946 (92.2) 818 (8.2) 111 (1.1)
Alabama 174 138 (79.3) 3 (2.2) 1 (0.7)
Alaska 61 61 (100.0) 4 (6.6) 2 (3.3)
Arizona 229 201 (87.8) 17 (8.5) 2 (1.0)
Arkansas 72 69 (95.8) 1 (1.4) 0 (0.0)
California 2,241 2,136 (95.3) 209 (9.8) 31 (1.5)
Colorado 86 86 (100.0) 11 (12.8) 1 (1.2)
Connecticut 72 71 (98.6) 3 (4.2) 1 (1.4)
Delaware 23 23 (100.0) 0 (0.0) 0 (0.0)
District of Columbia 65 62 (95.4) 6 (9.7) 2 (3.2)
Florida 845 795 (94.1) 72 (9.1) 5 (0.6)
Georgia 388 368 (94.8) 27 (7.3) 0 (0.0)
Hawaii 83 82 (98.8) 9 (11.0) 0 (0.0)
Idaho 19 16 (84.2) 0 (0.0) 0 (0.0)
Illinois 437 404 (92.4) 26 (6.4) 1 (0.2)
Indiana 98 92 (93.9) 2 (2.2) 0 (0.0)
Iowa 29 29 (100.0) 1 (3.4) 0 (0.0)
Kansas 64 57 (89.1) 4 (7.0) 2 (3.5)
Kentucky 71 66 (93.0) 3 (4.5) 0 (0.0)
Louisiana 168 132 (78.6) 4 (3.0) 1 (0.8)
Maine 13 12 (92.3) 1 (8.3) 0 (0.0)
Maryland 196 195 (99.5) 13 (6.7) 0 (0.0)
Massachusetts 200 197 (98.5) 26 (13.2) 4 (2.0)
Michigan 176 173 (98.3) 10 (5.8) 1 (0.6)
Minnesota 177 175 (98.9) 19 (10.9) 2 (1.1)
Mississippi 88 85 (96.6) 4 (4.7) 0 (0.0)
Missouri 82 81 (98.8) 9 (11.1) 2 (2.5)
Montana 11 10 (90.9) 1 (10.0) 1 (10.0)
Nebraska 19 19 (100.0) 1 (5.3) 0 (0.0)
Nevada 87 86 (98.9) 8 (9.3) 0 (0.0)
New Hampshire 12 12 (100.0) 2 (16.7) 0 (0.0)
New Jersey 386 373 (96.6) 43 (11.5) 5 (1.3)
New Mexico 44 41 (93.2) 2 (4.9) 0 (0.0)
New York State3 239 238 (99.6) 34 (14.3) 3 (1.3)
New York City 717 691 (96.4) 70 (10.1) 15 (2.2)
North Carolina 302 290 (96.0) 22 (7.6) 0 (0.0)
North Dakota 7 7 (100.0) 0 (0.0) 0 (0.0)
Ohio 183 175 (95.6) 13 (7.4) 1 (0.6)
Oklahoma 77 71 (92.2) 3 (4.2) 0 (0.0)
Oregon 73 72 (98.6) 3 (4.2) 1 (1.4)
Pennsylvania 245 206 (84.1) 22 (10.7) 6 (2.9)
Rhode Island 13 13 (100.0) 2 (15.4) 0 (0.0)
South Carolina 173 165 (95.4) 7 (4.2) 0 (0.0)
South Dakota 11 11 (100.0) 1 (9.1) 0 (0.0)
Tennessee 207 196 (94.7) 2 (1.0) 0 (0.0)
Texas 1,218 918 (75.4) 43 (4.7) 9 (1.0)
Utah 22 22 (100.0) 3 (13.6) 0 (0.0)
Vermont 8 7 (87.5) 1 (14.3) 1 (14.3)
Virginia 267 228 (85.4) 21 (9.2) 4 (1.8)
Washington 216 210 (97.2) 26 (12.4) 5 (2.4)
West Virginia 22 14 (63.6) -- -- -- --
Wisconsin 64 62 (96.9) 3 (4.8) 2 (3.2)
Wyoming 3 3 (100.0) 0 (0.0) 0 (0.0)
American Samoa4 ... ... ... ... ... ... ...
Fed. States of Micronesia4 26 21 (80.8) 0 (0.0) 0 (0.0)
Guam4 32 29 (90.6) 2 (6.9) 0 (0.0)
Marshall Islands4 17 16 (94.1) 1 (6.3) 1 (6.3)
N. Mariana Islands4 14 6 (42.9) -- -- -- --
Puerto Rico4 105 99 (94.3) 5 (5.1) 1 (1.0)
Republic of Palau4 2 1 (50.0) -- -- -- --
U.S. Virgin Islands4 ... ... ... ... ... ... ...
1Patients tested to at least isoniazid and rifampin
2Isolates may be resistant to other drugs. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District 
of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
3Excludes New York City.
4Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
Table 36. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility 
Results, by Resistance to INH or Multidrug Resistance: Reporting Areas, 2006
Reporting Area
Total 
Culture
Positive
Cases
Cases with Initial Drug-
Susceptibility Testing Performed1
Resistance2
No. (%)
Isoniazid1 Isoniazid and Rifampin1
No. No.(%) (%)
61
United States 4,702 3,157 (67.1) -- --
Alabama 62 55 (88.7) 6 (10.9)
Alaska 23 20 (87.0) 1 (5.0)
Arizona 106 89 (84.0) 9 (10.1)
Arkansas 25 21 (84.0) 3 (14.3)
California 859 0 (0.0) -- --
Colorado 36 35 (97.2) 5 (14.3)
Connecticut 37 28 (75.7) 5 (17.9)
Delaware 6 6 (100.0) 2 (33.3)
District of Columbia 30 26 (86.7) 5 (19.2)
Florida 375 348 (92.8) 100 (28.7)
Georgia 194 174 (89.7) 34 (19.5)
Hawaii 33 13 (39.4) -- --
Idaho 8 1 (12.5) -- --
Illinois 175 149 (85.1) 18 (12.1)
Indiana 41 26 (63.4) -- --
Iowa 15 12 (80.0) 3 (25.0)
Kansas 30 30 (100.0) 1 (3.3)
Kentucky 23 22 (95.7) 3 (13.6)
Louisiana 74 58 (78.4) 11 (19.0)
Maine 6 5 (83.3) 0 (0.0)
Maryland 99 85 (85.9) 16 (18.8)
Massachusetts 117 84 (71.8) -- --
Michigan 59 44 (74.6) -- --
Minnesota 75 68 (90.7) 6 (8.8)
Mississippi 30 29 (96.7) 7 (24.1)
Missouri 37 29 (78.4) 4 (13.8)
Montana 6 6 (100.0) 0 (0.0)
Nebraska 9 9 (100.0) 0 (0.0)
Nevada 32 31 (96.9) 4 (12.9)
New Hampshire 6 6 (100.0) 0 (0.0)
New Jersey 223 158 (70.9) -- --
New Mexico 11 10 (90.9) 0 (0.0)
New York State3 111 86 (77.5) 16 (18.6)
New York City 381 320 (84.0) 64 (20.0)
North Carolina 132 126 (95.5) 14 (11.1)
North Dakota 4 4 (100.0) 0 (0.0)
Ohio 81 73 (90.1) 6 (8.2)
Oklahoma 35 34 (97.1) 3 (8.8)
Oregon 26 24 (92.3) 2 (8.3)
Pennsylvania 99 67 (67.7) -- --
Rhode Island 11 8 (72.7) -- --
South Carolina 64 62 (96.9) 12 (19.4)
South Dakota 5 5 (100.0) 2 (40.0)
Tennessee 83 71 (85.5) 10 (14.1)
Texas 555 390 (70.3) -- --
Utah 12 12 (100.0) 1 (8.3)
Vermont -- --       --                                          --                                 --
Virginia 119 95 (79.8) 13 (13.7)
Washington 94 82 (87.2) 5 (6.1)
West Virginia 5 1 (20.0) -- --
Wisconsin 21 18 (85.7) 0 (0.0)
Wyoming 1 1 (100.0) 0 (0.0)
American Samoa4 ... ... ... ... ...
Fed. States of Micronesia4 14 8 (57.1) -- --
Guam4 13 10 (76.9) 0 (0.0)
Marshall Islands4 4 4 (100.0) 0 (0.0)
N. Mariana Islands4 18 18 (100.0) 0 (0.0)
Puerto Rico4 31 30 (96.8) 11 (36.7)
Republic of Palau4 3 3 (100.0) 0 (0.0)
U.S. Virgin Islands4 ... ... ... ... ...
Table 37. Tuberculosis Cases and Percentages Among Persons Aged 25–44 by HIV Status: 
Reporting Areas, 2006
1Includes only those cases in persons with negative, positive, or indeterminate HIV test results.
2Counts and percentages shown only for reporting areas with information reported for >75% of cases. All 2006 California cases had an 
unknown HIV status because CA HIV data for 2006 were not available at time of publication.
3Excludes New York City.
4Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
Reporting Area
Total 
Cases
Cases with Information on HIV Status1 Cases in Persons with HIV-Positive Results2
No. (%) No. (%)
62
United States 12,971 12,598 (97.1) (52.6) (3.2) (0.1) (1.2) (42.7) (0.1)
Alabama 191 191 (100.0) (54.5) (3.7) (0.5) (1.0) (40.3) (0.0)
Alaska 63 61 (96.8) (65.6) (3.3) (0.0) (0.0) (31.1) (0.0)
Arizona 274 220 (80.3) (53.6) (4.1) (0.9) (5.0) (36.4) (0.0)
Arkansas 95 82 (86.3) (90.2) (0.0) (0.0) (0.0) (9.8) (0.0)
California 2,646 2,525 (95.4) (57.4) (2.7) (0.0) (1.9) (38.0) (0.0)
Colorado 117 116 (99.1) (54.3) (0.9) (0.0) (0.9) (44.0) (0.0)
Connecticut 85 85 (100.0) (36.5) (4.7) (0.0) (0.0) (58.8) (0.0)
Delaware 27 27 (100.0) (48.1) (0.0) (0.0) (0.0) (51.9) (0.0)
District of Columbia 67 67 (100.0) (82.1) (0.0) (0.0) (0.0) (17.9) (0.0)
Florida 981 977 (99.6) (41.5) (2.8) (0.2) (3.2) (52.1) (0.3)
Georgia 465 430 (92.5) (32.3) (3.7) (0.2) (0.5) (63.3) (0.0)
Hawaii 113 90 (79.6) (60.0) (6.7) (0.0) (0.0) (33.3) (0.0)
Idaho 19 18 (94.7) (44.4) (5.6) (0.0) (11.1) (38.9) (0.0)
Illinois 525 484 (92.2) (58.7) (3.7) (0.2) (0.0) (37.4) (0.0)
Indiana 109 109 (100.0) (56.0) (2.8) (0.0) (0.0) (41.3) (0.0)
Iowa 40 40 (100.0) (42.5) (2.5) (0.0) (0.0) (55.0) (0.0)
Kansas 81 81 (100.0) (33.3) (7.4) (0.0) (0.0) (59.3) (0.0)
Kentucky 84 84 (100.0) (58.3) (2.4) (0.0) (2.4) (36.9) (0.0)
Louisiana 194 184 (94.8) (48.9) (1.6) (1.1) (0.0) (48.4) (0.0)
Maine 15 15 (100.0) (66.7) (6.7) (0.0) (0.0) (26.7) (0.0)
Maryland 245 244 (99.6) (40.6) (3.7) (0.0) (0.4) (55.3) (0.0)
Massachusetts 251 240 (95.6) (46.3) (5.0) (0.0) (1.3) (47.5) (0.0)
Michigan 211 211 (100.0) (59.7) (4.7) (0.0) (0.0) (35.5) (0.0)
Minnesota 193 193 (100.0) (53.4) (5.2) (0.0) (0.0) (40.9) (0.5)
Mississippi 107 107 (100.0) (59.8) (1.9) (0.0) (1.9) (36.4) (0.0)
Missouri 92 91 (98.9) (50.5) (6.6) (0.0) (0.0) (42.9) (0.0)
Montana 13 13 (100.0) (69.2) (0.0) (0.0) (0.0) (30.8) (0.0)
Nebraska 22 22 (100.0) (36.4) (0.0) (0.0) (0.0) (63.6) (0.0)
Nevada 97 95 (97.9) (34.7) (3.2) (0.0) (0.0) (62.1) (0.0)
New Hampshire 15 15 (100.0) (46.7) (6.7) (0.0) (0.0) (46.7) (0.0)
New Jersey 492 492 (100.0) (49.0) (3.9) (0.0) (0.8) (45.9) (0.4)
New Mexico 46 44 (95.7) (40.9) (0.0) (0.0) (0.0) (56.8) (2.3)
New York State2 301 290 (96.3) (45.9) (5.2) (0.7) (0.3) (47.9) (0.0)
New York City 916 893 (97.5) (53.1) (3.6) (0.0) (0.0) (43.3) (0.0)
North Carolina 357 356 (99.7) (52.2) (2.0) (0.3) (2.2) (43.0) (0.3)
North Dakota 9 8 (88.9) (25.0) (0.0) (0.0) (0.0) (75.0) (0.0)
Ohio 223 222 (99.6) (59.0) (3.6) (0.9) (0.9) (35.6) (0.0)
Oklahoma 133 133 (100.0) (58.6) (2.3) (0.0) (0.0) (38.3) (0.8)
Oregon 77 76 (98.7) (55.3) (3.9) (0.0) (5.3) (35.5) (0.0)
Pennsylvania 307 304 (99.0) (35.9) (2.0) (0.0) (0.7) (61.5) (0.0)
Rhode Island 23 23 (100.0) (39.1) (4.3) (0.0) (0.0) (56.5) (0.0)
South Carolina 215 214 (99.5) (54.2) (1.9) (0.0) (2.3) (41.6) (0.0)
South Dakota 13 13 (100.0) (69.2) (7.7) (0.0) (0.0) (23.1) (0.0)
Tennessee 261 261 (100.0) (58.2) (3.8) (0.0) (0.0) (37.5) (0.4)
Texas 1,479 1,479 (100.0) (59.4) (3.7) (0.1) (0.5) (35.9) (0.3)
Utah 28 28 (100.0) (46.4) (0.0) (0.0) (0.0) (53.6) (0.0)
Vermont 8 8 (100.0) (62.5) (0.0) (0.0) (0.0) (37.5) (0.0)
Virginia 306 306 (100.0) (58.8) (2.0) (0.0) (0.7) (38.6) (0.0)
Washington 250 246 (98.4) (46.3) (3.7) (0.0) (1.2) (48.8) (0.0)
West Virginia 22 20 (90.9) (60.0) (5.0) (0.0) (0.0) (35.0) (0.0)
Wisconsin 64 61 (95.3) (44.3) (3.3) (0.0) (1.6) (50.8) (0.0)
Wyoming 4 4 (100.0) (25.0) (0.0) (0.0) (0.0) (75.0) (0.0)
American Samoa3 ... ... ... ... ... ... ... ... ...
Fed. States of Micronesia3 54 49 (90.7) (79.6) (0.0) (0.0) (0.0) (20.4) (0.0)
Guam3 44 39 (88.6) (64.1) (5.1) (0.0) (0.0) (30.8) (0.0)
Marshall Islands3 24 24 (100.0) (62.5) (0.0) (0.0) (0.0) (37.5) (0.0)
N. Mariana Islands3 34 32 (94.1) (15.6) (0.0) (0.0) (0.0) (84.4) (0.0)
Puerto Rico3 104 102 (98.1) (77.5) (1.0) (0.0) (0.0) (20.6) (1.0)
Republic of Palau3 3 3 (100.0) (0.0) (0.0) (0.0) (0.0) (100.0) (0.0)
U.S. Virgin Islands3 ... ... ... ... ... ... ... ... ...
Table 38. Tuberculosis Cases and Percentages by Occupation, Age >15: Reporting Areas, 
2006
1Occupation within past 24 months of TB diagnosis. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and 
the District of Columbia). Percentages shown only for reporting areas with information reported for >75% of cases.
2Excludes New York City.
3Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
Reporting Area
Total 
Cases
Cases with
Information on 
Occupation
Percentage of Cases by Occupation1
No. (%)
Unemployed
Past 24 Mos.
Health Care 
Worker
Correctional
Employee
Migrant
Worker
Other
Occupation
Multiple
Occupations
63
United States 14,502 14,209 13,768 (96.9) (57.1) (17.8) (25.1)
Alabama 211 198 198 (100.0) (70.2) (4.5) (25.3)
Alaska 43 42 42 (100.0) (16.7) (0.0) (83.3)
Arizona 272 267 247 (92.5) (62.8) (22.7) (14.6)
Arkansas 133 126 50 (39.7) -- -- --
California 2,992 2,948 2,930 (99.4) (52.9) (29.6) (17.6)
Colorado 128 126 126 (100.0) (72.2) (4.0) (23.8)
Connecticut 101 98 98 (100.0) (12.2) (41.8) (45.9)
Delaware 33 32 32 (100.0) (68.8) (9.4) (21.9)
District of Columbia 81 80 80 (100.0) (48.8) (37.5) (13.8)
Florida 1,074 1,043 1,039 (99.6) (72.9) (13.0) (14.1)
Georgia 537 526 509 (96.8) (73.3) (7.9) (18.9)
Hawaii 116 113 110 (97.3) (40.9) (10.9) (48.2)
Idaho 11 11 10 (90.9) (40.0) (40.0) (20.0)
Illinois 567 554 552 (99.6) (45.3) (24.8) (29.9)
Indiana 128 126 126 (100.0) (1.6) (17.5) (81.0)
Iowa 47 47 47 (100.0) (4.3) (2.1) (93.6)
Kansas 62 61 61 (100.0) (36.1) (8.2) (55.7)
Kentucky 127 124 124 (100.0) (62.1) (13.7) (24.2)
Louisiana 248 241 217 (90.0) (57.1) (7.4) (35.5)
Maine 20 20 20 (100.0) (100.0) (0.0) (0.0)
Maryland 313 306 302 (98.7) (86.8) (6.0) (7.3)
Massachusetts 283 279 275 (98.6) (44.0) (9.5) (46.5)
Michigan 272 265 262 (98.9) (63.7) (17.2) (19.1)
Minnesota 199 197 197 (100.0) (52.8) (43.7) (3.6)
Mississippi 119 112 112 (100.0) (98.2) (1.8) (0.0)
Missouri 127 122 121 (99.2) (14.9) (27.3) (57.9)
Montana 15 15 15 (100.0) (40.0) (0.0) (60.0)
Nebraska 39 38 38 (100.0) (0.0) (31.6) (68.4)
Nevada 95 93 93 (100.0) (90.3) (7.5) (2.2)
New Hampshire 24 24 24 (100.0) (0.0) (4.2) (95.8)
New Jersey 482 474 474 (100.0) (66.2) (29.1) (4.6)
New Mexico 42 39 38 (97.4) (63.2) (23.7) (13.2)
New York State3 323 319 315 (98.7) (56.5) (22.5) (21.0)
New York City 1,037 1,022 1,013 (99.1) (36.4) (19.7) (43.8)
North Carolina 381 372 370 (99.5) (58.1) (7.8) (34.1)
North Dakota 4 4 4 (100.0) (0.0) (0.0) (100.0)
Ohio 219 212 209 (98.6) (51.7) (21.5) (26.8)
Oklahoma 178 176 176 (100.0) (99.4) (0.6) (0.0)
Oregon 106 104 104 (100.0) (48.1) (8.7) (43.3)
Pennsylvania 328 320 317 (99.1) (77.3) (20.5) (2.2)
Rhode Island 51 50 50 (100.0) (98.0) (2.0) (0.0)
South Carolina 233 229 227 (99.1) (84.1) (3.5) (12.3)
South Dakota 11 10 10 (100.0) (80.0) (0.0) (20.0)
Tennessee 278 270 267 (98.9) (44.6) (6.4) (49.1)
Texas 1,672 1,638 1,412 (86.2) (55.8) (11.8) (32.4)
Utah 36 35 35 (100.0) (22.9) (5.7) (71.4)
Vermont 6 6 6 (100.0) (0.0) (33.3) (66.7)
Virginia 329 329 319 (97.0) (76.8) (13.5) (9.7)
Washington 245 243 242 (99.6) (65.3) (3.7) (31.0)
West Virginia 24 24 24 (100.0) (20.8) (0.0) (79.2)
Wisconsin 95 94 94 (100.0) (2.1) (1.1) (96.8)
Wyoming 5 5 5 (100.0) (0.0) (60.0) (40.0)
American Samoa4 3 3 0 (0.0) -- -- --
Fed. States of Micronesia4 8 8 3 (37.5) -- -- --
Guam4 51 49 47 (95.9) (91.5) (8.5) (0.0)
Marshall Islands4 41 40 36 (90.0) (100.0) (0.0) (0.0)
N. Mariana Islands4 55 55 55 (100.0) (98.2) (1.8) (0.0)
Puerto Rico4 123 108 108 (100.0) (87.0) (10.2) (2.8)
Republic of Palau4 5 5 5 (100.0) (60.0) (0.0) (40.0)
U.S. Virgin Islands4     ... ... … ... ... ... ...
1Most recent year for which data are available.
2Health Department: All outpatient care provided by the state or local health department; Private/Other: All care (except contact inves-
tigation and dispensing of medication) provided by non–health department providers; Both Health Department and Private/Other: Both
sectors involved in the care of the patient. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of 
Columbia). Percentages shown only for reporting areas with information reported for >75% of cases.
3Excludes New York City.
4Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
Table 39. Tuberculosis Cases and Percentages by Type of Health Care Provider: Reporting 
Areas, 20041
Reporting Area
Total 
Cases
Percentage of Cases by
Type of Health Care Provider2
No. (%)
Health
Department
Private/
Other
Both Health 
Department and 
Private/Other
Cases in 
Persons
Alive at 
Diagnosis
Cases with Information on
Type of Health Care Provider
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United States 14,502 14,078 13,664 (97.1) (58.9) (27.5)
Alabama 211 198 198 (100.0) (15.7) (83.8)
Alaska 43 42 42 (100.0) (95.2) (4.8)
Arizona 272 262 244 (93.1) (79.9) (12.7)
Arkansas 133 125 121 (96.8) (18.2) (42.1)
California 2,992 2,904 2,879 (99.1) (61.6) (20.7)
Colorado 128 126 126 (100.0) (92.1) (4.8)
Connecticut 101 97 97 (100.0) (17.5) (52.6)
Delaware 33 32 32 (100.0) (43.8) (50.0)
District of Columbia 81 80 80 (100.0) (28.8) (16.3)
Florida 1,074 1,032 1,027 (99.5) (54.6) (39.9)
Georgia 537 519 506 (97.5) (84.4) (13.8)
Hawaii 116 113 110 (97.3) (5.5) (79.1)
Idaho 11 10 9 (90.0) (44.4) (22.2)
Illinois 567 546 545 (99.8) (55.8) (20.2)
Indiana 128 126 126 (100.0) (64.3) (31.0)
Iowa 47 47 47 (100.0) (55.3) (27.7)
Kansas 62 60 59 (98.3) (94.9) (3.4)
Kentucky 127 124 124 (100.0) (62.9) (29.8)
Louisiana 248 240 215 (89.6) (83.7) (7.4)
Maine 20 20 20 (100.0) (95.0) (0.0)
Maryland 313 303 301 (99.3) (85.0) (11.6)
Massachusetts 283 279 276 (98.9) (37.0) (33.0)
Michigan 272 265 262 (98.9) (19.8) (30.2)
Minnesota 199 196 196 (100.0) (79.6) (18.9)
Mississippi 119 111 111 (100.0) (43.2) (56.8)
Missouri 127 122 119 (97.5) (41.2) (38.7)
Montana 15 15 15 (100.0) (80.0) (6.7)
Nebraska 39 38 38 (100.0) (63.2) (5.3)
Nevada 95 92 92 (100.0) (85.9) (5.4)
New Hampshire 24 24 24 (100.0) (54.2) (37.5)
New Jersey 482 472 471 (99.8) (42.7) (24.0)
New Mexico 42 39 37 (94.9) (97.3) (2.7)
New York State4 323 318 318 (100.0) (20.1) (73.6)
New York City 1,037 1,013 1,002 (98.9) (0.5) (68.5)
North Carolina 381 372 370 (99.5) (94.6) (5.4)
North Dakota 4 4 4 (100.0) (25.0) (25.0)
Ohio 219 209 208 (99.5) (55.8) (26.9)
Oklahoma 178 176 176 (100.0) (100.0) (0.0)
Oregon 106 103 103 (100.0) (63.1) (35.9)
Pennsylvania 328 318 310 (97.5) (60.3) (23.5)
Rhode Island 51 50 50 (100.0) (28.0) (72.0)
South Carolina 233 229 227 (99.1) (93.8) (1.8)
South Dakota 11 10 10 (100.0) (80.0) (10.0)
Tennessee 278 269 266 (98.9) (63.2) (36.1)
Texas 1,672 1,621 1,352 (83.4) (82.7) (14.3)
Utah 36 35 35 (100.0) (97.1) (2.9)
Vermont 6 6 6 (100.0) (33.3) (16.7)
Virginia 329 320 313 (97.8) (86.6) (10.2)
Washington 245 243 242 (99.6) (85.1) (13.2)
West Virginia 24 24 24 (100.0) (62.5) (29.2)
Wisconsin 95 94 94 (100.0) (36.2) (53.2)
Wyoming 5 5 5 (100.0) (20.0) (60.0)
American Samoa5 3 3 0 (0.0) -- --
Fed. States of Micronesia5 8 8 3 (37.5) -- --
Guam5 51 49 47 (95.9) (4.3) (95.7)
Marshall Islands5 41 39 36 (92.3) (5.6) (91.7)
N. Mariana Islands5 55 55 55 (100.0) (92.7) (5.5)
Puerto Rico5 123 108 107 (99.1) (61.7) (0.0)
Republic of Palau5 5 5 5 (100.0) (0.0) (100.0)
U.S. Virgin Islands5 ... ... ... ... ... ...
Table 40. Tuberculosis Cases and Percentages by Directly Observed Therapy (DOT): Report-
ing Areas, 20041
1Most recent year for which data are available.
2Includes persons alive at diagnosis with an initial drug regimen of one or more drugs prescribed.
3Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for 
reporting areas with information reported for >75% of cases.
4Excludes New York City.
5Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
Reporting Area
Total 
Cases
Percentage of Cases by
Directly Observed Therapy3
No. (%) DOT Only
Both DOT and 
Self-Administered
Cases with 
Initial Drug 
Regimen
Prescribed2
Cases with Information on
Directly Observed Therapy
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Table 41. Tuberculosis Cases and Percentages by Completion of Tuberculosis Therapy 
(COT): Reporting Areas, 20041
1Most recent year for which data are available.
2Initial isolate susceptible to rifampin (n=9,699) or susceptibility unknown (n=157); culture negative (n=2,418); culture status un-
known (n=656); age unknown (n=1).
3Initial isolate rifampin resistant, or pediatric patients (aged <15) with meningeal, bone, joint, or miliary disease.
4Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, who did not die during 
therapy. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages 
shown only for reporting areas with information reported for >90% of cases.
5Excludes New York City.
6Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available. See Technical Notes for description of Completion of Therapy calculation (page 9).
Reporting Area
Total 
Cases
All Drug Therapy
No.4 COT(%) No.4 COT(%)
Therapy <1 Year Indicated2
COT <1 Year(%)
Therapy >1 Year Indicated3
No.4 COT(%)
United States 14,502 12802 (82.3) (91.0) 335 (77.9) 13137 (90.7)
Alabama 211 179 (89.9) (96.6) 8 (100.0) 187 (96.8)
Alaska 43 38 (84.2) (100.0) 0 ... 38 (100.0)
Arizona 272 246 (74.8) (85.4) 5 (80.0) 251 (85.3)
Arkansas 133 114 (88.6) (93.0) 3 (66.7) 117 (92.3)
California 2,992 2639 (81.5) (92.0) 79 (75.9) 2718 (91.6)
Colorado 128 116 (96.6) (98.3) 4 (100.0) 120 (98.3)
Connecticut 101 85 (77.6) (95.3) 3 (100.0) 88 (95.5)
Delaware 33 29 (93.1) (93.1) 0 ... 29 (93.1)
District of Columbia 81 66 (93.9) (98.5) 1 (100.0) 67 (98.5)
Florida 1,074 928 (85.9) (94.6) 18 (83.3) 946 (94.4)
Georgia 537 458 (83.2) (91.7) 11 (90.9) 469 (91.7)
Hawaii 116 108 (79.6) (88.9) 1 (100.0) 109 (89.0)
Idaho 11 10 (80.0) (80.0) 0 ... 10 (80.0)
Illinois 567 505 (79.6) (93.3) 8 (62.5) 513 (92.8)
Indiana 128 111 (93.7) (98.2) 0 ... 111 (98.2)
Iowa 47 47 (76.6) (91.5) 0 ... 47 (91.5)
Kansas 62 57 (84.2) (89.5) 1 (100.0) 58 (89.7)
Kentucky 127 110 (87.3) (98.2) 2 (100.0) 112 (98.2)
Louisiana 248 231 -- -- 1 -- 232 --
Maine 20 18 (66.7) (94.4) 0 ... 18 (94.4)
Maryland 313 279 (90.7) (97.1) 6 (100.0) 285 (97.2)
Massachusetts 283 256 (76.6) (93.4) 5 (100.0) 261 (93.5)
Michigan 272 239 (87.0) (93.7) 6 (83.3) 245 (93.5)
Minnesota 199 187 (90.9) (95.7) 5 (80.0) 192 (95.3)
Mississippi 119 101 (83.2) (94.1) 5 (80.0) 106 (93.4)
Missouri 127 111 (82.0) (89.2) 1 (100.0) 112 (89.3)
Montana 15 14 (92.9) (100.0) 0 ... 14 (100.0)
Nebraska 39 37 (86.5) (94.6) 0 ... 37 (94.6)
Nevada 95 88 (90.9) (93.2) 2 (100.0) 90 (93.3)
New Hampshire 24 21 (100.0) (100.0) 2 (100.0) 23 (100.0)
New Jersey 482 429 (82.3) (92.8) 14 (71.4) 443 (92.1)
New Mexico 42 33 (84.8) (93.9) 2 (50.0) 35 (91.4)
New York State5 323 293 (86.3) (97.3) 10 (80.0) 303 (96.7)
New York City 1,037 901 (84.5) (90.9) 40 (62.5) 941 (89.7)
North Carolina 381 332 (92.5) (96.7) 10 (80.0) 342 (96.2)
North Dakota 4 4 (100.0) (100.0) 0 ... 4 (100.0)
Ohio 219 190 (87.9) (92.6) 3 (100.0) 193 (92.7)
Oklahoma 178 164 (80.5) (95.1) 2 (100.0) 166 (95.2)
Oregon 106 97 (89.7) (92.8) 0 ... 97 (92.8)
Pennsylvania 328 280 -- -- 8 -- 288 --
Rhode Island 51 49 (85.7) (91.8) 0 ... 49 (91.8)
South Carolina 233 213 (82.6) (90.6) 1 (100.0) 214 (90.7)
South Dakota 11 9 (44.4) (88.9) 0 ... 9 (88.9)
Tennessee 278 237 (85.7) (93.2) 2 (100.0) 239 (93.3)
Texas 1,672 1472 -- -- 49 -- 1521 --
Utah 36 32 (96.9) (100.0) 2 (100.0) 34 (100.0)
Vermont 6 6 (66.7) (83.3) 0 ... 6 (83.3)
Virginia 329 292 (88.4) (92.1) 7 (85.7) 299 (92.0)
Washington 245 226 (88.1) (95.6) 7 (85.7) 233 (95.3)
West Virginia 24 21 (81.0) (100.0) 1 (100.0) 22 (100.0)
Wisconsin 95 89 (79.8) (92.1) 0 ... 89 (92.1)
Wyoming 5 5 (100.0) (100.0) 0 ... 5 (100.0)
American Samoa6 ... ... ... ... ... ... ... ...
Fed. States of Micronesia6   ... ... ... ... ... ... ... ...
Guam6 51 45 (84.4) (86.7) 0 ... 45 (86.7)
Marshall Islands6 ... ... ... ... ... ... ... ...
N. Mariana Islands6 ... ... ... ... ... ... ... ...
Puerto Rico6 123 89 (79.8) (92.1) 1 (100.0) 90 (92.2)
Republic of Palau6 ... ... ... ... ... ... ... ...
U.S. Virgin Islands6     ... ... ... ... ... ... ... ...
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United States 14,078 11,910 (84.6) 348 (2.5) 322 (2.3) 79 (0.6) 941 (6.7) 478 (3.4)
Alabama 198 181 (91.4) 2 (1.0) 2 (1.0) 1 (0.5) 11 (5.6) 1 (0.5)
Alaska 42 38 (90.5) 0 (0.0) 0 (0.0) 0 (0.0) 4 (9.5) 0 (0.0)
Arizona 262 214 (81.7) 5 (1.9) 15 (5.7) 2 (0.8) 11 (4.2) 15 (5.7)
Arkansas 125 108 (86.4) 1 (0.8) 3 (2.4) 0 (0.0) 8 (6.4) 5 (4.0)
California 2,904 2,489 (85.7) 125 (4.3) 64 (2.2) 10 (0.3) 186 (6.4) 30 (1.0)
Colorado 126 118 (93.7) 0 (0.0) 1 (0.8) 0 (0.0) 6 (4.8) 1 (0.8)
Connecticut 97 84 (86.6) 4 (4.1) 0 (0.0) 0 (0.0) 9 (9.3) 0 (0.0)
Delaware 32 27 (84.4) 1 (3.1) 0 (0.0) 1 (3.1) 3 (9.4) 0 (0.0)
District of Columbia 80 66 (82.5) 1 (1.3) 0 (0.0) 0 (0.0) 13 (16.3) 0 (0.0)
Florida 1,032 893 (86.5) 28 (2.7) 20 (1.9) 1 (0.1) 86 (8.3) 4 (0.4)
Georgia 519 430 (82.9) 12 (2.3) 12 (2.3) 9 (1.7) 50 (9.6) 6 (1.2)
Hawaii 113 97 (85.8) 4 (3.5) 2 (1.8) 1 (0.9) 4 (3.5) 5 (4.4)
Idaho 10 8 (80.0) 1 (10.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (10.0)
Illinois 546 476 (87.2) 14 (2.6) 12 (2.2) 3 (0.5) 33 (6.0) 8 (1.5)
Indiana 126 109 (86.5) 0 (0.0) 2 (1.6) 0 (0.0) 15 (11.9) 0 (0.0)
Iowa 47 43 (91.5) 2 (4.3) 1 (2.1) 1 (2.1) 0 (0.0) 0 (0.0)
Kansas 60 52 (86.7) 2 (3.3) 3 (5.0) 0 (0.0) 2 (3.3) 1 (1.7)
Kentucky 124 110 (88.7) 0 (0.0) 1 (0.8) 0 (0.0) 12 (9.7) 1 (0.8)
Louisiana 240 181 (75.4) 5 (2.1) 12 (5.0) 0 (0.0) 8 (3.3) 34 (14.2)
Maine 20 17 (85.0) 0 (0.0) 1 (5.0) 0 (0.0) 2 (10.0) 0 (0.0)
Maryland 303 277 (91.4) 3 (1.0) 2 (0.7) 2 (0.7) 18 (5.9) 1 (0.3)
Massachusetts 279 244 (87.5) 6 (2.2) 9 (3.2) 0 (0.0) 18 (6.5) 2 (0.7)
Michigan 265 229 (86.4) 2 (0.8) 5 (1.9) 6 (2.3) 20 (7.5) 3 (1.1)
Minnesota 196 183 (93.4) 4 (2.0) 1 (0.5) 4 (2.0) 4 (2.0) 0 (0.0)
Mississippi 111 99 (89.2) 5 (4.5) 0 (0.0) 0 (0.0) 5 (4.5) 2 (1.8)
Missouri 122 100 (82.0) 5 (4.1) 2 (1.6) 4 (3.3) 10 (8.2) 1 (0.8)
Montana 15 14 (93.3) 0 (0.0) 0 (0.0) 0 (0.0) 1 (6.7) 0 (0.0)
Nebraska 38 35 (92.1) 2 (5.3) 0 (0.0) 0 (0.0) 1 (2.6) 0 (0.0)
Nevada 92 84 (91.3) 5 (5.4) 1 (1.1) 0 (0.0) 2 (2.2) 0 (0.0)
New Hampshire 24 23 (95.8) 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.2) 0 (0.0)
New Jersey 472 408 (86.4) 3 (0.6) 30 (6.4) 1 (0.2) 29 (6.1) 1 (0.2)
New Mexico 39 32 (82.1) 0 (0.0) 0 (0.0) 2 (5.1) 4 (10.3) 1 (2.6)
New York State5 318 293 (92.1) 1 (0.3) 5 (1.6) 2 (0.6) 15 (4.7) 2 (0.6)
New York City 1,013 844 (83.3) 24 (2.4) 22 (2.2) 7 (0.7) 72 (7.1) 44 (4.3)
North Carolina 372 329 (88.4) 1 (0.3) 10 (2.7) 0 (0.0) 30 (8.1) 2 (0.5)
North Dakota 4 4 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Ohio 209 179 (85.6) 4 (1.9) 5 (2.4) 2 (1.0) 16 (7.7) 3 (1.4)
Oklahoma 176 158 (89.8) 6 (3.4) 2 (1.1) 0 (0.0) 10 (5.7) 0 (0.0)
Oregon 103 90 (87.4) 1 (1.0) 3 (2.9) 0 (0.0) 6 (5.8) 3 (2.9)
Pennsylvania 318 223 (70.1) 9 (2.8) 10 (3.1) 1 (0.3) 30 (9.4) 45 (14.2)
Rhode Island 50 45 (90.0) 3 (6.0) 1 (2.0) 0 (0.0) 1 (2.0) 0 (0.0)
South Carolina 229 194 (84.7) 6 (2.6) 4 (1.7) 6 (2.6) 15 (6.6) 4 (1.7)
South Dakota 10 8 (80.0) 0 (0.0) 1 (10.0) 0 (0.0) 1 (10.0) 0 (0.0)
Tennessee 269 223 (82.9) 1 (0.4) 5 (1.9) 4 (1.5) 30 (11.2) 6 (2.2)
Texas 1,621 1,206 (74.4) 39 (2.4) 31 (1.9) 4 (0.2) 100 (6.2) 241 (14.9)
Utah 35 34 (97.1) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.9) 0 (0.0)
Vermont 6 5 (83.3) 0 (0.0) 0 (0.0) 1 (16.7) 0 (0.0) 0 (0.0)
Virginia 320 275 (85.9) 8 (2.5) 14 (4.4) 1 (0.3) 21 (6.6) 1 (0.3)
Washington 243 222 (91.4) 3 (1.2) 4 (1.6) 1 (0.4) 10 (4.1) 3 (1.2)
West Virginia 24 22 (91.7) 0 (0.0) 0 (0.0) 0 (0.0) 2 (8.3) 0 (0.0)
Wisconsin 94 82 (87.2) 0 (0.0) 4 (4.3) 2 (2.1) 5 (5.3) 1 (1.1)
Wyoming 5 5 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
American Samoa6 3 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3 (100.0)
Fed. States of Micronesia6 8 2 (25.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (12.5) 5 (62.5)
Guam6 49 39 (79.6) 2 (4.1) 0 (0.0) 0 (0.0) 4 (8.2) 4 (8.2)
Marshall Islands6 39 34 (87.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5 (12.8)
N. Mariana Islands6 55 49 (89.1) 6 (10.9) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Puerto Rico6 108 83 (76.9) 0 (0.0) 5 (4.6) 1 (0.9) 18 (16.7) 1 (0.9)
Republic of Palau6 5 4 (80.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (20.0)
U.S. Virgin Islands6 ... ... ... ... ... ... ... ... ... ... ... ... ...
Table 42. Tuberculosis Cases and Percentages by Reason Therapy Stopped: 
Reporting Areas, 20041
1Most recent year for which data are available.
2Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed. Percentage for U.S. based on 52 
reporting areas (50 states, New York City, and the District of Columbia).
3Died = Died of any cause.
4Includes cases reported as Other, Missing, or Unknown.
5Excludes New York City.
6Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Ellipses indicate data not available.
Reporting Area
Completed Moved Lost Refused Died3 Unknown4
No. No. No. No. No. No.(%) (%) (%) (%) (%) (%)
Cases with 
Initial Drug 
Regimen
Prescribed2
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United States 12,802 3,768 (80.0) 138 (81.9) 3,107 (83.2) 3,508 (82.9) 2,227 (83.8) 54 (85.2)
Alabama 179 15 (80.0) 0 ... 17 (94.1) 95 (89.5) 52 (92.3) 0 ...
Alaska 38 0 ... 27 (85.2) 7 (71.4) 2 (100.0) 1 (100.0) 1 (100.0)
Arizona 246 133 (68.4) 15 (66.7) 26 (92.3) 27 (88.9) 44 (79.5) 1 (0.0)
Arkansas 114 21 (76.2) 2 (100.0) 29 (89.7) 22 (95.5) 39 (89.7) 1 (100.0)
California 2,639 1,051 (78.5) 4 (100.0) 1,140 (83.7) 187 (81.3) 248 (83.9) 9 (88.9)
Colorado 116 49 (100.0) 1 (0.0) 13 (100.0) 34 (94.1) 19 (94.7) 0 ...
Connecticut 85 28 (89.3) 0 ... 22 (77.3) 17 (52.9) 18 (83.3) 0 ...
Delaware 29 7 (100.0) 0 ... 6 (83.3) 12 (100.0) 4 (75.0) 0 ...
District of Columbia 66 10 (90.0) 0 ... 6 (100.0) 44 (93.2) 5 (100.0) 1 (100.0)
Florida 928 263 (84.4) 2 (50.0) 67 (85.1) 372 (86.0) 221 (87.8) 3 (100.0)
Georgia 458 83 (81.9) 0 ... 45 (75.6) 264 (84.1) 64 (87.5) 2 (50.0)
Hawaii 108 3 (66.7) 0 ... 101 (81.2) 0 ... 4 (50.0) 0 ...
Idaho 10 4 (50.0) 0 ... 0 ... 1 (100.0) 5 (100.0) 0 ...
Illinois 505 141 (80.9) 2 (50.0) 116 (81.0) 166 (74.7) 75 (85.3) 5 (100.0)
Indiana 111 19 (94.7) 1 (100.0) 16 (93.8) 39 (92.3) 36 (94.4) 0 ...
Iowa 47 9 (77.8) 0 ... 11 (100.0) 12 (58.3) 15 (73.3) 0 ...
Kansas 57 26 (84.6) 0 ... 9 (100.0) 12 (75.0) 10 (80.0) 0 ...
Kentucky 110 21 (76.2) 0 ... 5 (100.0) 15 (100.0) 69 (87.0) 0 ...
Louisiana 231 10 (70.0) 0 ... 23 (60.9) 137 (71.5) 61 (65.6) 0 ...
Maine 18 0 ... 0 ... 1 (100.0) 7 (57.1) 9 (66.7) 1 (100.0)
Maryland 279 37 (81.1) 0 ... 72 (95.8) 139 (90.6) 31 (90.3) 0 ...
Massachusetts 256 47 (80.9) 1 (100.0) 96 (76.0) 61 (78.7) 51 (70.6) 0 ...
Michigan 239 29 (82.8) 0 ... 51 (88.2) 101 (82.2) 57 (96.5) 1 (100.0)
Minnesota 187 26 (88.5) 7 (85.7) 36 (94.4) 98 (90.8) 20 (90.0) 0 ...
Mississippi 101 5 (20.0) 1 (100.0) 4 (50.0) 66 (86.4) 25 (92.0) 0 ...
Missouri 111 13 (84.6) 0 ... 14 (92.9) 41 (75.6) 43 (83.7) 0 ...
Montana 14 1 (100.0) 5 (100.0) 1 (100.0) 0 ... 6 (83.3) 1 (100.0)
Nebraska 37 12 (83.3) 1 (100.0) 4 (75.0) 11 (90.9) 7 (85.7) 2 (100.0)
Nevada 88 32 (87.5) 3 (100.0) 15 (93.3) 12 (100.0) 26 (88.5) 0 ...
New Hampshire 21 5 (100.0) 0 ... 8 (100.0) 4 (100.0) 4 (100.0) 0 ...
New Jersey 429 150 (88.0) 0 ... 143 (76.2) 92 (81.5) 44 (84.1) 0 ...
New Mexico 33 19 (84.2) 9 (88.9) 0 ... 0 ... 5 (80.0) 0 ...
New York City 901 278 (85.6) 0 ... 274 (85.4) 272 (82.7) 71 (83.1) 6 (83.3)
New York State5 293 87 (85.1) 0 ... 70 (85.7) 72 (84.7) 63 (90.5) 1 (100.0)
North Carolina 332 88 (86.4) 4 (100.0) 38 (97.4) 136 (94.9) 66 (92.4) 0 ...
North Dakota 4 0 ... 1 (100.0) 1 (100.0) 0 ... 2 (100.0) 0 ...
Ohio 190 23 (87.0) 0 ... 31 (77.4) 73 (94.5) 61 (85.2) 2 (100.0)
Oklahoma 164 27 (70.4) 32 (84.4) 18 (77.8) 30 (86.7) 53 (81.1) 4 (75.0)
Oregon 97 23 (95.7) 1 (100.0) 31 (93.5) 14 (85.7) 28 (82.1) 0 ...
Pennsylvania 280 30 (50.0) 0 ... 100 (66.0) 87 (62.1) 63 (77.8) 0 ...
Rhode Island 49 17 (82.4) 0 ... 7 (85.7) 12 (83.3) 13 (92.3) 0 ...
South Carolina 213 34 (73.5) 0 ... 18 (72.2) 125 (84.8) 36 (88.9) 0 ...
South Dakota 9 2 (50.0) 4 (25.0) 0 ... 0 ... 3 (66.7) 0 ...
Tennessee 237 26 (84.6) 0 ... 16 (87.5) 106 (82.1) 89 (89.9) 0 ...
Texas 1,472 730 (73.4) 1 (0.0) 180 (75.0) 337 (74.8) 218 (68.8) 6 (50.0)
Utah 32 10 (100.0) 1 (100.0) 8 (100.0) 5 (80.0) 8 (100.0) 0 ...
Vermont 6 0 ... 0 ... 1 (100.0) 2 (50.0) 3 (66.7) 0 ...
Virginia 292 73 (91.8) 1 (0.0) 90 (90.0) 84 (81.0) 42 (95.2) 2 (100.0)
Washington 226 26 (92.3) 11 (90.9) 90 (87.8) 47 (87.2) 47 (85.1) 5 (100.0)
West Virginia 21 2 (100.0) 0 ... 0 ... 2 (100.0) 17 (76.5) 0 ...
Wisconsin 89 21 (81.0) 1 (100.0) 29 (82.8) 14 (85.7) 24 (70.8) 0 ...
Wyoming 5 2 (100.0) 0 ... 1 (100.0) 0 ... 2 (100.0) 0 ...
American Samoa6 3 0 ... 0 ... 3 (0.0) 0 ... 0 ... 0 ...
Fed. States of Micronesia6 5 0 ... 0 ... 5 (40.0) 0 ... 0 ... 0 ...
Guam6 45 0 ... 0 ... 37 (91.9) 0 ... 0 ... 8 (50.0)
Marshall Islands6 38 0 ... 0 ... 35 (80.0) 0 ... 0 ... 3 (33.3)
N. Mariana Islands6 54 0 ... 0 ... 53 (86.8) 0 ... 0 ... 1 (100.0)
Puerto Rico6 89 88 (79.5) 0 ... 1 (100.0) 0 ... 0 ... 0 ...
Republic of Palau6 5 0 ... 0 ... 5 (80.0) 0 ... 0 ... 0 ...
U.S. Virgin Islands6 ... ... ... ... ... ... ... ... ... ... ... ... ...
Table 43. Completion of Tuberculosis Therapy (COT) Cases and Percentages1 by Hispanic 
Ethnicity and Non-Hispanic Race: Reporting Areas, 20042
1Percentages shown only for reporting areas with information reported for >90% of cases, and indicate the percentage of those who completed 
therapy within 1 year. 
2Most recent year for which data are available.
3Therapy < 1 year indicated in persons alive at diagnosis with an initial regimen of one or more drugs prescribed, who did not die during therapy. 
4Persons of Hispanic or Latino origin may be of any race.
5Excludes New York City.
6Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
Note: Case counts and percentage for race categories do not include persons of Hispanic ethnicity. Ellipses indicate data not available.
See Technical Notes for description of Completion of Therapy calculation (page 9).
Reporting Area
Total
Cases3
Unknown or 
MissingWhiteBlackHispanic4
American Indian 
or Alaska Native
Asian or Pacifi c 
Islander
Non-Hispanic
No. (%) No. No. No. No.(%) (%) (%) (%)No. (%)
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United States 14,139 (81.5) 13,922 (81.5) 13,130 (82.1) 13,069 (82.7) 12,802 (82.3)
Alabama 258 (88.8) 223 (81.2) 201 (90.0) 232 (86.6) 179 (89.9)
Alaska 105 (89.5) 50 (88.0) 45 (91.1) 51 (92.2) 38 (84.2)
Arizona 228 (78.1) 251 (82.1) 222 (80.2) 260 (79.6) 246 (74.8)
Arkansas 175 (84.0) 138 (92.0) 114 (86.8) 116 (87.1) 114 (88.6)
California 2,912 (80.1) 2,938 (80.9) 2,791 (82.7) 2,839 (81.4) 2,639 (81.5)
Colorado 80 (95.0) 125 (92.0) 96 (84.4) 102 (93.1) 116 (96.6)
Connecticut 91 (69.2) 112 (73.2) 89 (70.8) 100 (76.0) 85 (77.6)
Delaware 21 (81.0) 30 (93.3) 22 (90.9) 28 (85.7) 29 (93.1)
District of Columbia 70 (80.0) 62 (85.5) 75 (98.7) 68 (91.2) 66 (93.9)
Florida 994 (81.8) 1,007 (81.6) 931 (82.3) 917 (85.9) 928 (85.9)
Georgia 591 (82.1) 500 (82.6) 456 (78.9) 480 (79.6) 458 (83.2)
Hawaii 117 (75.2) 138 (74.6) 136 (69.9) 99 (78.8) 108 (79.6)
Idaho 13 (53.8) 7 (71.4) 12 (58.3) 13 (84.6) 10 (80.0)
Illinois 630 (83.8) 633 (78.2) 577 (77.6) 563 (80.8) 505 (79.6)
Indiana 119 (89.9) 97 (92.8) 105 (96.2) 118 (95.8) 111 (93.7)
Iowa 38 (89.5) 36 (77.8) 33 (81.8) 37 (91.9) 47 (76.6)
Kansas 70 (82.9) 70 (72.9) 73 (83.6) 64 (78.1) 57 (84.2)
Kentucky 117 (88.0) 131 (87.8) 129 (85.3) 120 (85.8) 110 (87.3)
Louisiana 284 (78.5) 259 (74.5) 207 (81.6) 219 (81.7) 231 (68.8)
Maine 22 (72.7) 19 (94.7) 18 (77.8) 23 (69.6) 18 (66.7)
Maryland 253 (85.0) 230 (90.0) 261 (87.7) 239 (87.9) 279 (90.7)
Massachusetts 258 (85.3) 247 (77.3) 254 (76.8) 243 (80.2) 256 (76.6)
Michigan 244 (83.6) 271 (81.9) 261 (82.0) 205 (84.9) 239 (87.0)
Minnesota 169 (85.8) 218 (84.9) 218 (85.3) 200 (89.5) 187 (90.9)
Mississippi 153 (84.3) 137 (83.9) 112 (83.0) 112 (71.4) 101 (83.2)
Missouri 181 (83.4) 137 (84.7) 114 (86.0) 105 (73.3) 111 (82.0)
Montana 19 (89.5) 17 (94.1) 10 (90.0) 5 (100.0) 14 (92.9)
Nebraska 22 (63.6) 31 (83.9) 23 (69.6) 25 (68.0) 37 (86.5)
Nevada 90 (84.4) 87 (81.6) 70 (98.6) 96 (91.7) 88 (90.9)
New Hampshire 22 (77.3) 19 (89.5) 18 (88.9) 13 (92.3) 21 (100.0)
New Jersey 473 (76.1) 456 (76.5) 474 (79.1) 450 (81.8) 429 (82.3)
New Mexico 37 (70.3) 44 (86.4) 49 (83.7) 37 (86.5) 33 (84.8)
New York City 1,111 (84.1) 1,049 (85.5) 910 (86.2) 982 (86.5) 901 (84.5)
New York State4 353 (80.7) 369 (83.2) 314 (77.1) 296 (82.8) 293 (86.3)
North Carolina 388 (91.0) 339 (88.8) 366 (90.7) 323 (89.5) 332 (92.5)
North Dakota 5 (100.0) 5 (100.0) 6 (100.0) 4 (50.0) 4 (100.0)
Ohio 297 (74.4) 256 (79.7) 219 (80.4) 193 (90.7) 190 (87.9)
Oklahoma 128 (84.4) 160 (80.6) 168 (85.7) 137 (70.1) 164 (80.5)
Oregon 111 (80.2) 111 (88.3) 101 (88.1) 96 (84.4) 97 (89.7)
Pennsylvania 334 (74.6) 277 (76.9) 299 (75.6) 288 (79.5) 280 (65.7)
Rhode Island 43 (76.7) 60 (73.3) 44 (68.2) 40 (90.0) 49 (85.7)
South Carolina 244 (77.9) 227 (85.0) 222 (80.2) 232 (86.6) 213 (82.6)
South Dakota 12 (75.0) 12 (66.7) 9 (88.9) 16 (68.8) 9 (44.4)
Tennessee 322 (80.4) 263 (85.2) 277 (84.1) 237 (81.0) 237 (85.7)
Texas 1,310 (79.8) 1,426 (76.6) 1,342 (76.5) 1,389 (76.7) 1,472 (73.1)
Utah 40 (75.0) 31 (83.9) 30 (93.3) 35 (97.1) 32 (96.9)
Vermont 2 (100.0) 7 (100.0) 8 (87.5) 8 (100.0) 6 (66.7)
Virginia 253 (87.0) 267 (81.6) 285 (86.7) 299 (87.3) 292 (88.4)
Washington 231 (82.3) 240 (85.0) 238 (83.2) 234 (82.5) 226 (88.1)
West Virginia 24 (54.2) 25 (64.0) 26 (65.4) 17 (70.6) 21 (81.0)
Wisconsin 73 (83.6) 75 (81.3) 67 (83.6) 61 (86.9) 89 (79.8)
Wyoming 2 (100.0) 3 (100.0) 3 (100.0) 3 (100.0) 5 (100.0)
American Samoa5 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3 (0.0)
Fed. States of Micronesia5 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5 (40.0)
Guam5 47 (93.6) 54 (75.9) 79 (51.9) 58 (87.9) 45 (84.4)
Marshall Islands5 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 38 (76.3)
N. Mariana Islands5 72 (83.3) 50 (88.0) 50 (70.0) 42 (78.6) 54 (87.0)
Puerto Rico5 126 (87.3) 92 (92.4) 93 (79.6) 89 (70.8) 89 (79.8)
Republic of Palau5 0 (0.0) 0 (0.0) 0 (0.0) 7 (57.1) 5 (80.0)
U.S. Virgin Islands5 ... ... ... ... ... ... ... ... ... ...
Reporting Area
2000 2001 2002 2003 2004
Year
No.2 No.2 No.2No.2(%)3 (%)3 (%)3 (%)3 (%)3
Table 44. Tuberculosis Cases and Percentages in Persons Completing Therapy for Whom 
Therapy Was Indicated for One Year or Less: Reporting Areas, 2000–20041
1Most recent year for which data are available.
2Total cases for which therapy less than 1 year indicated in persons alive at diagnosis, with an initial regimen of one or more drugs pre-
scribed, who did not die during therapy. 
3Percentage of total cases in persons who completed therapy for whom therapy less than 1 year was indicated.
4Excludes New York City.
5Not included in U.S. totals. Data for 2006 are interim as of April 6, 2007.
See Technical Notes for description of Completion of Therapy calculation (page 9).
No.2
69
70
71
Albuquerque, NM 9 9
Anaheim, CA 28 24
Arlington, TX 19 28
Atlanta, GA 38 36
Austin, TX 38 47
Baltimore, MD 35 68
Birmingham, AL 18 15
Boston, MA 61 57
Buffalo, NY 6 8
Charlotte, NC 50 46
Chicago, IL 290 328
Cincinnati, OH 22 20
Cleveland, OH 22 46
Colorado Springs, CO 6 8
Columbus, OH 74 74
Corpus Christi, TX 34 22
Dallas, TX 169 154
Denver, CO 46 48
Detroit, MI 59 84
El Paso, TX 65 45
Fort Worth, TX 62 81
Fresno, CA 35 45
Honolulu, HI 49 46
Houston, TX 377 341
Indianapolis, IN 47 45
Jacksonville, FL 87 77
Kansas City, MO 23 23
Las Vegas, NV 72 74
Long Beach, CA 38 53
Los Angeles, CA 333 349
Louisville, KY 18 25
Memphis, TN 101 87
Mesa, AZ 16 15
Miami, FL 127 97
Milwaukee, WI 21 22
Minneapolis, MN 63 54
Nashville, TN 49 53
Newark, NJ 41 47
New Orleans, LA 30 61
New York, NY 954 984
Norfolk, VA 7 23
Oakland, CA 50 46
Oklahoma City, OK 28 35
Omaha, NE 9 16
Philadelphia, PA 143 116
Phoenix, AZ 100 100
Pittsburgh, PA 7 11
Portland, OR 29 39
Sacramento, CA 67 122
St. Louis, MO 30 29
St. Paul, MN 42 30
San Antonio, TX 89 73
San Diego, CA 202 165
San Francisco, CA 120 132
San Jose, CA 155 126
Santa Ana, CA 38 34
Seattle, WA 86 73
Tampa, FL 56 69
Toledo, OH 5 11
Tucson, AZ 29 24
Tulsa, OK 20 21
Virginia Beach, VA 11 12
Washington, DC 72 55
Wichita, KS 23 18
TOTAL - 64 CITIES 5,050 5,126
San Juan, PR 9 13
Table 45. Tuberculosis Cases in Selected Cities1: 2006 and 2005
Cases2
2006 2005City
1Historical list of cities.
2Case counts are based on verifi ed cases in persons residing within city limits. 
Residence within city limits was determined by the health department.
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Table 46. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan 
Statistical Areas with >500,000 Population, 2006 and 2005
Metropolitan
Statistical Area
Cases Case Rates
Population
Estimates
20062006 20062005 2005
Akron, OH 5 10 (0.7) (1.4) 700,943
Albany-Schenectady-Troy, NY 17 16 (2.0) (1.9) 850,957
Albuquerque, NM 12 13 (1.5) (1.6) 816,811
Allentown-Bethlehem-Easton, PA-NJ 22 13 (2.7) (1.6) 800,336
Atlanta-Sandy Springs-Marietta, GA 280 296 (5.4) (6.0) 5,138,223
Augusta-Richmond County, GA-SC 35 30 (6.7) (5.8) 523,249
Austin-Round Rock, TX 52 57 (3.4) (3.9) 1,513,565
Bakersfi eld, CA 40 42 (5.1) (5.5) 780,117
Baltimore-Towson, MD 83 122 (3.1) (4.6) 2,658,405
Baton Rouge, LA 17 17 (2.2) (2.3) 766,514
Birmingham-Hoover, AL 44 44 (4.0) (4.0) 1,100,019
Boise City-Nampa, ID 5 11 (0.9) (2.0) 567,640
Boston-Cambridge-Quincy, MA-NH 176 169 (4.0) (3.8) 4,455,217
Bridgeport-Stamford-Norwalk, CT 33 39 (3.7) (4.3) 900,440
Buffalo-Niagara Falls, NY 15 13 (1.3) (1.1) 1,137,520
Cape Coral-Fort Myers, FL 19 16 (3.3) (2.9) 571,344
Charleston-North Charleston, SC 34 44 (5.6) (7.4) 603,178
Charlotte-Gastonia-Concord, NC-SC 81 72 (5.1) (4.7) 1,583,016
Chicago-Naperville-Joliet, IL 522 564 (5.5) (6.0) 9,505,748
Cincinnati-Middleton, OH-KY-IN 36 42 (1.7) (2.0) 2,104,218
Cleveland-Elyria-Mentor, OH 47 69 (2.2) (3.2) 2,114,155
Colorado Springs, CO 10 9 (1.7) (1.5) 599,127
Columbia, SC 20 14 (2.8) (2.0) 703,771
Columbus, OH 90 82 (5.2) (4.8) 1,725,570
Dallas-Fort Worth-Arlington, TX 422 402 (7.0) (6.9) 6,003,967
Dayton, OH 15 7 (1.8) (0.8) 838,940
Denver-Aurora, CO 85 71 (3.5) (3.0) 2,408,750
Des Moines-West Des Moines, IA 15 13 (2.8) (2.5) 534,230
Detroit-Warren-Livonia, MI 131 170 (2.9) (3.8) 4,468,966
El Paso, TX 72 49 (9.8) (6.8) 736,310
Fresno, CA 62 69 (7.0) (7.9) 891,756
Grand Rapids-Wyoming, MI 22 13 (2.8) (1.7) 774,084
Greensboro-High Point, NC 42 32 (6.1) (4.7) 685,378
Greenville, SC 11 6 (1.8) (1.0) 601,986
Harrisburg-Carlisle, PA 5 23 (1.0) (4.4) 525,380
Hartford-West Hartford-East Hartford, CT 20 26 (1.7) (2.2) 1,188,841
Honolulu, HI 95 83 (10.4) (9.2) 909,863
Houston-Sugar Land-Baytown, TX 473 454 (8.5) (8.5) 5,539,949
Indianapolis-Carmel, IN 51 52 (3.1) (3.2) 1,666,032
Jackson, MS 31 24 (5.9) (4.6) 529,456
Jacksonville, FL 96 93 (7.5) (7.5) 1,277,997
Kansas City, MO-KS 50 47 (2.5) (2.4) 1,967,405
Knoxville, TN 15 14 (2.2) (2.1) 667,384
Lakeland, FL 31 53 (5.5) (9.8) 561,606
Las Vegas-Paradise, NV 89 90 (5.0) (5.3) 1,777,539
Little Rock-North Little Rock, AR 11 22 (1.7) (3.4) 652,834
Los Angeles-Long BeachSanta Ana, CA 1,157 1,215 (8.9) (9.4) 12,950,129
Louisville-Jefferson County, KY-IN 28 38 (2.3) (3.1) 1,222,216
Madison, WI 11 16 (2.0) (3.0) 543,022
McAllen-Edinburg-Mission, TX 68 92 (9.7) (13.6) 700,634
Memphis, TN-MS-AR 121 97 (9.5) (7.7) 1,274,704
Miami-Fort Lauderdale-Miami Beach, FL 369 420 (6.8) (7.7) 5,463,857
Milwaukee-Waukesha-West Allis, WI 33 35 (2.2) (2.3) 1,509,981
Minneapolis-St. Paul-Bloomington, MN-WI 169 167 (5.3) (5.3) 3,175,041
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Modesto, CA 16 11 (3.1) (2.2) 512,138
Nashville-Davidson-Murfreesboro, TN 82 100 (5.6) (7.0) 1,455,097
New Haven-Milford, CT 22 25 (2.6) (3.0) 845,244
New Orleans-Metairie-Kenner, LA 80 115 (7.8) (8.8) 1,024,678
New York-Northern New Jersey-Long Island, NY-NJ-PA 1,574 1,569 (8.4) (8.3) 18,818,536
Oklahoma City, OK 46 44 (3.9) (3.8) 1,172,339
Omaha-Council Bluffs, NE-IA 13 19 (1.6) (2.3) 822,549
Orlando-Kissimmee, FL 141 121 (7.1) (6.3) 1,984,855
Oxnard-Thousand Oaks-Ventura, CA 49 55 (6.1) (6.9) 799,720
Palm Bay-Melbourne-Titusville, FL 8 14 (1.5) (2.6) 534,359
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 285 244 (4.9) (4.2) 5,826,742
Phoenix-Mesa-Scottsdale, AZ 205 194 (5.1) (5.0) 4,039,182
Pittsburgh, PA 31 37 (1.3) (1.6) 2,370,776
Portland-South Portland-Biddeford, ME 10 7 (1.9) (1.4) 513,667
Portland-Vancouver-Beaverton, OR-WA 51 74 (2.4) (3.5) 2,137,565
Poughkeepsie-Newburgh-Middletown, NY 13 9 (1.9) (1.3) 671,538
Providence-New Bedford-Fall River, RI-MA 38 61 (2.4) (3.8) 1,612,989
Raleigh-Cary, NC 56 40 (5.6) (4.2) 994,551
Richmond, VA 42 51 (3.5) (4.3) 1,194,008
Riverside-San Bernardino-Ontario, CA 132 122 (3.3) (3.1) 4,026,135
Rochester, NY 25 22 (2.4) (2.1) 1,035,435
Sacramento--Arden Arcade--Roseville, CA 110 160 (5.3) (7.8) 2,067,117
St. Louis, MO-IL 52 53 (1.9) (1.9) 2,796,368
Salt Lake City, UT 26 22 (2.4) (2.1) 1,067,722
San Antonio, TX 108 86 (5.6) (4.6) 1,942,217
San Diego-Carlsbad-San Marcos, CA 315 305 (10.7) (10.4) 2,941,454
San Francisco-Oakland-Fremont, CA 400 427 (9.6) (10.3) 4,180,027
San Jose-Sunnyvale-Santa Clara, CA 229 199 (12.8) (11.3) 1,787,123
Sarasota-Bradenton-Venice, FL 33 29 (4.8) (4.3) 682,833
Scranton--Wilkes-Barre, PA 8 7 (1.5) (1.3) 550,841
Seattle-Tacoma-Bellevue, WA 192 176 (5.9) (5.5) 3,263,497
Springfi eld, MA 17 22 (2.5) (3.2) 686,174
Stockton, CA 78 63 (11.6) (9.5) 673,170
Syracuse, NY 14 18 (2.2) (2.8) 650,051
Tampa-St. Petersburg-Clearwater, FL 123 125 (4.6) (4.7) 2,697,731
Toledo, OH 12 13 (1.8) (2.0) 653,695
Tucson, AZ 35 33 (3.7) (3.6) 946,362
Tulsa, OK 27 31 (3.0) (3.5) 897,752
Virginia Beach-Norfolk-Newport News, VA-NC 51 67 (3.1) (4.1) 1,649,457
Washington-Arlington-Alexandria, DC-VA-MD-WV 421 388 (8.0) (7.4) 5,290,400
Wichita, KS 30 22 (5.1) (3.7) 592,126
Worchester, MA 32 26 (4.1) (3.3) 784,992
Youngstown-Warren-Boardman, OH-PA 6 7 (1.0) (1.2) 586,939
Total - 97 Areas 10,733 10,910 (5.5) (5.7) 194,048,471
San Juan-Caguas-Guaynabo, PR 88 95 (3.4) (3.7) 2,590,824
Table 46. (Cont’d) Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan 
Statistical Areas with >500,000 Population, 2006 and 2005
Metropolitan
Statistical Area
Cases Case Rates
Population
Estimates
20062006 20062005 2005
Note: In 2006, there were 97 metropolitan statistical areas with a population of 500,000 or more.
2006 and 2005 population case counts and rates updated using U.S. Census Metropolitan Statistical Areas and Components, December
2006, with Codes (http://www.census.gov/population/www/estimates/metro_general/2006/List4.txt).
See Technical Notes (page 9) for defi nition of MSA.
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Akron, OH 5 5 (100.0) 0 (0.0) 0 (0.0) 0
Albany-Schenectady-Troy, NY 17 10 (58.8) 7 (41.2) 0 (0.0) 0
Albuquerque, NM 12 7 (58.3) 3 (25.0) 2 (16.7) 1
Allentown-Bethlehem-Easton, PA-NJ 22 17 (77.3) 4 (18.2) 1 (4.5) 0
Atlanta-Sandy Springs-Marietta, GA 280 183 (65.4) 70 (25.0) 27 (9.6) 7
Augusta-Richmond County, GA-SC 35 28 (80.0) 4 (11.4) 3 (8.6) 2
Austin-Round Rock, TX 52 37 (71.2) 11 (21.2) 4 (7.7) 0
Bakersfi eld, CA 40 26 (65.0) 8 (20.0) 6 (15.0) 2
Baltimore-Towson, MD 83 55 (66.3) 23 (27.7) 5 (6.0) 1
Baton Rouge, LA 17 10 (58.8) 5 (29.4) 2 (11.8) 0
Birmingham-Hoover, AL 44 31 (70.5) 10 (22.7) 3 (6.8) 0
Boise City-Nampa, ID 5 4 (80.0) 1 (20.0) 0 (0.0) 0
Boston-Cambridge-Quincy, MA-NH 188 106 (56.4) 47 (25.0) 35 (18.6) 7
Bridgeport-Stamford-Norwalk, CT 33 22 (66.7) 9 (27.3) 2 (6.1) 1
Buffalo-Niagara Falls, NY 15 11 (73.3) 2 (13.3) 2 (13.3) 0
Cape Coral-Fort Myers, FL 19 16 (84.2) 3 (15.8) 0 (0.0) 0
Charleston-North Charleston, SC 34 18 (52.9) 12 (35.3) 4 (11.8) 3
Charlotte-Gastonia-Concord, NC-SC 81 56 (69.1) 19 (23.5) 6 (7.4) 3
Chicago-Naperville-Joliet, IL 522 343 (65.7) 144 (27.6) 34 (6.5) 10
Cincinnati-Middleton, OH-KY-IN 36 32 (88.9) 3 (8.3) 1 (2.8) 0
Cleveland-Elyria-Mentor, OH 47 31 (66.0) 14 (29.8) 2 (4.3) 1
Colorado Springs, CO 10 8 (80.0) 1 (10.0) 1 (10.0) 0
Columbia, SC 20 15 (75.0) 3 (15.0) 2 (10.0) 1
Columbus, OH 90 61 (67.8) 22 (24.4) 7 (7.8) 0
Dallas-Fort Worth-Arlington, TX 422 297 (70.4) 77 (18.2) 48 (11.4) 17
Dayton, OH 15 10 (66.7) 5 (33.3) 0 (0.0) 0
Denver-Aurora, CO 85 48 (56.5) 24 (28.2) 13 (15.3) 1
Des Moines-West Des Moines, IA 15 9 (60.0) 6 (40.0) 0 (0.0) 0
Detroit-Warren-Livonia, MI 131 89 (67.9) 38 (29.0) 4 (3.1) 0
El Paso, TX 72 50 (69.4) 16 (22.2) 6 (8.3) 2
Fresno, CA 62 55 (88.7) 4 (6.5) 3 (4.8) 2
Grand Rapids-Wyoming, MI 22 9 (40.9) 11 (50.0) 2 (9.1) 0
Greensboro-High Point, NC 42 27 (64.3) 9 (21.4) 6 (14.3) 1
Greenville, SC 11 8 (72.7) 2 (18.2) 1 (9.1) 0
Harrisburg-Carlisle, PA 5 3 (60.0) 1 (20.0) 1 (20.0) 0
Hartford-West Hartford-East Hartford, CT 20 13 (65.0) 7 (35.0) 0 (0.0) 0
Honolulu, HI 95 72 (75.8) 13 (13.7) 10 (10.5) 2
Houston-Sugar Land-Baytown, TX 473 358 (75.7) 83 (17.5) 32 (6.8) 13
Indianapolis-Carmel, IN 51 38 (74.5) 9 (17.6) 4 (7.8) 3
Jackson, MS 31 28 (90.3) 1 (3.2) 2 (6.5) 1
Jacksonville, FL 96 83 (86.5) 10 (10.4) 3 (3.1) 2
Kansas City, MO-KS 50 39 (78.0) 7 (14.0) 4 (8.0) 2
Knoxville, TN 15 12 (80.0) 3 (20.0) 0 (0.0) 0
Lakeland, FL 31 30 (96.8) 0 (0.0) 1 (3.2) 0
Las Vegas-Paradise, NV 89 66 (74.2) 17 (19.1) 6 (6.7) 0
Little Rock-North Little Rock, AR 11 9 (81.8) 1 (9.1) 1 (9.1) 0
Los Angeles-Long Beach-Santa Ana, CA 1,157 802 (69.3) 253 (21.9) 102 (8.8) 15
Louisville-Jefferson County, KY-IN 28 21 (75.0) 4 (14.3) 3 (10.7) 1
Madison, WI 11 8 (72.7) 3 (27.3) 0 (0.0) 0
McAllen-Edinburg-Mission, TX 68 57 (83.8) 9 (13.2) 2 (2.9) 2
Memphis, TN-MS-AR 121 65 (53.7) 31 (25.6) 25 (20.7) 1
Miami-Fort Lauderdale-Miami Beach, FL 369 291 (78.9) 69 (18.7) 9 (2.4) 1
Milwaukee-Waukesha-West Allis, WI 33 20 (60.6) 9 (27.3) 4 (12.1) 4
Minneapolis-St. Paul-Bloomington, MN-WI 169 88 (52.1) 57 (33.7) 24 (14.2) 0
Table 47. Tuberculosis Cases by Pulmonary and Extrapulmonary Disease: Metropolitan 
Statistical Areas with >500,000 Population, 2006
Metropolitan
Statistical Area
Pulmonary1 Extrapulmonary2
No. (%)
Total
Cases
Total3
No. (%) No.
Cases in Persons with Both Pul-
monary and Extrapulm. Disease
Miliary
No. (%)
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Modesto, CA 16 12 (75.0) 4 (25.0) 0 (0.0) 0
Nashville-Davidson-Murfreesboro, TN 82 67 (81.7) 12 (14.6) 3 (3.7) 0
New Haven-Milford, CT 22 13 (59.1) 6 (27.3) 3 (13.6) 0
New Orleans-Metairie-Kenner, LA 80 64 (80.0) 13 (16.3) 3 (3.8) 2
New York-Northern New Jersey-Long Island, NY-NJ-PA 1,574 1,056 (67.1) 348 (22.1) 170 (10.8) 10
Oklahoma City, OK 46 33 (71.7) 12 (26.1) 1 (2.2) 0
Omaha-Council Bluffs, NE-IA 13 7 (53.8) 6 (46.2) 0 (0.0) 0
Orlando-Kissimmee, FL 141 107 (75.9) 15 (10.6) 18 (12.8) 1
Oxnard-Thousand Oaks-Ventura, CA 49 33 (67.3) 14 (28.6) 2 (4.1) 0
Palm Bay-Melbourne-Titusville, FL 8 4 (50.0) 3 (37.5) 1 (12.5) 0
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 285 187 (65.6) 68 (23.9) 29 (10.2) 6
Phoenix-Mesa-Scottsdale, AZ 205 158 (77.1) 27 (13.2) 20 (9.8) 7
Pittsburgh, PA 31 19 (61.3) 9 (29.0) 3 (9.7) 0
Portland-South Portland-Biddeford, ME 10 5 (50.0) 5 (50.0) 0 (0.0) 0
Portland-Vancouver-Beaverton, OR-WA 51 34 (66.7) 17 (33.3) 0 (0.0) 0
Poughkeepsie-Newburgh-Middletown, NY 13 10 (76.9) 3 (23.1) 0 (0.0) 0
Providence-New Bedford-Fall River, RI-MA 38 20 (52.6) 16 (42.1) 2 (5.3) 0
Raleigh-Cary, NC 56 37 (66.1) 16 (28.6) 3 (5.4) 1
Richmond, VA 42 29 (69.0) 8 (19.0) 5 (11.9) 3
Riverside-San Bernardino-Ontario, CA 132 102 (77.3) 23 (17.4) 7 (5.3) 1
Rochester, NY 25 14 (56.0) 6 (24.0) 5 (20.0) 0
Sacramento-Arden Arcade-Roseville, CA 110 82 (74.5) 17 (15.5) 11 (10.0) 2
St. Louis, MO-IL 52 33 (63.5) 12 (23.1) 7 (13.5) 0
Salt Lake City, UT 26 14 (53.8) 9 (34.6) 3 (11.5) 1
San Antonio, TX 108 70 (64.8) 25 (23.1) 13 (12.0) 6
San Diego-Carlsbad-San Marcos, CA 315 185 (58.7) 65 (20.6) 65 (20.6) 18
San Francisco-Oakland-Fremont, CA 400 255 (63.8) 109 (27.3) 36 (9.0) 3
San Jose-Sunnyvale-Santa Clara, CA 229 154 (67.2) 61 (26.6) 14 (6.1) 2
Sarasota-Bradenton-Venice, FL 33 28 (84.8) 2 (6.1) 3 (9.1) 0
Scranton-Wilkes-Barre, PA 8 4 (50.0) 4 (50.0) 0 (0.0) 0
Seattle-Tacoma-Bellevue, WA 192 112 (58.3) 54 (28.1) 26 (13.5) 4
Springfi eld, MA 17 10 (58.8) 2 (11.8) 5 (29.4) 0
Stockton, CA 78 59 (75.6) 15 (19.2) 4 (5.1) 1
Syracuse, NY 14 7 (50.0) 6 (42.9) 1 (7.1) 1
Tampa-St. Petersburg-Clearwater, FL 123 99 (80.5) 19 (15.4) 5 (4.1) 0
Toledo, OH 12 7 (58.3) 5 (41.7) 0 (0.0) 0
Tucson, AZ 35 28 (80.0) 7 (20.0) 0 (0.0) 0
Tulsa, OK 27 18 (66.7) 7 (25.9) 2 (7.4) 0
Virginia Beach-Norfolk-Newport News, VA-NC 51 31 (60.8) 12 (23.5) 8 (15.7) 3
Washington-Arlington-Alexandria, DC-VA-MD-WV 421 294 (69.8) 97 (23.0) 30 (7.1) 3
Wichita, KS 30 24 (80.0) 3 (10.0) 3 (10.0) 0
Worchester, MA 32 25 (78.1) 4 (12.5) 3 (9.4) 1
Youngstown-Warren-Boardman, OH-PA 6 4 (66.7) 2 (33.3) 0 (0.0) 0
Total -  97 Areas 10,745 7,391 (68.8) 2,372 (22.1) 979 (9.1) 185
San Juan-Caguas-Guaynabo, PR 88 80 (90.9) 6 (6.8) 2 (2.3) 0
Table 47. (Cont’d) Tuberculosis Cases by Pulmonary and Extrapulmonary Disease: 
Metropolitan Statistical Areas with >500,000 Population, 2006
Metropolitan
Statistical Area
Total
Cases
1Includes cases in persons with pulmonary listed as major site of disease and no additional site of disease.
2Includes cases in persons with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, genitourinary, or other site, excluding pulmo-
nary, listed as major site of disease.
3Includes miliary cases.
Note: 3 (<0.1%) case had missing and/or unknown site of disease. 
See Technical Notes (page 9) for defi nition of MSA.
Pulmonary1 Extrapulmonary2
No. (%)
Total3
No. (%) No.
Cases in Persons with Both Pul-
monary and Extrapulm. Disease
Miliary
No. (%)
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Table 48. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with >500,000 
Population, 2006
Akron, OH 5 0 1 0 2 1 1 0
Albany-Schenectady-Troy, NY 17 0 1 1 7 3 5 0
Albuquerque, NM 12 0 0 0 1 7 4 0
Allentown-Bethlehem-Easton, PA-NJ 22 0 0 0 5 9 8 0
Atlanta-Sandy Springs-Marietta, GA 280 16 5 33 119 83 23 1
Augusta-Richmond County, GA-SC 35 0 0 6 13 12 4 0
Austin-Round Rock, TX 52 5 0 2 19 23 3 0
Bakersfi eld, CA 40 1 1 9 9 9 11 0
Baltimore-Towson, MD 83 2 1 7 31 24 18 0
Baton Rouge, LA 17 1 0 2 11 2 1 0
Birmingham-Hoover, AL 44 0 0 3 13 16 12 0
Boise City-Nampa, ID 5 0 1 0 3 1 0 0
Boston-Cambridge-Quincy, MA-NH 188 7 1 16 80 48 36 0
Bridgeport-Stamford-Norwalk, CT 33 0 0 5 14 9 5 0
Buffalo-Niagara Falls, NY 15 0 0 2 3 3 7 0
Cape Coral-Fort Myers, FL 19 2 0 6 6 5 0 0
Charleston-North Charleston, SC 34 2 0 5 9 11 7 0
Charlotte-Gastonia-Concord, NC-SC 81 1 1 12 27 30 10 0
Chicago-Naperville-Joliet, IL 522 28 15 46 158 172 103 0
Cincinnati-Middleton, OH-KY-IN 36 0 1 4 11 11 9 0
Cleveland-Elyria-Mentor, OH 47 2 2 7 12 6 18 0
Colorado Springs, CO 10 0 0 0 3 4 3 0
Columbia, SC 20 0 0 2 6 5 7 0
Columbus, OH 90 4 5 18 41 13 9 0
Dallas-Fort Worth-Arlington, TX 422 15 8 54 168 128 49 0
Dayton, OH 15 0 0 5 1 1 8 0
Denver-Aurora, CO 85 3 2 15 24 21 20 0
Des Moines-West Des Moines, IA 15 0 0 2 6 4 3 0
Detroit-Warren-Livonia, MI 131 3 0 11 35 46 36 0
El Paso, TX 72 6 2 5 12 17 30 0
Fresno, CA 62 3 1 9 21 14 14 0
Grand Rapids-Wyoming, MI 22 1 0 3 9 4 5 0
Greensboro-High Point, NC 42 1 1 11 17 7 5 0
Greenville, SC 11 0 0 4 3 2 2 0
Harrisburg-Carlisle, PA 5 1 0 1 2 0 1 0
Hartford-West Hartford-East Hartford, CT 20 0 0 3 9 5 3 0
Honolulu, HI 95 0 2 14 26 30 23 0
Houston-Sugar Land-Baytown, TX 473 10 17 54 179 155 58 0
Indianapolis-Carmel, IN 51 4 4 5 23 8 7 0
Jackson, MS 31 1 3 1 7 13 6 0
Jacksonville, FL 96 9 1 8 28 39 11 0
Kansas City, MO-KS 50 6 0 5 15 17 7 0
Knoxville, TN 15 0 0 1 1 4 9 0
Lakeland, FL 31 1 0 2 8 15 5 0
Las Vegas-Paradise, NV 89 2 2 8 27 42 8 0
Little Rock-North Little Rock, AR 11 0 0 1 1 6 3 0
Los Angeles-Long Beach-Santa Ana, CA 1,157 39 13 122 363 363 257 0
Louisville-Jefferson County, KY-IN 28 0 0 4 12 9 3 0
Madison, WI 11 3 0 1 3 2 2 0
McAllen-Edinburg-Mission, TX 68 4 5 3 18 23 15 0
Memphis, TN-MS-AR 121 10 5 10 48 36 12 0
Miami-Fort Lauderdale-Miami Beach, FL 369 12 3 34 142 129 49 0
Milwaukee-Waukesha-West Allis, WI 33 2 1 4 8 8 10 0
Minneapolis-St. Paul-Bloomington, MN-WI 169 7 13 42 61 28 18 0
Metropolitan
Statistical Area
Total
Cases Under 5 15 –24
Unknown
or
Missing
5–14 25–44 45–64 >65
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Table 48. (Cont’d) Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with 
>500,000 Population, 2006
Metropolitan
Statistical Area Under 5
Total
Cases 15 –24
Unknown
or
Missing
Note: See Technical Notes (page 9) for defi nition of MSA.
5–14 25–44 45–64 >65
Modesto, CA 16 0 0 1 4 5 6 0
Nashville-Davidson-Murfreesboro, TN 82 2 1 12 27 21 19 0
New Haven-Milford, CT 22 0 1 1 9 5 6 0
New Orleans-Metairie-Kenner, LA 80 4 4 6 32 27 7 0
New York-Northern New Jersey-Long Island, NY-NJ-PA 1,574 33 26 171 650 425 269 0
Oklahoma City, OK 46 2 1 3 13 18 9 0
Omaha-Council Bluffs, NE-IA 13 0 0 1 8 2 2 0
Orlando-Kissimmee, FL 141 6 4 18 52 47 14 0
Oxnard-Thousand Oaks-Ventura, CA 49 1 1 8 13 8 18 0
Palm Bay-Melbourne-Titusville, FL 8 0 0 1 2 2 3 0
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 285 16 17 27 82 83 60 0
Phoenix-Mesa-Scottsdale, AZ 205 13 9 22 83 48 30 0
Pittsburgh, PA 31 0 1 1 9 11 9 0
Portland-South Portland-Biddeford, ME 10 0 0 2 4 2 2 0
Portland-Vancouver-Beaverton, OR-WA 51 0 1 8 21 12 9 0
Poughkeepsie-Newburgh-Middletown, NY 13 0 0 0 4 6 3 0
Providence-New Bedford-Fall River, RI-MA 38 0 3 4 17 12 2 0
Raleigh-Cary, NC 56 1 2 8 28 11 6 0
Richmond, VA 42 1 0 3 12 14 12 0
Riverside-San Bernardino-Ontario, CA 132 4 1 12 47 32 36 0
Rochester, NY 25 2 2 1 3 8 9 0
Sacramento-Arden Arcade-Roseville, CA 110 0 1 17 31 39 22 0
St. Louis, MO-IL 52 3 2 4 19 13 11 0
Salt Lake City, UT 26 5 1 2 9 7 2 0
San Antonio, TX 108 8 1 9 30 37 23 0
San Diego-Carlsbad-San Marcos, CA 315 19 13 43 90 82 68 0
San Francisco-Oakland-Fremont, CA 400 2 3 44 126 109 116 0
San Jose-Sunnyvale-Santa Clara, CA 229 6 4 20 86 56 57 0
Sarasota-Bradenton-Venice, FL 33 0 2 3 10 18 0 0
Scranton-Wilkes-Barre, PA 8 0 0 1 2 1 4 0
Seattle-Tacoma-Bellevue, WA 192 5 3 22 76 46 40 0
Springfi eld, MA 17 0 0 2 8 5 2 0
Stockton, CA 78 3 0 6 20 24 25 0
Syracuse, NY 14 0 1 2 4 5 2 0
Tampa-St. Petersburg-Clearwater, FL 123 2 2 5 50 42 22 0
Toledo, OH 12 0 0 1 2 3 6 0
Tucson, AZ 35 1 1 3 9 14 7 0
Tulsa, OK 27 2 2 1 7 12 3 0
Virginia Beach-Norfolk-Newport News, VA-NC 51 4 1 9 11 12 14 0
Washington-Arlington-Alexandria, DC-VA-MD-WV 421 9 13 57 176 110 56 0
Wichita, KS 30 0 0 4 13 10 3 0
Worchester, MA 32 0 0 7 18 3 4 0
Youngstown-Warren-Boardman, OH-PA 6 0 0 1 0 2 3 0
Total -  97 Areas 10,745 368 242 1,201 3,797 3,132 2,004 1
San Juan-Caguas-Guaynabo, PR 88 3 3 6 26 31 19 0
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Akron, OH 5 0 0 0 0 0 5 0 0
Albany-Schenectady-Troy, NY 17 1 0 8 5 0 3 0 0
Albuquerque, NM 12 7 1 2 0 0 2 0 0
Allentown-Bethlehem-Easton, PA-NJ 22 7 0 7 1 0 7 0 0
Atlanta-Sandy Springs-Marietta, GA 280 65 0 52 131 0 32 0 0
Augusta-Richmond County, GA-SC 35 4 0 4 20 0 7 0 0
Austin-Round Rock, TX 52 27 0 5 8 0 12 0 0
Bakersfi eld, CA 40 27 0 8 3 0 2 0 0
Baltimore-Towson, MD 83 14 0 15 42 0 12 0 0
Baton Rouge, LA 17 3 0 3 9 0 2 0 0
Birmingham-Hoover, AL 44 8 0 3 22 0 11 0 0
Boise City-Nampa, ID 5 2 0 1 0 1 1 0 0
Boston-Cambridge-Quincy, MA-NH 188 31 0 60 60 0 36 1 0
Bridgeport-Stamford-Norwalk, CT 33 13 0 6 6 0 8 0 0
Buffalo-Niagara Falls, NY 15 0 0 4 4 0 7 0 0
Cape Coral-Fort Myers, FL 19 9 0 0 5 0 5 0 0
Charleston-North Charleston, SC 34 4 0 5 22 0 3 0 0
Charlotte-Gastonia-Concord, NC-SC 81 12 0 11 37 0 20 1 0
Chicago-Naperville-Joliet, IL 522 140 1 141 168 0 72 0 0
Cincinnati-Middleton, OH-KY-IN 36 4 0 3 13 0 15 1 0
Cleveland-Elyria-Mentor, OH 47 2 0 9 21 0 15 0 0
Colorado Springs, CO 10 5 0 2 2 0 0 1 0
Columbia, SC 20 6 1 0 7 0 6 0 0
Columbus, OH 90 6 0 6 64 0 14 0 0
Dallas-Fort Worth-Arlington, TX 422 137 2 69 145 0 68 1 0
Dayton, OH 15 0 0 2 10 0 3 0 0
Denver-Aurora, CO 85 37 0 19 19 0 10 0 0
Des Moines-West Des Moines, IA 15 2 0 6 5 0 2 0 0
Detroit-Warren-Livonia, MI 131 13 0 32 60 0 26 0 0
El Paso, TX 72 62 1 1 1 0 7 0 0
Fresno, CA 62 30 0 18 2 1 10 1 0
Grand Rapids-Wyoming, MI 22 6 1 4 6 0 5 0 0
Greensboro-High Point, NC 42 5 0 14 20 0 3 0 0
Greenville, SC 11 4 0 0 4 1 2 0 0
Harrisburg-Carlisle, PA 5 1 0 1 1 0 2 0 0
Hartford-West Hartford-East Hartford, CT 20 1 0 8 5 0 6 0 0
Honolulu, HI 95 0 0 79 0 11 5 0 0
Houston-Sugar Land-Baytown, TX 473 185 2 87 128 0 69 2 0
Indianapolis-Carmel, IN 51 18 0 8 13 0 12 0 0
Jackson, MS 31 3 0 3 17 0 8 0 0
Jacksonville, FL 96 6 0 12 57 0 21 0 0
Kansas City, MO-KS 50 22 0 4 15 0 9 0 0
Knoxville, TN 15 0 0 0 1 0 14 0 0
Lakeland, FL 31 4 0 0 14 0 13 0 0
Las Vegas-Paradise, NV 89 36 0 22 17 0 14 0 0
Little Rock-North Little Rock, AR 11 1 0 0 5 0 5 0 0
Los Angeles-Long Beach-Santa Ana, CA 1,157 474 1 489 90 2 99 2 0
Louisville-Jefferson County, KY-IN 28 3 0 2 10 0 13 0 0
Madison, WI 11 5 0 3 0 0 3 0 0
McAllen-Edinburg-Mission, TX 68 68 0 0 0 0 0 0 0
Memphis, TN-MS-AR 121 18 0 8 87 2 6 0 0
Miami-Fort Lauderdale-Miami Beach, FL 369 143 0 22 167 0 37 0 0
Milwaukee-Waukesha-West Allis, WI 33 8 0 8 10 0 7 0 0
Minneapolis-St. Paul-Bloomington, MN-WI 169 16 3 41 94 0 14 1 0
Table 49. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan 
Statistical Areas with >500,000 Population, 2006
Metropolitan
Statistical Area Asian
American
Indian or 
Alaska
Native
Total
Cases
Black
or
African
American
Native
Hawaiian or 
Other Pacifi c 
Islander White
Multiple
Race2
Unknown
or
Missing
Hispanic
or
Latino1
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Modesto, CA 16 4 0 10 0 1 1 0 0
Nashville-Davidson-Murfreesboro, TN 82 11 0 11 36 0 23 1 0
New Haven-Milford, CT 22 3 0 5 7 0 7 0 0
New Orleans-Metairie-Kenner, LA 80 7 0 5 40 0 28 0 0
New York-Northern New Jersey-Long Island, NY-NJ-PA 1,574 507 0 469 411 3 181 2 1
Oklahoma City, OK 46 6 5 12 5 0 18 0 0
Omaha-Council Bluffs, NE-IA 13 5 0 2 3 0 1 2 0
Orlando-Kissimmee, FL 141 28 0 16 68 1 28 0 0
Oxnard-Thousand Oaks-Ventura, CA 49 33 0 11 1 0 4 0 0
Palm Bay-Melbourne-Titusville, FL 8 2 0 1 1 0 4 0 0
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 285 39 0 69 135 2 40 0 0
Phoenix-Mesa-Scottsdale, AZ 205 124 3 23 19 0 36 0 0
Pittsburgh, PA 31 0 0 7 9 0 15 0 0
Portland-South Portland-Biddeford, ME 10 0 0 1 6 0 3 0 0
Portland-Vancouver-Beaverton, OR-WA 51 6 1 18 10 2 14 0 0
Poughkeepsie-Newburgh-Middletown, NY 13 3 0 3 4 0 3 0 0
Providence-New Bedford-Fall River, RI-MA 38 14 0 7 5 0 12 0 0
Raleigh-Cary, NC 56 9 0 18 23 0 6 0 0
Richmond, VA 42 3 0 6 24 0 9 0 0
Riverside-San Bernardino-Ontario, CA 132 76 2 33 1 0 17 2 1
Rochester, NY 25 0 0 1 14 0 10 0 0
Sacramento-Arden Arcade-Roseville, CA 110 25 0 52 13 2 18 0 0
St. Louis, MO-IL 52 1 0 10 26 0 15 0 0
Salt Lake City, UT 26 9 0 4 6 3 4 0 0
San Antonio, TX 108 68 0 11 12 0 16 1 0
San Diego-Carlsbad-San Marcos, CA 315 168 2 98 21 0 26 0 0
San Francisco-Oakland-Fremont, CA 400 70 1 237 54 4 34 0 0
San Jose-Sunnyvale-Santa Clara, CA 229 30 0 167 12 1 19 0 0
Sarasota-Bradenton-Venice, FL 33 13 0 1 6 0 11 2 0
Scranton-Wilkes-Barre, PA 8 2 0 0 1 0 5 0 0
Seattle-Tacoma-Bellevue, WA 192 24 4 98 32 3 31 0 0
Springfi eld, MA 17 4 0 8 2 0 3 0 0
Stockton, CA 78 26 0 39 7 0 5 1 0
Syracuse, NY 14 1 0 3 8 0 2 0 0
Tampa-St. Petersburg-Clearwater, FL 123 36 0 16 23 0 47 1 0
Toledo, OH 12 0 0 0 7 0 5 0 0
Tucson, AZ 35 17 1 4 4 0 9 0 0
Tulsa, OK 27 8 3 2 9 0 5 0 0
Virginia Beach-Norfolk-Newport News, VA-NC 51 8 0 11 31 0 1 0 0
Washington-Arlington-Alexandria, DC-VA-MD-WV 421 96 0 128 175 0 21 1 0
Wichita, KS 30 3 0 11 5 0 10 1 0
Worchester, MA 32 10 0 12 6 1 3 0 0
Youngstown-Warren-Boardman, OH-PA 6 0 0 0 3 0 3 0 0
Total -  97 Areas 10,745 3,204 35 2,957 2,938 41 1,543 25 2
San Juan-Caguas-Guaynabo, PR 88 88 0 0 0 0 0 0 0
Table 49. (Cont’d) Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metro-
politan Statistical Areas with >500,000 Population, 2006
1Persons of Hispanic or Latino origin may be of any race or multiple race.
2Indicates two or more races reported for a person.
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other 
Pacifi c Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does 
not include persons of Hispanic ethnicity.
See Technical Notes (page 9) for defi nition of MSA and Hispanic ethnicity and non-Hispanic race.
Metropolitan
Statistical Area Asian
American
Indian or 
Alaska
Native
Total
Cases
Black
or
African
American
Native
Hawaiian or 
Other Pacifi c 
Islander White
Multiple
Race2
Unknown
or
Missing
Hispanic
or
Latino1
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Akron, OH 5 5 (100.0) 0 (0.0) 0 (0.0)
Albany-Schenectady-Troy, NY 17 6 (35.3) 11 (64.7) 0 (0.0)
Albuquerque, NM 12 4 (33.3) 8 (66.7) 0 (0.0)
Allentown-Bethlehem-Easton, PA-NJ 22 6 (27.3) 16 (72.7) 0 (0.0)
Atlanta-Sandy Springs-Marietta, GA 280 133 (47.5) 147 (52.5) 0 (0.0)
Augusta-Richmond County, GA-SC 35 29 (82.9) 6 (17.1) 0 (0.0)
Austin-Round Rock, TX 52 35 (67.3) 17 (32.7) 0 (0.0)
Bakersfi eld, CA 40 11 (27.5) 29 (72.5) 0 (0.0)
Baltimore-Towson, MD 83 37 (44.6) 46 (55.4) 0 (0.0)
Baton Rouge, LA 17 11 (64.7) 6 (35.3) 0 (0.0)
Birmingham-Hoover, AL 44 32 (72.7) 12 (27.3) 0 (0.0)
Boise City-Nampa, ID 5 1 (20.0) 4 (80.0) 0 (0.0)
Boston-Cambridge-Quincy, MA-NH 188 49 (26.1) 138 (73.4) 1 (0.5)
Bridgeport-Stamford-Norwalk, CT 33 8 (24.2) 25 (75.8) 0 (0.0)
Buffalo-Niagara Falls, NY 15 6 (40.0) 9 (60.0) 0 (0.0)
Cape Coral-Fort Myers, FL 19 6 (31.6) 13 (68.4) 0 (0.0)
Charleston-North Charleston, SC 34 25 (73.5) 9 (26.5) 0 (0.0)
Charlotte-Gastonia-Concord, NC-SC 81 51 (63.0) 29 (35.8) 1 (1.2)
Chicago-Naperville-Joliet, IL 522 236 (45.2) 273 (52.3) 13 (2.5)
Cincinnati-Middleton, OH-KY-IN 36 24 (66.7) 12 (33.3) 0 (0.0)
Cleveland-Elyria-Mentor, OH 47 33 (70.2) 14 (29.8) 0 (0.0)
Colorado Springs, CO 10 3 (30.0) 7 (70.0) 0 (0.0)
Columbia, SC 20 13 (65.0) 7 (35.0) 0 (0.0)
Columbus, OH 90 33 (36.7) 57 (63.3) 0 (0.0)
Dallas-Fort Worth-Arlington, TX 422 213 (50.5) 209 (49.5) 0 (0.0)
Dayton, OH 15 10 (66.7) 5 (33.3) 0 (0.0)
Denver-Aurora, CO 85 29 (34.1) 56 (65.9) 0 (0.0)
Des Moines-West Des Moines, IA 15 2 (13.3) 13 (86.7) 0 (0.0)
Detroit-Warren-Livonia, MI 131 80 (61.1) 51 (38.9) 0 (0.0)
El Paso, TX 72 29 (40.3) 43 (59.7) 0 (0.0)
Fresno, CA 62 19 (30.6) 41 (66.1) 2 (3.2)
Grand Rapids-Wyoming, MI 22 8 (36.4) 14 (63.6) 0 (0.0)
Greensboro-High Point, NC 42 20 (47.6) 22 (52.4) 0 (0.0)
Greenville, SC 11 7 (63.6) 4 (36.4) 0 (0.0)
Harrisburg-Carlisle, PA 5 3 (60.0) 2 (40.0) 0 (0.0)
Hartford-West Hartford-East Hartford, CT 20 7 (35.0) 13 (65.0) 0 (0.0)
Honolulu, HI 95 18 (18.9) 77 (81.1) 0 (0.0)
Houston-Sugar Land-Baytown, TX 473 247 (52.2) 226 (47.8) 0 (0.0)
Indianapolis-Carmel, IN 51 21 (41.2) 30 (58.8) 0 (0.0)
Jackson, MS 31 25 (80.6) 6 (19.4) 0 (0.0)
Jacksonville, FL 96 76 (79.2) 20 (20.8) 0 (0.0)
Kansas City, MO-KS 50 21 (42.0) 29 (58.0) 0 (0.0)
Knoxville, TN 15 14 (93.3) 1 (6.7) 0 (0.0)
Lakeland, FL 31 28 (90.3) 3 (9.7) 0 (0.0)
Las Vegas-Paradise, NV 89 26 (29.2) 63 (70.8) 0 (0.0)
Little Rock-North Little Rock, AR 11 10 (90.9) 1 (9.1) 0 (0.0)
Los Angeles-Long Beach-Santa Ana, CA 1,157 245 (21.2) 906 (78.3) 6 (0.5)
Louisville-Jefferson County, KY-IN 28 21 (75.0) 7 (25.0) 0 (0.0)
Madison, WI 11 5 (45.5) 5 (45.5) 1 (9.1)
McAllen-Edinburg-Mission, TX 68 24 (35.3) 44 (64.7) 0 (0.0)
Memphis, TN-MS-AR 121 94 (77.7) 27 (22.3) 0 (0.0)
Miami-Fort Lauderdale-Miami Beach, FL 369 132 (35.8) 237 (64.2) 0 (0.0)
Milwaukee-Waukesha-West Allis, WI 33 17 (51.5) 16 (48.5) 0 (0.0)
Minneapolis-St. Paul-Bloomington, MN-WI 169 25 (14.8) 144 (85.2) 0 (0.0)
Table 50. Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born Per-
sons: Metropolitan Statistical Areas with >500,000 Population, 2006
Metropolitan
Statistical Area
U.S.-born Persons
Foreign-born
Persons1 Unknown
No. No.(%) (%)
Total
Cases No. (%)
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Modesto, CA 16 2 (12.5) 14 (87.5) 0 (0.0)
Nashville-Davidson-Murfreesboro, TN 82 50 (61.0) 32 (39.0) 0 (0.0)
New Haven-Milford, CT 22 12 (54.5) 10 (45.5) 0 (0.0)
New Orleans-Metairie-Kenner, LA 80 69 (86.3) 11 (13.8) 0 (0.0)
New York-Northern New Jersey-Long Island, NY-NJ-PA 1,574 424 (26.9) 1,145 (72.7) 5 (0.3)
Oklahoma City, OK 46 29 (63.0) 17 (37.0) 0 (0.0)
Omaha-Council Bluffs, NE-IA 13 1 (7.7) 12 (92.3) 0 (0.0)
Orlando-Kissimmee, FL 141 82 (58.2) 59 (41.8) 0 (0.0)
Oxnard-Thousand Oaks-Ventura, CA 49 9 (18.4) 40 (81.6) 0 (0.0)
Palm Bay-Melbourne-Titusville, FL 8 5 (62.5) 3 (37.5) 0 (0.0)
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 285 141 (49.5) 144 (50.5) 0 (0.0)
Phoenix-Mesa-Scottsdale, AZ 205 74 (36.1) 123 (60.0) 8 (3.9)
Pittsburgh, PA 31 19 (61.3) 12 (38.7) 0 (0.0)
Portland-South Portland-Biddeford, ME 10 4 (40.0) 6 (60.0) 0 (0.0)
Portland-Vancouver-Beaverton, OR-WA 51 15 (29.4) 36 (70.6) 0 (0.0)
Poughkeepsie-Newburgh-Middletown, NY 13 7 (53.8) 6 (46.2) 0 (0.0)
Providence-New Bedford-Fall River, RI-MA 38 5 (13.2) 33 (86.8) 0 (0.0)
Raleigh-Cary, NC 56 24 (42.9) 32 (57.1) 0 (0.0)
Richmond, VA 42 31 (73.8) 11 (26.2) 0 (0.0)
Riverside-San Bernardino-Ontario, CA 132 36 (27.3) 95 (72.0) 1 (0.8)
Rochester, NY 25 14 (56.0) 11 (44.0) 0 (0.0)
Sacramento-Arden Arcade-Roseville, CA 110 33 (30.0) 76 (69.1) 1 (0.9)
St. Louis, MO-IL 52 30 (57.7) 22 (42.3) 0 (0.0)
Salt Lake City, UT 26 9 (34.6) 17 (65.4) 0 (0.0)
San Antonio, TX 108 71 (65.7) 37 (34.3) 0 (0.0)
San Diego-Carlsbad-San Marcos, CA 315 81 (25.7) 234 (74.3) 0 (0.0)
San Francisco-Oakland-Fremont, CA 400 90 (22.5) 310 (77.5) 0 (0.0)
San Jose-Sunnyvale-Santa Clara, CA 229 25 (10.9) 201 (87.8) 3 (1.3)
Sarasota-Bradenton-Venice, FL 33 14 (42.4) 19 (57.6) 0 (0.0)
Scranton-Wilkes-Barre, PA 8 6 (75.0) 2 (25.0) 0 (0.0)
Seattle-Tacoma-Bellevue, WA 192 45 (23.4) 147 (76.6) 0 (0.0)
Springfi eld, MA 17 3 (17.6) 14 (82.4) 0 (0.0)
Stockton, CA 78 28 (35.9) 50 (64.1) 0 (0.0)
Syracuse, NY 14 5 (35.7) 9 (64.3) 0 (0.0)
Tampa-St. Petersburg-Clearwater, FL 123 76 (61.8) 47 (38.2) 0 (0.0)
Toledo, OH 12 10 (83.3) 2 (16.7) 0 (0.0)
Tucson, AZ 35 19 (54.3) 16 (45.7) 0 (0.0)
Tulsa, OK 27 19 (70.4) 8 (29.6) 0 (0.0)
Virginia Beach-Norfolk-Newport News, VA-NC 51 32 (62.7) 19 (37.3) 0 (0.0)
Washington-Arlington-Alexandria, DC-VA-MD-WV 421 101 (24.0) 319 (75.8) 1 (0.2)
Wichita, KS 30 13 (43.3) 17 (56.7) 0 (0.0)
Worchester, MA 32 3 (9.4) 29 (90.6) 0 (0.0)
Youngstown-Warren-Boardman, OH-PA 6 5 (83.3) 1 (16.7) 0 (0.0)
Total -  97 Areas 10,745 4,044 (37.6) 6,658 (62.0) 43 (0.4)
San Juan-Caguas-Guaynabo, PR 88 78 (88.6) 10 (11.4) 0 (0.0)
Table 50. (Cont’d) Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born 
Persons: Metropolitan Statistical Areas with >500,000 Population, 2006
1Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin 
Islands, and U.S. minor and outlying Pacifi c islands. 
Note: See Technical Notes (page 9) for defi nition of MSA.
Metropolitan
Statistical Area
U.S.-born Persons
Foreign-born
Persons1 Unknown
No. No.(%) (%)
Total
Cases No. (%)
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Tuberculosis in the United States
National Tuberculosis Surveillance System Highlights from 2006
Slide 1 (title slide). Tuberculosis in the United States—National Tuberculosis Surveillance System, High-
lights from 2006.  This slide set was prepared by the Division of Tuberculosis Elimination, Centers for Dis-
ease Control and Prevention (CDC), Department of Health and Human Services (DHHS).  It provides trends 
for the recent past and highlights from data collected through the National Tuberculosis Surveillance System 
for 2006.  Since 1953, through the cooperation of state and local health departments, CDC has collected 
information on the newly reported cases of tuberculosis (TB) disease in the United States.  The data presented 
here were primarily collected via the expanded TB case report introduced in 1993.  Currently, each individual 
TB case report (Report of Verifi ed Case of Tuberculosis, or RVCT) is submitted electronically to CDC.  The 
data for this slide set are based on updates received by CDC as of April 6, 2007.  All case counts and rates for 
years 1993–2005 have been updated.
Slide 2. Reported TB Cases, United States, 1982–2006.  The resurgence of TB in the mid-1980s was 
marked by several years of increasing case counts until its peak in 1992.  Case counts began decreasing 
again in 1993, and 2006 marked the fourteenth year of decline in the total number of TB cases reported in the 
United States since the peak of the resurgence.  From 1992 until 2002, the total number of TB cases decreased 
5%–7% annually.  From 2002 to 2003, however, the total number of TB cases decreased by only 1.4%.  In 
2006, a total of 13,779 cases were reported from the 50 states and the District of Columbia.  This represents a 
decline of 2.1% from 2005 and of 48% from 1992.  (Note:  A provisional total of 13,767 was reported in the 
MMWR in March 2007.)
Slide 3. TB Morbidity, United States, 2001–2006.   This slide provides the total number of reported U.S. TB 
cases and the associated TB rates for each of the past 6 years.  Rate is defi ned as cases per 100,000 popula-
tion.  The number of TB cases decreased from 15,945 in 2001 to 13,779 in 2006, and the TB rate also de-
creased, from 5.6 in 2001 to 4.6 in 2006. 
Slide 4. TB Case Rates, United States, 2006.  This map shows TB rates for 2006.  Twenty-six states had a 
rate of less than or equal to 3.5 TB cases per 100,000, the interim goal for the year 2000 established by the 
Advisory Council for the Elimination of Tuberculosis.  This group of states has remained fairly constant over 
the last decade; fi ve states (CT, MI, NM, OR, and PA) joined the group in 2000, one state (MO) joined the 
group in 2001 (also in 1998 for one year only), and one state (KY) joined the group in 2003. Twelve states 
and the District of Columbia (DC) reported a rate above the 2006 national average of 4.6 cases per 100,000: 
AK, AZ, CA, FL, GA, HI, LA, NJ, NY, SC, TN and TX.  These 12 states and DC accounted for 65% of the 
national total and experienced substantial overall decreases in cases and rates from 1992 through 2006. 
Slide 5. TB Case Rates by Age Group, United States, 1993–2006.  This slide shows the last 14 years’ de-
clining trend in TB rates by age group.  The largest declines occurred in persons 65 years and older (from 17.7 
per 100,000 in 1993 to 7.2 in 2006), in adults aged 45 to 64 years (from 12.4 to 5.4), in adults aged 25 to 44 
years (from 11.5 to 5.6), and in children under 15 years of age (from 2.9 to 1.3), each group having decreased 
approximately 50%.  The rate declined by 28% in those 15 to 24 years of age (from 5.0 to 3.6).
Slide 6. Reported TB Cases by Age Group, United States, 2006.  This pie chart shows the age distribution 
of persons reported with TB in 2006.  Six percent were children under 15 years of age and 11% were 15- to 
24-year-olds, whereas 34% were 25 to 44 years of age, 29% were 45- to 64-year-olds, and 19% were at least 
65 years old.
Slide 7. TB Case Rates by Age Group and Sex, United States, 2006.  This slide graphs the TB rates in 2006 
by age group and sex.  It shows that rates tended to increase with age, ranging from a low of less than 2 per 
100,000 in children to a high of approximately 10 per 100,000 in men 65 years and older.  The rates in men 45 
years and older were more than twice those in same-age women.
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Slide 8. TB Case Rates by Race/Ethnicity, United States, 1993–2006.  This slide shows the declining trend 
in TB rates by race/ethnicity during the last 14 years.  Asians and Pacifi c Islanders had the highest TB rates, 
which declined from 44.1 per 100,000 in 1993 to 25.2 in 2006, and had the smallest percentage decline over 
the time period (43%).  Rates declined by approximately 50% or more over the time period in the other racial/
ethnic groups: among non-Hispanic blacks or African-Americans, from 28.5 in 1993 to 10.2 in 2006; among 
Hispanics, from 19.9 to 9.2; among American Indians and Alaska Natives, from 13.9 to 7.4; and among 
non-Hispanic whites, from 3.6 to 1.2.  Since 2003, the Asian and Pacifi c Islander race category has included 
persons who reported race as either 1) Asian only or 2) Native Hawaiian or Other Pacifi c Islander only.  Al-
though these categories were reported separately beginning in 2003, they were merged for this slide to allow 
for continuity in reporting trends.
Several important factors likely contribute to the disproportionate burden of TB in minorities.  In persons who 
were born in countries where TB is common, TB disease may result from infection acquired in the country of 
origin.  Unequal distribution of TB risk factors, such as HIV infection, may also contribute to increased expo-
sure to TB or to an increased risk of developing TB once infected with M. tuberculosis.
Slide 9. Reported TB Cases by Race/Ethnicity, United States, 2006.  In 2006, 83% of all reported TB cases 
occurred in racial and ethnic minorities (30% in Hispanics, 27% in non-Hispanic blacks or African-Ameri-
cans, 24% in Asians, 1% in American Indians or Alaska Natives, and  <1% in Native Hawaiians or Other 
Pacifi c Islanders), whereas 17% of cases occurred in non-Hispanic whites.  Persons reporting two or more 
races totaled less than 1% of all cases.  This is the third year that Hispanics have constituted the single largest 
percentage of TB cases among all racial/ethnic groups. 
Slide 10. TB Case Rates by Age Group and Race/Ethnicity, United States, 2006.   This slide presents TB 
rates in 2006 by age group and race/ethnicity.  Risk increased with age across racial and ethnic groups, and 
rates were consistently higher in minority racial and ethnic groups than in non-Hispanic whites.  Rates were 
the highest in Asians and Native Hawaiians and Other Pacifi c Islanders, particularly in adult age groups.  The 
impact of foreign birth is a consideration in interpreting rate variations by race/ethnicity.  For example, 96% 
of cases in the Asian group occurred in foreign-born persons, compared with 75% of cases in Hispanics and 
30% of cases in non-Hispanic blacks or African-Americans.  Persons reporting two or more races totaled less 
than 1% of all cases.
Slide 11. Number of TB Cases in U.S.-born vs. Foreign-born Persons, United States, 1993–2006.  This 
graph plots the number of U.S.-born vs. foreign-born persons reported with TB each year, from 1993 through 
2006.  It illustrates the increase in the percentage of cases occurring in foreign-born persons during this 
period, from 29% in 1993 to 57% in 2006.  Overall, the number of cases in foreign-born persons remained 
virtually level, with approximately 7,000–8,000 cases each year, whereas the number in U.S.-born persons 
decreased from more than 17,000 in 1993 to less than 6,000 in 2006.
Slide 12. Trends in TB Cases in Foreign-born Persons, United States, 1986–2006.  This slide shows trends 
in TB cases in foreign-born persons in the United States from 1986, when information on country of birth was 
fi rst reported by all areas submitting reports to CDC, through 2006.  The number of TB cases in foreign-born 
persons increased from nearly 5,000 in 1986 to 7,000–8,000 each year since 1991.  The percentage of TB 
cases accounted for by foreign-born persons increased from 22% in 1986 to 57% in 2006.
Slide 13.  Reported TB Cases by Origin and Race/Ethnicity, United States, 2006.  Among U.S.-born 
persons with TB in 2006, 44% were non-Hispanic black or African-American, 33% were non-Hispanic white, 
17% were Hispanic or Latino, 3% were American Indian or Alaska Native, 2% were Asian, and <1% were 
Native Hawaiian or Other Pacifi c Islander.  Among the foreign-born, 40% were Asian, 39% were Hispanic or 
Latino, 14% were non-Hispanic black or African-American, and 5% were non-Hispanic white.  Cases among 
American Indians or Alaska Natives and among Native Hawaiians or Other Pacifi c Islanders constituted less 
than 1%, respectively, of the cases among the foreign-born and are not shown.  Persons reporting two or more 
races totaled less than 1% of all cases. 
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Slide 14.  Percentage of TB Cases Among Foreign-born Persons, United States, 1996 and 2006.  The 
percentage range of the total number of TB cases that occurred in foreign-born persons in each state is high-
lighted for 1996 and 2006 in these side-by-side maps.  The number of states with at least 50% of cases in the 
foreign-born increased from nine in 1996 to 27 in 2006. The number of states with at least 70% of cases in the 
foreign-born increased from two (HI and VT) in 1996 to eleven (CA, HI, IA, MA, MN, NE, NH, NJ, NY, RI 
and WA) in 2006 (not shown on slide). 
Slide 15. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2006.  TB rates in 
foreign-born persons remain higher than those in the U.S.-born population.  From 1993 through 2006, the 
rates in U.S.-born persons decreased from 7.4 per 100,000 to 2.3, whereas the rates in foreign-born persons 
decreased from 34.0 per 100,000 to 22.0.
Slide 16. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2006.  This is the 
same as Slide 15, but the rates are presented on a logarithmic scale to better illustrate the trend in TB rates 
among the U.S.-born and foreign-born. The lines show a greater rate of decline among the U.S.-born com-
pared with the foreign-born during this period.
Slide 17. Countries of Birth of Foreign-born Persons Reported with TB, United States, 2006.  This slide 
shows the overall distribution of the countries of birth of foreign-born persons reported with TB in 2006, with 
the top seven highlighted.  The list of countries has remained relatively constant since 1986, when information 
on country of birth was fi rst reported by all areas submitting reports to CDC.  However, for 2006, Guatemala 
replaced South Korea in the list of countries contributing the highest percentages of foreign-born patients.
The seven top countries accounted for 62% of the total, with Mexico accounting for 25%; the Philippines, 
11%; Viet Nam, 8%; India, 7%; China, 5%; Haiti, 3%; and Guatemala, 3%.  Persons from more than 135 
other countries each accounted for 2% or less of the total, but altogether accounted for 38% of foreign-born 
persons reported with TB.
Slide 18. Percent of Foreign-born with TB by Time of Residence in U.S. Prior to Diagnosis, 2006.  The 
length of U.S. residence among foreign-born persons prior to their TB diagnosis in 2006 is shown in these 
stacked bars.  Overall, 21% had been in the United States for less than 1 year, 23% between 1 and 4 years, 
and 56% for at least 5 years.  The distribution is also shown for the top three countries of birth: Mexico, the 
Philippines, and Viet Nam.  Among persons born in Mexico, 17% had been in the United States for less than 
1 year, 22% between 1 and 4 years, and 61% for at least 5 years. Among persons born in the Philippines, 26% 
had been in the United States for less than 1 year, 18% between 1 and 4 years, and 56% for at least 5 years.  
Among persons born in Viet Nam, 24% had been in the United States for less than 1 year, 14% between 1 and 
4 years, and 62% for at least 5 years.
Slide 19. Primary Anti-TB Drug Resistance, United States, 1993–2006.  Primary drug resistance is shown 
for the past 13 years.  The graph starts in 1993, the year in which the individual TB case reports submitted to 
the national surveillance system began collecting information on initial susceptibility test results for patients 
with culture-positive TB.  Data were available for more than 85% of culture-positive cases for each year.  
Primary resistance was calculated by using data from persons with no reported prior TB episode. Resistance 
to at least isoniazid remained between 7.0% and 8.4%.  However, resistance to at least isoniazid and rifampin, 
known as multidrug-resistant TB (MDR TB), decreased from 2.4% in 1993 to 1.1% in 1997, and remained at 
approximately 1 % up to and including 2006.
Slide 20. Primary MDR TB, United States, 1993–2006.  This graph focuses on trends in primary MDR TB 
(based on initial isolates from persons with no prior history of TB) in the United States from 1993 through 
2006.  The number of MDR TB cases, represented by bars, steadily declined from 410 in 1993 to 116 in 2001. 
Since then the total number of MDR TB cases has fl uctuated from 91 to 126 cases, with 91 cases reported for 
2006.  Primary MDR TB, shown by the line, decreased from 2.4% in 1993 to approximately 1.1% in 1997, 
and remained approximately at 1% up to and including 2006.
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Slide 21.  Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States, 1993–
2006.  This graph shows primary isoniazid resistance in U.S.-born vs. foreign-born persons.  Based on initial 
isolates from persons with no prior history of TB, the percentage of isoniazid resistance was approximately 
two times higher among foreign-born persons than among U.S.-born persons.  In foreign-born persons, the 
percentage declined from 12.3% in 1993 to 10.2% in 2006.  In U.S.-born persons, the percentage decreased 
from 6.8% in 1993 to 4.3% in 2006. 
Slide 22.  Primary MDR TB in U.S.-born vs. Foreign-born Persons, United States, 1993–2006.  This 
graph highlights primary MDR TB in U.S.-born versus foreign-born persons.  The percentage with primary 
MDR TB has declined among both groups, although the decline in the U.S.-born has been greater.  As a result, 
the proportion of primary MDR TB cases reported in foreign-born persons increased from approximately 
26% of all MDR TB cases in 1993 to approximately 73% of all MDR TB cases in 1999, and continued at this 
proportion through 2006 (not shown on slide).  Among the U.S.-born, the percentage with MDR TB remained 
between 0.5% and 0.7% from 1998 through 2004 and dropped to 0.4% in 2005.  The percentage among for-
eign-born persons has fl uctuated year by year, while averaging approximately 1.4% from 1998 through 2006.
Slide 23. Extensively Drug Resistant (XDR) TB, as Defi ned on Initial Drug Susceptibility Testing (DST), 
United States, 1993–2006. This graph shows the annual number of counted XDR TB cases as defi ned on 
initial DST from 1993–2006, reported as of July 18, 2007. Three XDR TB cases were reported in 2006. The 
most reported in a single year was 10 in 1993, while there were no cases reported in 2000 and 2003. There is 
no apparent trend in the number of cases over time. 
Slide 24. Reporting of HIV Test Results in Persons with TB by Age Group, United States, 1993–2005. 
This slide shows the completeness of reporting of HIV test results in persons with TB by age group from 1993 
through 2005.  The percentage of TB patients for whom test results were reported increased from 30% among 
all ages in 1993 to 57% in 2005, the latest year with available data.  Among adults aged 25–44 years, the 
percentage increased from 46% to 67% in 2005.  The numerator includes TB patients with positive, negative, 
or indeterminate HIV test results, and persons from California reported with AIDS (HIV test results are not 
reported to CDC from California).
Slide 25. Estimated HIV Coinfection in Persons Reported with TB, United States, 1993–2005.  This slide 
provides minimum estimates of HIV coinfection among persons reported with TB from 1993 through 2005, 
the latest year with available data.  Since the addition of the request for HIV status to the individual TB case 
report in 1993, incomplete reporting has provided a challenge to calculating reliable estimates.  Results from 
the cross-matching of TB and AIDS registries have been used to supplement reported HIV test results.  For 
all ages, the estimated percentage of HIV coinfection in persons reported with TB decreased from 15% to 7% 
overall and from 29% to 13% in persons aged 25 to 44 years during this period. 
Slide 26. Mode of Treatment Administration in Persons Reported with TB, United States, 1993–2004.
In 1993, the reporting areas began providing information about mode of treatment administration on the indi-
vidual TB case report form.  Treatment administered as only directly observed therapy (DOT) increased from 
21% in 1993 to 57% in 2004, the latest year with available data.  There was also an increase in the proportion 
of patients who received at least some portion of their treatment as DOT (based on combining the percentage 
of patients who received only DOT and the percentage for whom some portion was self-administered).  In 
2004, 84% of patients received at least some portion of their treatment as DOT.
Slide 27. Completion of TB Therapy, United States, 1993–2004.  The reporting areas began providing 
information on completion of therapy in 1993 through the individual TB case report form.  The calculations 
exclude patients with an initial isolate resistant to rifampin as well as children with meningeal, bone or joint, 
or miliary disease.  Overall completion of therapy has remained at approximately 92% from 1998 through 
2004. Completion in 1 year or less increased from 64% in 1993 to approximately 82% in 1998—2004, the 
latest year with available data.  The current DHHS Healthy People 2010 objective is completion of therapy in 
1 year or less in 90% of patients.  CDC is working with state and local health departments to determine and 
evaluate reasons for apparently delayed completion of therapy, which may vary by jurisdiction.
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Tuberculosis Case Defi nition for Public Health Surveillance1
Tuberculosis (Revised 9/96)
Clinical description
A chronic bacterial infection caused by Mycobacterium tuberculosis, characterized pathologically by 
the formation of granulomas. The most common site of infection is the lung, but other organs may be 
involved.
Clinical case defi nition
A case that meets all of the following criteria:
• A positive tuberculin skin test result; and
• Other signs and symptoms compatible with tuberculosis, such as an abnormal, unstable (i.e., 
worsening or improving) chest radiograph, or clinical evidence of current disease; and
• Treatment with two or more antituberculosis medications; and
• A completed diagnostic evaluation.
Laboratory criteria for diagnosis
• Isolation of M. tuberculosis from a clinical specimen,* or
• Demonstration of M. tuberculosis from a clinical specimen by nucleic acid amplifi cation test,† or
• Demonstration of acid-fast bacilli in a clinical specimen when a culture has not been or cannot be 
obtained
Case classifi cation
Confi rmed:  a case that meets the clinical case defi nition or is laboratory confi rmed
Comment
Only one case should be counted in a person within any consecutive 12-month period. However, a 
case in a patient who had previously had verifi ed disease should be reported again if more than 12 
months have elapsed since the patient was discharged from treatment. A case should also be re-
ported again if the patient was lost to supervision for >12 months and disease can be verifi ed again. 
Mycobacterial diseases other than those caused by M. tuberculosis complex should not be counted 
in tuberculosis morbidity statistics unless there is concurrent tuberculosis.
1CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(No. RR-10):40- 
41.
*Use of rapid identifi cation techniques for M. tuberculosis (e.g., DNA probes and mycolic acid 
high-pressure liquid chromatography performed on a culture from a clinical specimen) are accept-
able under this criterion.
†Nucleic acid amplifi cation (NAA) tests must be accompanied by culture for mycobacteria species. 
However, for surveillance purposes, CDC will accept results obtained from NAA tests approved by 
the Food and Drug Administration (FDA) and used according to the approved product labeling on 
the package insert.
Appendix A
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Appendix B
Recommendations for Counting Reported Tuberculosis Cases
(Revised July 1997)
Since publication of the “Recommendations for Counting Reported Tuberculosis Cases”1 in 
January 1977, numerous changes have occurred and many issues have been raised within the 
fi eld of tuberculosis (TB) surveillance.  This current version updates and supersedes the previous 
version; it clarifi es the parameters for counting TB cases among (a) immigrants, resident aliens, 
and border crossers, (b) military personnel stationed in the United States and abroad, and (c) 
persons diagnosed within the Indian Health Service and correctional facilities.
A distinction should be made between reporting TB cases to a health department and counting
TB cases for determining incidence of disease.  Throughout each year, TB cases and suspected 
cases are reported to public health authorities by sources such as clinics, hospitals, laboratories, 
and health care providers.  From these reports, the state or local TB control offi cer must deter-
mine which cases meet the current surveillance defi nition for TB disease.  These verifi ed TB 
cases are then counted and reported to the Centers for Disease Control and Prevention (CDC).
I. Reporting TB Cases. CDC recommends that health care providers and laboratories be 
required to report all TB cases or suspected cases to state and local health departments 
based on the current “Case Defi nition for Public Health Surveillance.”2 This notifi cation 
is essential in order for TB programs to
• Ensure case supervision,
• Ensure completion of appropriate therapy,
• Ensure completion of timely contact investigations,
• Evaluate program effectiveness, and
• Assess trends and characteristics of TB morbidity.
II. TB Surveillance. For purposes of surveillance, a case of TB is defi ned on the basis of   
 laboratory and/or clinical evidence of active disease due to M. tuberculosis complex.*
________________________________
* Because most laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis from very closely 
related species, these laboratories report culture results as being positive or negative for “Mycobacterium tuberculo-
sis complex.” Although in almost all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M.
tuberculosis, other species are possible. For example, one study in San Diego found that 6% of human tuberculosis was 
caused by Mycobacterium bovis; cultures from these cases would be reported by most laboratories as being positive for 
M. tuberculosis complex. Other species in the Mycobacterium tuberculosis complex include M. africanum, M. microti, 
M. canetii, M. caprae, and M. pinnipedii. Although M.  microti , M. canetii , M. caprae, and M. pinnipedii are newly 
described species, their inclusion in M. tuberculosis complex should not impact public health laboratories or programs 
because only a few laboratories identify to the species level. These seven species are almost identical in DNA homology 
studies. In terms of their ability to cause clinical disease and be transmissible from person to person, M. bovis, M. afri-
canum, M. microti, and M. canetti behave like M. tuberculosis; therefore, disease caused by any of the organisms should 
be reported as TB, using the Report of Verifi ed Case of Tuberculosis (RVCT). The only exception is the BCG strain of 
M. bovis, which may be isolated from persons who have received the vaccine for protection against TB or as cancer 
immunotherapy; disease caused by the BCG strain of M. bovis should not be reported as TB because the transmission is 
iatrogenic (treatment-induced), rather than person-to-person or communicable.
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a. Laboratory Case Defi nition
• Isolation of M. tuberculosis complex from a clinical specimen.  The use of rapid identi-
fi cation techniques for M. tuberculosis performed on a culture from a clinical specimen, 
such as DNA probes and high-pressure liquid chromatography (HPLC), is acceptable 
under this criterion.
OR
• Demonstration of M. tuberculosis from a clinical specimen by nucleic acid amplifi ca-
tion (NAA) test.  NAA tests must be accompanied by cultures of mycobacterial species.  
However, for surveillance purposes, CDC will accept results obtained from NAA tests 
that are approved by the Food and Drug Administration (FDA).  
OR
• Demonstration of acid-fast bacilli (AFB) in a clinical specimen when a culture has not 
been or cannot be obtained; historically this criterion has been most commonly used to 
diagnose TB in the postmortem setting.  
b. Clinical Case Defi nition. In the absence of laboratory confi rmation of M. tuberculosis com-
plex after a diagnostic process has been completed, persons must have all of the following 
criteria for clinical TB:
• Evidence of TB infection based on a positive tuberculin skin test result
AND
• One of the following:
(1) Signs and symptoms compatible with current TB disease, such as an abnormal, 
unstable (worsening or improving) chest radiograph, or
(2) Clinical evidence of current disease (e.g., fever, night sweats, cough, weight 
loss, hemoptysis)
AND
• Current treatment with two or more anti-TB medications 
NOTE: The case defi nition described herein was developed for use in this document and is not intended 
to replace the case defi nition for TB as stated in the current “Case Defi nitions for Infectious Conditions 
Under Public Health Surveillance.”
In addition, the software for TB surveillance developed by CDC includes a calculated variable called “Ver-
crit,” for which one of the values is “Provider Diagnosis.”  “Provider Diagnosis” is selected when the user 
chooses to override a “Suspect” default value in the case verifi cation screen as “Verifi ed by Provider Diag-
nosis.”  Thus, “Provider Diagnosis” is not a component of the case defi nition for TB in the current “Case 
Defi nitions for Infectious Conditions Under Public Health Surveillance” publication.  CDC’s national mor-
bidity reports have traditionally included all cases that are considered verifi ed by the reporting areas, without 
a requirement that cases meet the published case defi nition.
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III. Counting TB Cases. Cases that meet the current CDC surveillance case defi nition for 
verifi ed TB are counted by 52 reporting areas with count authority (50 states, District of 
Columbia, and New York City) to determine annual incidence for the United States.  The 
remaining 7 reporting areas (American Samoa, Federated States of Micronesia, Guam, 
Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands) report 
cases to CDC, but are not included in the annual incidence for the United States. The 
laboratory and clinical case defi nitions are the two diagnostic categories used by the CDC 
“Case Defi nitions for Infectious Conditions Under Public Health Surveillance.”
Most verifi ed TB cases are accepted for counting based on laboratory confi rmation 
of M. tuberculosis complex from a clinical specimen.
A person may have more than one discrete (separate and distinct) episode of TB.  
If disease recurs in a person within any 12-consecutive-month period, count only 
one episode as a case for that year.  However, if TB disease recurs in a person, and
if more than 12 months have elapsed since the person was discharged from or lost 
to supervision, the TB is considered a separate episode and should be counted as a 
new case. Note: Discharged from supervision implies completion of therapy.  
Mycobacterial diseases other than those caused by M. tuberculosis complex should 
not be counted in TB morbidity statistics unless there is concurrent TB. 
a. Verifi ed TB Cases
COUNT
Count only verifi ed TB cases that meet the laboratory or clinical case defi nitions 
(see Section II).  The diagnosis of TB must be verifi ed by the TB control offi cer 
or designee.  The current CDC surveillance case defi nition for TB describes and 
defi nes the criteria to be used in the case defi nition for TB disease. 
DO NOT COUNT
If diagnostic procedures have not been completed, do not count; wait for confi rma-
tion of disease.  Do not count a case for which two or more anti-TB medications 
have been prescribed for preventive therapy for exposure to multidrug- resistant 
(MDR) TB, or while the diagnosis is still pending.
b. Nontuberculous Mycobacterial Diseases (NTM)
COUNT
An episode of TB disease diagnosed concurrently with another nontuberculous my-
cobacterial disease should be counted as a TB case.
DO NOT COUNT
Disease attributed to or caused by nontuberculous mycobacteria alone should not be 
counted as a TB case.
c. TB Cases Reported at Death
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COUNT
TB cases fi rst reported to the health department at the time of a person’s death are 
counted as incident cases, provided the person had current disease at the time of 
death.  The TB control offi cer should verify the diagnosis of TB.
DO NOT COUNT
Do not count as a case of TB if there is no evidence of current disease at the time of 
death or at autopsy.
d. Immigrants, Refugees, Permanent Resident Aliens, Border Crossers,* and Foreign Visi-
tors3
COUNT
Immigrants and refugees who have been screened overseas for TB and
• have been classifi ed as Class B (B1, B2, or B3)4 or resident aliens,
• are not already on anti-TB medications for treatment of TB disease, and
• are examined after arriving in the United States and diagnosed with clini-
cally active TB requiring anti-TB medications,
• should be counted by the locality of their current residence at the time of 
diagnosis regardless of citizenship status.
Border crossers* and permanent resident aliens who are diagnosed with TB and 
plan to receive anti-TB therapy from a locality in the United States for 90 days or 
more should be counted by the locality where they receive anti-TB therapy.
Foreign visitors (e.g., students, commercial representatives, and diplomatic person-
nel) who are diagnosed with TB, are receiving anti-TB therapy, and plan to remain 
in the United States for 90 days or more should be counted by the locality of current 
residence.
*Border crosser — defi ned, in part, by the U.S. Citizenship and  Immigration 
Services (USCIS)3  as “a nonresident alien entering the United States across the 
Mexican border for stays of no more than 72 hours.”  Border crossers may go back 
and forth across the border many times in a short period.
DO NOT COUNT
TB cases in immigrants or refugees who have been classifi ed as Class A with a 
waiver (TB, Infectious, Noncommunicable for travel purposes)4 should not be 
counted as new cases even if the persons receive routine initial work-ups in the 
United States.  TB in persons who are temporarily (<90 days) in the United States, 
for whom therapy may have been started but who plan to return to their native 
country to continue therapy, should not be counted in the United States.
e. Out-of-State or Out-of-Area Residents 
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COUNT
A person’s TB case should be counted by the locality in which he or she resides at 
the time of diagnosis.  TB in a person who has no address should be counted by the 
locality that diagnosed and is treating the TB.  The TB control offi cer should notify 
the appropriate out-of-state or out-of-area TB control offi cer of the person’s home 
locality to (1) determine whether the case has already been counted to avoid “dou-
ble counting,” and (2) agree on which TB control offi ce should count the case if it 
has not yet been counted. 
DO NOT COUNT 
Do not count a case in a newly diagnosed TB patient who is an out-of-area resident 
and whose TB has already been counted by the out-of-area TB control offi ce.
f. Migrants and Other Transients
COUNT
Persons without any fi xed U.S. residence are considered to be the public health 
responsibility of their present locality and their TB case should be reported and 
counted where diagnosed.
DO NOT COUNT
Cases in transient TB patients should not be counted when there is evidence that 
they have already been counted by another locality.
g. Federal Facilities (e.g., Military and Veterans Administration Facilities)
COUNT
Cases in military personnel, dependents, or veterans should be reported and counted 
by the locality where the persons are residing in the United States at the time of 
diagnosis and initiation of treatment.
However, if military personnel or dependents are discovered to have TB at a mili-
tary base outside the United States but are referred elsewhere for treatment (e.g., a 
military base located within the United States), the TB case should be reported and 
counted where treated and not where the diagnosis was made.
DO NOT COUNT
Do not count if the case was already counted by another locality in the United 
States.
h. Indian Health Service
COUNT
TB should be reported to the local health authority (e.g., state or county) and count-
ed where diagnosed and treatment initiated.  However, for a specifi c group such as 
the Navajo Nation, which is geographically located in multiple states, health depart-
ments should discuss each case and determine which locality should count the case.
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DO NOT COUNT
Do not count if the case was already counted by another locality.
i. Correctional Facilities (e.g., Local, State, Federal, and Military)
COUNT
Persons who reside in local, state, federal, or military correctional facilities may 
frequently be transferred or relocated within and/or between various correctional 
facilities. TB in these persons should be reported to the local health authority and 
counted by the locality where the diagnosis was made and treatment plans were 
initiated.
DO NOT COUNT
Do not count correctional facility residents’ TB cases that were counted elsewhere 
by another locality or correctional facility, even if treatment continues at another 
locale or correctional facility.
j. Peace Corps, Missionaries, and Other Citizens Residing Outside the United States
DO NOT COUNT
TB in persons diagnosed outside the United States should not be counted.  TB in 
these persons should be counted by the country in which they are residing regard-
less of their plans to return to the United States for further work-up or treatment.
IV. Suggested Administrative Practices
To promote uniformity in TB case counting, the following administrative procedures 
are recommended:
(a) All TB cases verifi ed by the 52 reporting areas with count authority (50 states, District 
of Columbia, and New York City) during the calendar year (by December 31) will be 
included in the annual U.S. incidence count for that year.  All tuberculosis cases verifi ed 
during the calendar year by a reporting area with count authority from one of the remain-
ing 7 reporting areas (American Samoa, Federated States of Micronesia, Guam, Northern 
Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands) are also count-
ed but are not included in the annual incidence for the United States.  Cases for which 
bacteriologic results are pending or for which confi rmation of disease is questionable 
for any other reason should not be counted until their status is clearly determined; they 
should be counted at the time they meet the criteria for counting.  This means that a case 
reported in one calendar year could be included in the morbidity count for the follow-
ing year.  The reporting area with count authority should ensure that there is agreement 
between fi nal local and state TB fi gures reported to CDC. Currently, some reporting areas 
may not use this suggested protocol.  Some of these areas may wait until the beginning of 
the following year when they have received and processed all of the TB cases for inclu-
sion in the annual case count for the previous year.  If reporting areas decide to revise 
their protocols, they should be aware that their TB trends may change.
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(b) TB is occasionally reported to health departments over the telephone, by letter or fax, or 
on forms other than the Report of Verifi ed Case of Tuberculosis (RVCT).  Such informa-
tion should be accepted as an offi cial morbidity report if suffi cient details are provided; 
otherwise, the notifi cation should be used as an indicator of a possible TB case (suspect) 
which should be investigated promptly for confi rmation.
V. TB Surveillance Defi nitions
Case - an episode of TB disease in a person meeting the laboratory or clinical cri-
teria for TB as defi ned in the document “Case Defi nitions for Infectious Conditions 
Under Public Health Surveillance”2 (see Section II for criteria).
Suspect - a person for whom there is a high index of suspicion for active TB (e.g., 
a known contact to an active TB case or a person with signs or symptoms consistent 
with TB) who is currently under evaluation for TB disease.
Verifi cation of a TB case - the process whereby a TB case, after the diagnostic 
evaluation is complete, is reviewed at the local level (e.g., state or county) by a TB 
control offi cial who is familiar with TB surveillance defi nitions; if all the criteria for 
a TB case are met, the TB case is then verifi ed and eligible for counting. 
Counting of a TB case - the process whereby a reporting area with count author-
ity evaluates verifi ed TB cases (e.g., assesses for case duplication).  These cases 
are then counted for morbidity in that locality (e.g., state or county) and reported to 
CDC for national morbidity counting.
Mycobacterium tuberculosis complex (M. tuberculosis complex) - Because most 
laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis
from very closely related species, these laboratories report culture results as being 
positive or negative for “Mycobacterium tuberculosis complex.” Although in almost 
all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M.
tuberculosis, other species are possible. For example, one study in San Diego found 
that 6% of human tuberculosis was caused by Mycobacterium bovis; cultures from 
these cases would be reported by most laboratories as being positive for M. tuber-
culosis complex. Other species in the Mycobacterium tuberculosis complex include
M. africanum, M. microti, M. canetii, M. caprae, and M. pinnipedii. Although M.
microti , M. canetii , M. caprae, and M. pinnipedii are newly described species, 
their inclusion in M. tuberculosis complex should not impact public health laborato-
ries or programs because only a few laboratories identify to the species level. These 
seven species are almost identical in DNA homology studies. In terms of their abil-
ity to cause clinical disease and be transmissible from person to person, M. bovis,
M. africanum, M. microti, and M. canetti behave like M. tuberculosis; therefore, 
disease caused by any of the organisms should be reported as TB, using the Report 
of Verifi ed Case of Tuberculosis (RVCT). The only exception is the BCG strain of 
M. bovis, which may be isolated from persons who have received the vaccine for 
protection against TB or as cancer immunotherapy; disease caused by the BCG 
127
strain of M. bovis should not be reported as TB because the transmission is iatro-
genic (treatment-induced), rather than person-to-person or communicable.
Nontuberculous mycobacteria (NTM) - mycobacteria other than Mycobacterium
tuberculosis complex that can cause human infection or disease.  Common nontu-
berculous mycobacteria include M. avium complex or MAC (M. avium, M. intracel-
lulare), M. kansasii, M. marinum, M. scrofulaceum, M. chelonae, M. fortuitum, and 
M. simiae.  Other terms have been used to represent NTM, including MOTT (myco-
bacteria other than TB) and “atypical” mycobacteria.
Reporting area - areas responsible for counting and reporting verifi ed TB cases to 
CDC.  Currently there are 60 reporting areas: the 50 states, District of Columbia, 
New York City, American Samoa, Federated States of Micronesia, Guam, Northern 
Mariana Islands, Marshall Islands, Puerto Rico, Republic of Palau, and U.S. Virgin 
Islands.  The annual incidence of tuberculosis for the United States is based on 52 
reporting areas (the 50 states, District of Columbia, and New York City).
Alien - defi ned by the U.S. Citizenship and Immigration Services (USCIS)3  as 
“any person not a citizen or national of the United States.”
Border crosser - defi ned, in part, by the USCIS3 as “a nonresident alien entering 
the United States across the Mexican border for stays of no more than 72 hours.”
Border crossers may go back and forth across the border many times in a short 
period.
No TB Classifi cation - Applicants with normal tuberculosis screening examina-
tions.
Class A TB with waiver - All applicants who have tuberculosis disease and have 
been granted a waiver.
Class B1 TB, Pulmonary - 
No treatment
• Applicants who have medical history, physical exam, HIV, or CXR fi ndings 
suggestive of pulmonary tuberculosis but have negative AFB sputum smears 
and cultures and are not diagnosed with tuberculosis or can wait to have 
tuberculosis treatment started after immigration.
Completed treatment
• Applicants who were diagnosed with pulmonary tuberculosis and success-
fully completed directly observed therapy prior to immigration. The cover 
sheet should indicate if the initial sputum smears and cultures were positive 
and if drug susceptibility testing results are available.
Class B1 TB, Extrapulmonary - Applicants with evidence of extrapulmonary 
tuberculosis. Document the anatomic site of infection.
128
Class B2 TB, LTBI Evaluation - Applicants who have a tuberculin skin test 10
mm but otherwise have a negative evaluation for tuberculosis. The size of the TST 
reaction, the applicant’s status with respect to LTBI treatment, and the medication(s) 
used should be documented. For applicants who had more than one TST, whether 
the applicant converted the TST should be documented (i.e., initial TST <10 mm 
but subsequent TST 10 mm).
Class B3 TB, Contact Evaluation - Applicants who are a recent contact of a 
known tuberculosis case. The size of the applicant’s TST reaction should be docu-
mented. Information about the source case, name, alien number, relationship to 
contact, and type of tuberculosis should also be documented.
Immigrant - defi ned by the USCIS3  as “an alien admitted to the United States as 
a lawful permanent resident.  Immigrants are those persons lawfully accorded the 
privilege of residing permanently in the United States.  They may be issued immi-
grant visas by the Department of State overseas or adjusted to permanent resident 
status by the USCIS of the United States.”
Permanent Resident Alien - see Immigrant. 
Waivers - A provision allows applicants undergoing pulmonary or laryngeal tuber-
culosis treatment to petition for a Class A waiver. Waivers should be pursued for 
any immigrant or refugee who has a complicated clinical course and would benefi t 
from receiving treatment of their tuberculosis in the United States. Applicants diag-
nosed with tuberculosis disease who are both smear- and culture-negative and will 
be traveling to the United States prior to start of treatment do not need to complete 
the waiver process.
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1. Reference to details of FDA-approved labeling for NAA (IIa) was deleted from this 
document in September 2002.
2. A note of clarifi cation was added to Section III, Counting TB Cases, in September 
2003.
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